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ABSTUACT
LIPID ALDEHYDES ARE SUBSTRATES AND TRANSCRIPTIONAL
REGULATORS OF CYTOCHROMES P450
Immaculate Amunom
May 10,2008

4-hydroxy-2-nonenal (4-HNE) and propene-2-al (acrolein) are highly reactive
a,~-unsaturated

aldehydes. 4-HNE and acrolein are generated ill vivo as products oj' lipid

peroxidation. These aldehydes are implicated in the onset of several diseases including
atherosclerosis and neurodegenerative disease. They also react with nucleophilic cellular
macromolecules including proteins, DNA and phospholipids. Some of these reactions in
l'ivo lead to inhibition of enzyme activities, depletion of glutathione and oxicbti\l' stress.

Because of their pathophysiological relevance, attention has focused during the last
decade on the ability of mammals to metabolize these lipid aldehydes.
The purpose of this study was therefore to determine the rok of cytochro!1l~
P450s in the metabolism of lipid aldehydes and how exposure to lipid aldehydes
influences the regulation of the expression of xenobiotic metabolizing enzymes.
Cytochrome P450s are a superfamily of heme proteins that catalyze the NADPH and Chdependent monooxygenation of a wide variety of compounds. [n addition. P450s arc
capable of catalyzing the biosynthesis of several molecules including the synthesis of
sterols, fatty acids, and eicosanoids. In this study used a fluorescence spectroscopy and
high performance lipid chromatography technique, coupled with mass spectrometry to
demonstrate that CYPs metabolize lipid aldehydes. This metabolism invol\'es

Vl

monooxygenation by mouse, rat and human P450s, of 4-HNE to 4-hydroxynom:nnic acid
and the reduction of 4-HNE to 1,4-dihydroxynonene by specific P450s. By using general
and specific P450 inhibitors, we have determined that hepatic P450s differentially
contribute to 4-HNE metabolism. While Cyp2c29 catalyzes oxidative metabolism. Cyp~,a
predominantly catalyzes the reduction of 4-HNE.
We demonstrated by microarray analysis and quantitative real-time peR that
expression of Cyp2c29, Cyp2c37 and Cyp3a25 is induced by acrolein and hutylatcc!
hydroxyanisole, both activators of AP-l in mouse liver. These P450s include Cyp2.:29.
Cyp2a5 and CyplA2. BHA and acrolein also induced other xenobiotic mdabolil'ing
enzymes such as GSTml, heme oxygenase-l and NADHP quinone oxidoreductase
Certain transcription factors function to regulate gene expression in response to
xcnobiotic challenge. Lipid aldehydes in particular regulate gene expression through the
action of two transcription factors, namely AP-l and Nrf2. We determined that Cyp2L'2(j
is regulated by activator protein I (AP-I) transcription factor. Nrl2 was nut invohd

ill

the induction of Cyp2c29 expression. The results from this study show that there is lipid
aldehyde-dependent regulation of P450 gene expression. The induced Cyp2c29 goes

Ol1

to metabolize substrate in a manner reminiscent of a self-regulatory loop nf hiolog:eai
activity.
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CHAPTER I
INTRODUCTION

Peroxidation of co-6 polyunsaturated fatty acids proceeds by a free-radical chain
reaction mechanism that yields lipid hydroperoxides as a major initial product.
Subsequently, decomposition of the lipid hydroperoxides generates reactive lipid
aldehydes such as malondialdehyde, glyoxal, propene-2-al, 4-hydrcxy-2-mm.:naL and ,]oxo-2-nonenal (Uchida, 2003). Plants also produce lipid aldehydes. Ihms-2-hcxenaJ is a
plant aldehyde. It occurs in green plants as a product of oxidative degradation of plant
lipids (Visser et aI., 1979). Studies have shown that trans-2-hexenal and other plant
alLlchydes can be active as host plant attractants (Visser et 0/., 197R), as enhatlCcrs ,)1'
other host plant odors (Guerin et 01., 1988), indicators of fruit ripeness (Engel ('/ ui ..
1(88) llr defensive secretions (Neri el al., 2005). Two very important lipid aldehydes to
which humans are exposed are propene-2-al (Beauchamp et 01., 1985) and 4-hydroxy-2t10nenal. They form the bulk of reactive endogenous lipid aldehydes characterized in l'im
to date and are implicated in a series of pathological conditions including atherosclcn,sis
and Parkinson's disease (Pauli and Shaur, 20(0).

4-IIVDROXY-2- NONENAL (4-HNE)
4-HNE is a long-chain u, ~-unsaturated aldehyde. It has 9 em-bon atoms. in,,'luTng
a carbonyl group and a 4-hydroxy group (Figure lA). Initially discovered by Bcnedetti

e(

al. (1980) during the investigation of lipid peroxidation by liver microsomes. 4-H NE has
subsequently been shown to be formed predominantly from the peroxidation of the

(1)-6

polyunsaturated fatty acids linoleic acid and arachidonic acid (Schneider e/ al .. 2001 ). 4HNE is the most abundant and cytotoxic lipid aldehyde described to date (Esterbauer c/

aI., 1991 and Uchida, 2003). Lipid peroxidation resulting in the production of'l-IINF

IS

a direct consequence of oxidative stress. Sies (1991) described oxidative stress as an
imbalance between oxidants and antioxidants, potentially leading to damage. Unde,'
physiological conditions, the cellular concentration of 4-HNE ranges 6'0111 0.1 plVl I,) :1
~lM.

However, under oxidative stress conditions in vitro, 4-HNE may

aCCllll111btc

to

higher concentrations from 10 11M to 5 mM (Esterbaucr et 01., 1991: Uchida. 2()Ol).
Several mechanisms have been put forward to explain the mechanism

0

r :l-IIN I·.

formation. The most recent mechanism established by Schneider (20() 1) uti li;/ed the ()~nd

13-hydroperoxides oflinoleic acid as starting material. Following two distinct

pathways (Figure 1B), 4-hydroperoxy-2E-nonenal is generated and subsequently
converted to 4-HNE.

PROPENE-2-AL (ACROLEIN)
Acrolein. ~ike 4-HNE, is an CJ..~-unsaturated aldehyde. It is co~orless. voiatik ,mel
soluble in water, ethanol and diethyl ether (WHO 1992). Acrolein is a three-carbon
compound with two reactive sites: a carbon-carbon double bond and a terminal carhollyl
group (Figure lA). Acrolein was first isolated from dry distillation Ofi~lts ill 1843 by
Redtenbacher (Beauchamp et aZ., 1985 review). Since then, several other sources have
been discovered. For example, acrolein is a lipid peroxidation product formed li'om

2
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Metal-catalyzed catalyzed oxidation of arachidonic acid (Uchida ct a/., 19(8). In addition
to lipid peroxidation. acrolein is a by-product of over-heating organic matter and occurs
as an ubiquitous pollutant in the environment, for example, incomplete combustion 01"
plastic materials, cigarette smoke, and over-heating of frying oils (Beauchamp

eI

01.

1(88). 1\ recent study determined the amount of acrolein in a single putT of cigarette

smoke to range from l.6 - 22

~lg/cigarette

depending on the carbon filter oCthe cigarette

(Thweatt ct al., 2007). Acrolein is formed in air as a photochemical reaction product.
during the biotransformation of allyl compounds and the anticancer drug.
cyclophosphamide (Boor, 1983; Fraiser et af.. 1991). Acrolein is also generated li"11m the
metabolism of spermine and spermidine by the microsomal enzyme mOl1oLlminl": u"idase
in liver and heart cells (Timbrell, 1991). It has been estimated to represent 5<% oCthe total
aldehyde found in polluted air, but is proportionally the most damaging chemical
contaminant because it is highly irritating, and, as an

a,~-unsaturated

compound. is

\IT)"

electrophilic (Witz, 1989) allowing it to rapidly react with many nucleophilic sites.
Levels of acrolein in ambient air are estimated at only 0.04 to 0.08 ppm. although it is
found at up to 90 ppm in cigarette smoke (Costa and Amdur, 1(96). Subchronicinhalation studies have reported physiological effects at 0.4 ppm. The lethal dose 01'
acrolein in humans is a 10 min exposure of 351 mg/m 3 (Stanford Research Institute.
1(78).

MOLECULAR EFFECTS OF 4-HNE AND ACROLEIN

4-HNE and acrolein are diffusible aldehydes. They can act locally or cntcr the
general circulation. Because these aldehydes are highly reactive elcctrophi!C~. they

5

readily react with cellular nucleophilic macromolecules such as proteins and DNA
(Esterbauer et af., 1991). The use of matrix assisted laser desorption lionization- time oj'
flight (MALDI-TOF) mass spectrometry and liquid chromatography/mass
spectrometry/mass spectrometry (LC/MS/MS) has allowed for the identification of points
of macromolecular modification by 4-HNE and acrolein.
4-Hydroxy-2-nonenal can form adducts with proteins by reacting with cysteine
sulfhydryl groups, histidine imidazole groups and lysine £-amino groups (Uchida, 20(3).
Absorbed acrolein reacts directly with protein and non-protein sulfhydryl groups and
with primary and secondary amines found in proteins and nucleic acids (Fry e/ a/., 1993).
Enzymes with sulfhydryl groups in their active site can be inhihited by hoth 4-11NE and
acrolein. For example, acrolein inhibits rat DNA polymerase (Munsch

e/

(fl., 1973). Iligh

levels of acrolein inhibit GST mu and GST pi (>250 f..tM; Berhane and Mannervik, 1990),
and aldehyde dehydrogenase (>200

~lM;

Silva and O'Brien, 1989). High levels of 4-HNI':

differentially inhibit cytoehromes P450 (Kuo et af., 1997).
4-HNE and acrolein are believed to be involved in aging, chemical-drug toxicity
and the pathogenesis of a number of human diseases. The concentration of 4-HNE is
elevated in diseased regions of the brain of patients with Alzheimer's disease
(l\1arkesbery and Lovell, 1998; Picklo et af., 2(02), in human hippocampus after global
ischemia (McKracken e/ af., 2001) and in Lewy bodies in neurocortical and hrain stcrn
neurons in Parkinson's disease (Zarkovic, 2003). Among other effects, recent findings
suggest that in vivo, covalent modification oflow-density lipoprotein (LDL) by 4- I IN I~
and acrolein renders LDL more atherogenic and enhances foam-cell formation
(Esterbauer 1993; Uchida et al., 1998). Proteins modified by 4-HNE have been detected

6

in atherosclerotic lesions. 4-HNE modification of mitochondrial proteins occurs during
cardiac reperfusion in hearts isolated from senescent rats, thus, establishing a link
between 4-HNE and cardiac reperfusion injury (Lucas and Szweda. 19(9). Upon
incubation with low density lipoprotein, acrolein preferentially reacts with lysine residues
forming N(1-acetyl-N"-(3-formyl-3,4-dehydropiperidino) lysine or FDP-lysine (lichida ,,/

aI, 1(98). 4-HNE and acrolein generated during oxidation of low-density lipoprotein
form covalent adducts with apolipoprotein B (Hubatsch cl al., 1998) and trigger the
uptake of low density lipoprotein by scavenger receptors located on vascular tissues,
including vascular smooth muscle cells (Steinbrecher et al., 1990). Thercfore, the
metabolism of these compounds to less reactive products that can be excreted or
subjected to further metabolism is of great importance.

MULTIPLE PATHWAYS ACCOUNT FOR 4-HNE METABOLISM:
Glutathione S-Transferase, Aldehyde Dehydrogenase And Aldose Reductase
The ability to withstand toxic chemicals and oxidative stress is esscntial Cor the
survival of all organisms. Various mechanisms have evolved to protect cells against
foreign compounds and reactive oxygen species including efflux pumps, anti ox id,mt
proteins and glutathione COSH), xenobiotic metabolism, sequestration oC toxins and DN.\
repair (Hayes and McLellan 1999). When administered in vivo. radiolabelcd

"1-)

[Nl: is

rapidly metabolized and excreted into urine as a group of polar products from (n-llxidi/ed
4-hydroxynonenoic acid (HNA) and their low density lipoprotein conjugatcs, as vvcll as a
group of less polar mercapturic acid thioesters originating fr0111 the mctabolism

or thc

aldehyde moiety of 4-HNE (Alary ct a11995; De Zwart ct al., 1996). In the study by
Alary ('/ al. aftcr intravenous administration of 4-HNE into rats, HNJ\ and mercapturic

7

acid conjugates accounted for 40%-50% and 30% of the injected dose, respectively. This
pattern indicates that both oxidation and glutathione (OSH) conjugation arc the main
metabolic pathways of4-HNE metabolism. Moreover, in vitro studies of4-HNE
metabolism performed with isolated hepatocytcs (Hartley et aI., 1995; Siems e/ at..
1997; Amunom et aI., 2006), enterocytes (Boon et af., 1999), liver slices (Laurent ef ({/,
2(00), and perfused organs such as liver, kidney, and heart ( Boon et aI., 1999; Grunc ef
aI., 1997) suggest that HNA and glutathione-conjugated 4-HNE account for the major

metabolites of 4-HNE. These metabolic studies of the lipid peroxidation-derivcd
aldehyde 4-HNE suggest that metabolic pathways involving glutathione S-transtCnlse
(GST), aldehyde dehydrogenase (ALDH) and aldose reductase CAR) arc involved in
disposition of 4-HNE and related aldehydes. In isolated rat hepatocytes, GST catalyzed
the Michael addition of 4-HNE to glutathione (GSH), ALDH oxidized 4-HNE to 4hydroxynonenoic acid and aldose reductase reduced 4-HNE to 1A-dihydroxy-2-no;1l~llc
(Hartley er al., 1995, Srivastava et al., 2001). Figure 2, taken from Alary ef 01. (2003)
shows the pathways established for 4-HNE metabolism.
Little is known about the contribution of cytoehromes P450 to the mctc:bolisll1 01'
lipid aldehydes. There is a single study demonstrating that in PP AR wild-type, but not
PPAR knockout mice, fibratc treatment resulted in the increase in 4,9-dihydroxy-2nonenoic acid, the co-hydroxylated metabolite of 4-HNE and its oxidized form. 4hydroxy-2-nonene-l,9-dicarboxylic acid (Oueraud et al., 1999). This suggests a possible
role of the Cyp4a family in 4-HNE metabolism. There are no other reports of P450s
involved in lipid aldehyde metabolism.

8
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CYTOCHROMES P450 (CYP)
The history of cytochrome P450 began in 1955 with the first experimenteli
evidence demonstrating that an enzyme system in the endoplasmic reticulum orthe liver
was able to oxidize xenobiotic compounds (Axelrod, 1955). Subsequently, Omura and
Sato (1964) named this enzyme cytochrome P450 because the pigment (P) in liver
microsomes had a 450-nm spectral peak when reduced and bound to carbon monoxide. In
the late 1970s, only six P450 enzymes were known to exist. With advances in cloning
and purification techniques, many other P450s have since been discovcred. As 01'2006.
there are 57 CYP genes in the human genome
(http://drnelson.utmem.edu/CytochromeP450.html).
A basic structural model for P450s has been established based on the structur,d
comparison of published bacterial P450 crystal structures P450cam. 1>450BM-».
P';50terp. and P450eryF (Graham-Lorence and Peterson. 1996). P450s are
t\VO

elll1~p()sed

or

main domains, a predominantly a-helical domain accounting for approximately 70(Yo

of the protein, and a predominantly

~-sheet

domain accounting

{(n°

22% of the protein.

The (X-helices are denoted A-L with the I and L helices contacting the heme. Residues in
the B, I and F helices contact the substrate. The most conserved region in the P450 is a
sequence containing a cysteine that acts as the thiolate ligand to the heme iron. This
sequence is used to identify P450s in gene banks. Along with the cysteille in tbe

hCI11l'

binding region is the highly conserved amino acid sequencc
F(G/S)XGX(H/R)XCXGX(I/UF)A (Guengerich, 2000; Graham-L and Peterson. 1ql)()).

A nomenclature system for the cytochrome P450 gene superfamily exists and is
continuously updated (http://drnelson.utmem.edu/CytochromeP450.html: Nebert e/ a/..

11

1987). Based on this nomenclature, cytochrome P450 proteins are arranged illto 1~1l~1ilies
and subfamilies based on their percentage of amino acid identity. P450 enzymes that
share ~ 40% identity are assigned to a particular family and are designated by an Arabic
numeral, for example CYPI. Those sharing ~5:5% amino acid identity are grouped into a
particular subfamily designated by a letter, e.g. CYPIA.
There are two main types ofP450s. The type I P450s are found in bacteria and in
mitochondria and receive electrons from NADPH through a flavoprotein (ferreduxin
reductase) and an iron/sulfur protein (ferredoxin). The type II P450s are found in the
endoplasmic reticulum and receive electrons from NADPH through a single protein,
NADPH:cytochrome P450 oxidoreductase or CYPOR (Miller, J98g). CYPOR is a

n-

kDa protein that forms a complex with the P450 in the endoplasmic reticulummel1lbrane
(Hubbard et al., 2001). Of the 57 P450 genes in the human genome. 50 arc type II.
Among thesc 50, about 15 are involved in drug metabolism, 20 arc invohcd in the
biosynthcsis of sterols, fatty acids, and eicosanoids, and 15 arc "'orphan" enzymes,

\\i10Sl'

activities remain unknown or ill-defined (Guengerich, 2004).
The oxidative metabolism of substrates by P450s involves the transfer of two electrons to
the P450. The first electron transferred to endoplasmic reticulum-localized cytochromes
P450 is always by CYPOR. The second electron can either come from CYPOR or from
cytochrome h5 (Porter, 2002). The generally accepted steps for substrate metabolism by
P450s are summarized in the P450 catalytic cycle (Figure 3). The reactions in this cycle
include oxygen binding (steps 1-6), followed by the oxidation of substrate (steps 7 and R)
and the release of product (step 9) (Guengerich, 2(01).

12

Figure 3. Generalized reactions of the cytochrome P450 catalytic cycle. The reactions in
this cycle include oxygen binding (steps] -6), oxidation of substrate (steps 7 and 8) and
the release of product (step 9). (Copied from Guengerich, 1001. Current Drug
Metabolism 2:93-] 15).
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Xenobiotics include drugs, food metabolites and environmental pollutants
pesticides, herbicides, and industrial combustion wastes. These compounds, as well
asendogenously generated compounds are substrates for cytochromes P450. 1n humans,
CYPs that metabolize xenobiotics are in the CYPl, CYP2, CYP3, and, to a lesser extent
CYP4 families. A list of putative mammalian filll-length P450 isofonns, their suhstrates
and inducers are shown (Table 1). While humans have only 57 functional CYP genes. the
mouse has up to 102 (Nelson et aI., 2004). P450s are mostly expressed in the liver:
however, some are extra-hepatic. Other organs ofP450 gene expression include hrain.
heart, lungs, kidney, and small intestine. The most abundant mammalian P450, CYP3A4.
is expressed in adult human liver and intestine (Choudhary e{ at., 2004). Table 2. adapted
from Hewitt et al., 2007, shows the relative abundance of human hepatic cytoehrollles
P450.

NUCLEAR RECEPTORS
Nuclear receptors comprise a superfamily of proteins which include the lluclear
hormone receptors, orphan nuclear receptors, the retinoid X receptor (RXR) and its
beterodimer partners, the thyroid hormone receptor, vitamin D3 receptor (VDR),
peroxisome proliferator-activated receptor (PPAR), the constitutive androstane receptor
(CAR), and the pregnane X receptor (Figure 4). Nuclear receptors translocate to the
nucleus in order to modulate transcription of target genes in response to extracelluar and
intracellular signals, culminating in an array ofresponses including metabolism,
differentiation and proliferation which influence physiological processes such as
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Table 1
A Summary of CYPs in various species showing the different isoforms, their substrates and inducers
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-

i

i.

J

, Dog
,

I

!

~--

~---

-~

- - --I

~~~i~~:te J_~~~~ost~rone., Midazola11
t~::{O;~I~~le,-Mid;i91~~~~-_ i S~jt?ster~I~~'= - _jTeSt~ter~ll~'-=~-_~
~-lA -ICYP -\ ~~~pin.~ - - ~- ---~~-TAII2--------~-h~il~~ZOlal!1~_~~-- -[ ~i~;Olan~ __ --~
~---- - -- - -- -~-~~~~ -~-----+----------~-~-~-~
~-- -~------~~--~---~----~
0M , BNF, 3-MC
Inducer t- OM, BNF, 3-MC
I BNF, 3-\1C, PB
PB
1

____

-

-------r------I

1

i

2B-~j ~~;trat~j ~~~~;~ti~-,-E~=~__~ __~-_=~~_+~~~~I~;~~ti!;~E~--~_-=-~ ~G~~lfgg~~l~R--=~-!- 2B 1-1-~~=~-~ji'
-- - ----r ---- -~ - -- - --~-~-- ~- -+-- ~---------~--~~-~~-t--~~ --~ --~ --~--j-~
- - - - -

Inducer

PB

--~----~~--I----~~-

I

• 2C _
c ____

1- ---1- Bup-'"2Piofl,-BR.,_f>~_
~! 2C8/9/18/19

~

,- --

~

pnduc;~--nII(2t9,2C-II1J>B_(2C=l~L-~-=: De~_-~_
I

CYP

: 4A

Substrate. Paclitaxal(2C8),
Tolbutamide,
--~
~---~~--~--~
,
Diclofenac
(2C9),
-- ---- -- ~~-~ -~ ---~-- ~ -~~-S-MP
--I (hydroxylation,2C19)
ICyp---j 4A9/Tl - - - - -

1-

I

-

!

_

_2D

!

i

j

:-----~-

I

2;\

i PB
-----~--~---___t- ---~--~~---~~-~
~R-, _~~, te~~()stero~1e _
1 BP~E~_
_ ___

_j
--- i ---- ~~
2C II, CYP2C6

§.~bstrat~i S-meJ)l~enytoll1(I'i-deln_ethylatloQl

f-:-- -

PB

~---~;~----- -~-----~-.--~--i --~-

-T--

---

-----+-~------

:Jn~~eI...L(;Iot'ilJ!a~_
S.tJ_bstrate_j'___ __
T cyp ~ __ 2D6 __
Inducer
No known inducer
;- S l;bst;;;:te- tDextro~i:;-~thoipj,an
!

t- CYP
--

I

-----

I lnducer
Substrat~

2A6
PB, RIF

!

Curcul11in

-

--

~T-~

J

----~- ~-

~~--

----4
- - - ------1

-==-=-__

--~-~

-;

----

.j
I

~--

--

-=_

~---~- ~--

!Qrz, diazapai!i__
~~

--- --

-=---=ti~_=---=-~-

~-------

I

I 2C21 (minor CYP)

I

__ L

--

I
I

-----~~

--~~~

----~ ~~------

,

;-Abse~--------- ~~--~----j -------~C lotThr~te_ (4A l)
__ ___--'-_ _ _
Lauric acid
Lauric acid
,
20112
_____ --=12cl9-13
-! 2.0-15 ____

~fAI/2/3/8-

-+-~---~~-I

:

- - ~--j----

I
~

2c29
lYI,-eny_toin____

PB
--+'- - - .-~'------jI

------

-----~----

~~

i

Dextrolllcth()rp~
-

-

Absent
.. ! ~(;\

i

Burforolol

~~ xtl~o~!l~~or~~I~

Burforolol
--~

2a412a5
PR
'-://\

\D

: 2£

-

Cyp
Inducer

!

2El
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RIF = rifampin, PB = phenobarbitone, Dex = dexamethasone,

B~F

_ - - - - - t-LI"l9~isoniazid)
-

= B-napthoflavone, 3-MC = 3-methylchloranthrene, ER =

ethoxyresorufin, MR = methoxyresorufin, BR = benzyloxyrcsorufin, PR = pentoxyresorufin, OM = omeprazole, p-NP= p-nitrophenol,

s- MP = S-Mephenytoin (Table adapted from Hewitt et al (2007) Drug Metabolism Reviews. 39:159-234).
t--

Table 2
Relative abundance of human cytochrome P450 enzymes and their contribution to
drug metabolism

Enzyme

Content in liver(% total CYP)

CYP3A4/5
CYP2D6
CYP2C9
CYP2C8
CYP2CI9
CYPIA2
CYP2El
CYP2B6
~"

29,30
1.5
12
7
0.2
12, 13
7
1.2, 5
.. --- ---- -..

~----

% Of drugs metaholized by enzymc
52

30
10, 11
no reiCrcnc,:

4
4. 6
2. 5
:'5

.-

(lahk copied from Hewitt et al.. (2007). Drug Metabolism Rc\ie\vs. 30:] 5l)-2.~'-i).
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reproduction and development (Robinson-Rechavi ct al., 2003; Olefsky. 2(01).
Nuclear hormone receptors are receptors for which ligands have been identitied.
They transduce signals from small molecules like glucocorticoids, mineralocorticoids.
sex steroids (estrogen, progesterone, and androgen), thyroid hormones, and vital1liJ: D~
within the cell cytoplasm. Orphan receptors are receptors for which the ligands are
unknown. Nuclear receptors have common structural features (Figure "1). The N-terminal
region contains the activation function-l (AF-l) domain. The central region is the ])1\/\
binding domain (DBD) responsible for targeting the receptor to the DNA response
element. The C-terminal region consists of the ligand-binding domain (LBD). responcibJc
for binding hormonal and non-hormonalligancls and receptor activation and the
or

activation function-2 (AF-2) domain. Nuclear receptors can exist as

h01110-

heterodimers with each partner binding to specific response element

SCc;1i'.?I1CCS

thaL

c\is~

as half-sites separated by variable length nucleotide spacers bet'vYeel1 direct or inverted
half-site repeats (Olefsky, 200 1). There are four categories of nuclear receptors
UvIangksdorf ct al. 1995). Class 1 receptors include the steroid hormone receptors_ ,,\'bcll
("unction as homodimcrs binding to half-site response element inverted repeats. ('lass :?
receptors exist as heterodimers with RXR and function in a ligand dependent manner.
The class 3 receptors are the orphan receptors, which function as homodimers hinding to
direct repeat response elements. Class 4 receptors function as monomers, binding to

(l

single half-site response clement.
A key function of nuclear receptors is the regulation of gcne expression. Th:s is
achieved through recruitment of coactivators and transcription factors to the target

19

Figure 4. Structure/function organization of nuclear receptors. (Copied from Olefsky

(2001) 1. Bio!. Chem. 276:36863-36864).
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Figure 4
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promoter, as well as chromatin remodeling. Several transcription factors arc known to
exist. For the purpose of this project, I will describe a group of transcription bctors
known as oxidative-stress sensitive transcription factors. These include activator protcin1 (AP-l), nuclear factor kB (NF kB), and nuclear factor E2-related factor 2 (Nr!'2).

OXIDATIVE STRESS-SENSITIVE TRANSCRIPTION FACTORS
Oxidative stress in the cell occurs when there is a productioa of more rcacti vc
oxygen or nitrogen species than antioxidants. These reactive oxygen species include
hydrogen peroxide (H 20 2) hydroxyl radical (OH), superoxide anion (0 2

)

and organic

peroxides. Oxidative stress can damage cells by causing lipid peroxidation, proteill. and
nucleic acid modification. In order to prevent damage, cells have developed an
antioxidant defense system that includes non-protein antioxidants (Vitamin C, ]) and !':.
glutathione) and protein antioxidants or enzymes; glutathione reductase, calala",,'

~lr:Li

sliperoxide dismutase. Another class of enzymes known as xenohiotie metabolizing
el~zymes

such as glutathione S-transferase and quinone oxidoreductase can prevent

oxidative stress by metabolizing chemicals that generate oxidative stress. The expression
of many of these xenobiotic metabolizing enzymes is regulated by thc oxidative strcsssensitive transcription factors AP-l, NF-kB and Nrf2.

AP-l is a redox-sensitive transcription factor and a member of the basic leucine
zipper family of proteins. AP-l family members include Fos, Jun and activating
transcription factor (ATF). AP-l exists as different dimeric combinations of basic leucine
zipper proteins from the Jun (c-Jun, JunB, and JunD), and Fos (c-Fos. Foss' Fra-l. and
Fra-2). and ATF (ATF2. ATF3, B-ATF) families. Jun proteins form homodimcrs that

22

bind to the AP-l DNA recognition clement known as TP A (12-0-tctradecal1oyl-p!Jorl luI
13 acetate) response element or TRE. The TRE consensus sequence is 5 '-TelA( ;/('1'(,.\.
3' (Angel et af., 1987). Unlike Jun, Fos family members do not form stable hOll1odill1ers.
Instead, they function as heterodimers composed ofFos and Jun family member proteins.
Fos and lun heterodimerize, forming an X-shaped structure that binds to the palindromic
TRE (Glover and Harrison, 1995). A common feature of the AP-l transcription

j~lctors

a basic DNA binding domain and a leucine zipper domain collectively known

blIP

domain (Figure 5). The leucine zipper domain is responsible for

,!S

dimeri/a~iOl;

()i'

is

th,'

protein, a prerequisite for DNA binding. The basic domain is used for I )J\li\ bimlill!'.
Whereas the bZ[P domain has been well characterized, less is known about the structural
properties of the transactivation domain. The activity of AP-l transcription LlClors is
regulated by many factors including cytokines, stress signals. growth
lll:cogCllic stimuli. Posttranslational regulation ofAP-1 involves

t~let,)rs.

alld

pl~!)sp!:oi') !<.l(1.11

mitpgen-activated and stress-induced protein kinases (MAPKs). Three MAPK
have been identified in vertebrates. These arc c-.Tun N-terminal kin,lse (.INK).

h

i~,!.'

j'all1ilil'~;

tlh.~

e;-.;traeellular regulating kinase (ERK) and the p38 kinase (Robinson <lnd Cobb.

]l)lJ7).

The c-Jun N-terminal kinascs (JNK) arc comprised of three iSOj'Ol"11S namely
.TNK I. JNK2 and JNK3 (Davis, 2000) . .INK is activated by a series

or events in the

MArK cascade. The kinase cascade is activated by compounds like acrolein (Ranganna
ef a/ ..

2(02), butylated hydroxylanisole (BI-IA) and its metabolite tertiary butylatcd

hydroquinone (tBHQ) (Keum et aI., 2006) and 4-HNE (Uchida et 01.. 1C)()l)Llh'

\1\P:~

kinase kinase (MAPKK kinase) phosphorylates and activates the MAPK kinase
(f\1APKK) (Hibi et of., 19(3). Activated MAPKK in turn phospborylaks and acti\ ~ltes

Figure 5. Functional domains of the activator protcin-l transcription factor. Thl:
bZrp domain of lun is shown in blue and the bZIP domain of Fos in red. The DN1\
backbone is shown in yellO\v. The Jun and Fos proteins exhibit several domains,
including the bZIP domain (leucine zipper plus basic domain), transactivation domains

and docking sites for several kinases, such as JNK or ERK. JNK phosphorylates serine
residues within the transacti vation domain oOun at position 63 and 73 and thereby
regulating its transactivation activity. Copied from Hess et of. (2004). Journal of Cell
Science 117 (5965-5973).
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Figure 5
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MAPK. which then phosphorylates .TNK. Upon activation by the MAPK cascade. thc
JNKs translocate to the nucleus, where they phosphorylate Jun within its N-tcrmin,;]
domain at serine residue 63 and 73. Activated JNK is also implicated in thc
phosphorylation-dependent activation of transcription factor Nrf2.
Nuclear factor KB (NF-KB) is also a redox-sensitive transcription ractor. NF-I\-f3
I~lmily

members include pSO/plOS, pS2/plOO, p6S/RclA, RelB, c-Rel. ])osal. OiL ,lml

Relish (Karin. 1999). Under basal condition. NF-KB is sequestered in the cytoplasm as

all

inactive complex with its inhibitor IKB. Exposure to oxidative stimuli leads to the
phosphorylation and proteasomal degradation ofIKI3. thereby reka~;ing \JF-d3. \J;"-k:3
activation is also mediated by tumor necrosis factor a (TNFa), intcrleukin ! (IL-I),
bacterial lipopolysaccharide (LPS), viral double stranded RNA and ionizing radiati,ll1.
These cause the phosphorylation-induced dcgradatiun of h:B ar:d tbe di::rlptioiJ \),' '\,~!
!i'om Id3. Free NF-tJ3 dimers tben translocatc to UK' nuclers 'vv:1l'r,'lhl:.

-J\: I,

:):'J, 1, :,~

promotcr of target gencs and regulate their transcription. (Karin., 1999: Schmidt

el

C/I..

I ()95).

The transcription factor nuclear factor E2-related factor 2 (NrJ'2.) is

a

ke:

rC!',ULlil)J

ni J\EET':pRE -driven transactivation of antioxidant genes. The cis-acting ckn:Cl1l
!.;nOWll as the antioxidant response clement (ARE) or cIcctrop11ilc rcs;)onsc -:lcn:c::t

(FpRF) is located in the promoter region of many genes encoding <lI1tio::ic.:lanl

;ll1d

detoxifying enzymcs. j'\rf2 is a basic region-leucine zipper (bZipHYrC transcripti()11
!~lctor

(Itoh cf of.. J (95). Under basal conditions, Nrf2 is sequestered in the CytOpl:1SIl: ')\

binding to Keap
1'1

J

protein, thereby repressing nuclear activatio); oflhe ;\I:F hy :\JJ.!',2 \ foil

al .. i 9(9). Upon activation, Nrf2 dissociates from KeapJ, transioeatcs to the lillCicll,
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and binds to the ARE as a heterodimer with the small Mafprotein ([toh

ef

(f/ .. 1()9!)

It)

induce gene expression.
Several factors can cause the dissociation from Kea)) 1 and activation of;'\j rf1.
Nrf2 can be activated by exogenous compounds, endogenous products of oxidative

Sl!TSS

or other stresses generated inside the body, such as 4-hydroxy-2-nonenal (N UIncl'v\aza
(fl.. 2003; Ishii

el aI.,

2004). Other compounds like BHA and tBHQ (Keul11

e/

c/

ill.. :::O()(l)

also activate Nrf2. tBHQ is the prototypical inducer of ARE driven genes and is a l11a:or
metabolite of the phenolic antioxidant BHA. tBHQ functions to disrupt Nr111i'011l i(eapi
by increasing the phosphorylation of JNK, which in turn. phospboryJaks Nrf2. Nrl2 is

then released from Keap 1, and translocates to the nucleus (Keul11 et 01 .. 20(6). The
phosphorylation ofNrf2 occurs on serine residue 40 (Chen and Kong. 20()4: l\. \\(\1\

('/

ul.,

20(4). There is also compelling evidence that some strong elcctrophilic compounds call
caLIse Nrf2 release by direct interaction with Keap 1. This oecurs throclgh lh-.: covalent
1'f-IcatlOn
.
moul
0 j'

,
cysteme
rCS1'd ues C2"'i7

e?73
- ,

C'288 . an d C-797 on K.cap 1 (\1l ) 'ir; J'.J)\a-;',()~:t()V~1
'/

el a/., 2002),

The ARE motif was originally identi lied by a mutagenesis study c,f the rat ( rSIYa ARE (Rushmore and Pickett, 1990), The consensus sequencc is 5'(;\/G)TGACnnnGC-3': n represents any nucleotide, The ARF has be:.T cUc\.:ld i:' l::,'
promoter region of the genes encoding GST-Ya (rat and mouse: Friling

el

(II.. 1990:

Rushmore e/ 01., 1990), GST -P (rat; Okuda e{ al., 1999), and rat and human NQO-l
(Favreau and Pickett, 1991; Li and JaiswaL 1992), mouse hcme oxygellase-1 (II O-J )
(Prestcra el aI., 1995), y-glutamylcysteine synthetase (yGCS) heavy S'JbUllit (Mldcah)
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and Gipp, ]995), mouse GST-Ml and M3 (Reinhart and Pearson, 19(3), and mouse
ferritin light chain (Wasserman and Fahl, 1997).
Little is known about the regulation of cytochrome P450 gene expression b: lipid
aldehydes acting through the oxidative stress-sensitive transcription factors. but late!)
there is increasing evidence that these transcription factors may regulate P450 gene
cxpn.:ssion.

The purpose of my research project is two-fold. 1. To determine the

rol~

of

cytochromes P450 in the metabolism of 4-HNE; 2. To investigate the regulation of
cytochrome P450 gene expression by lipid aldehydes. This is the first extensive study
of the P450s involved in lipid metabolism.
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CHAPTER II
CYTOCIIROMES P450 CATALYZE TIlE METABOLISM OF fl,fJ-

lJNSATlJRATED ALDEHYDES
(The oxidation reactions in this chapter were published in Archives of Biochcmistl'~'
and Biophysics 464: 187-196(2007».

INTRODlJCTION
rx,0-Unsaturated aldehydes are highly reactive molecules formed by biological
and chcmical processes. These aldehydes include propene-2-al (acrolein). Irans-2hexenal, and 4-hydroxy-2-nonenal (4-HNE). Acrolein is a toxic environmental aldehyde.
formed by combustion processes or metabolism of drugs like cyclophosphamide (Boor.
I ()83). It is among the most chemically reactive aldehydes known.

Tra17s-2-hcxen~11 i~

a

major plant natural product Conned from oxidation of linolenic acid that pro\'ides the
odor of apples and its closely related Corm is cis-2-hexanal vvhieh accounts for the smell
of Creshly cut grass. [/1 l'ifro, 4-HNE can be generated from the 9- and 13-hydroperoxides
of the (0-6 polyunsaturated ratty acid. linoleic acid (Schneider el (fl.. 2001 ). The

concentration of 4-HNE is significantly increased in plasma, various mgans. and cell
types including liver cclls under conditions of oxidative stress (Esterbauer e/ (f/ .. I ()91 ;
Poli and Schaur, 2000). Significant levels of 4-HNE (1-5

~lM)

generated during oxidative

stress have been shown to be associated with onset and progression of cardiovascular and
ncurodegenerative diseases (Awashthi ef al .. 2003; Srivastava et (fl.. 20(2). For example.
modifIcation of low density lipoproteins by ct.-IlNE renders this lipoprotein 1110re
atherogenic and results in foam cell 1'ormation. Moreover, 4-1 INI: l1lodilicd proteins han:
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been detected in atherogenic lesions (Esterbauer ef 01 .. 1993). At low ~LM concentrations.
4-H\JE affects cell proliferation and shows genotoxic cffects (Eckl ef ai., 19(3). u.[)Unsaturated aldehydes are also prevalent in thc environment and they display toxic
effects in ~lM concentrations (Esterbauer i'I al., 1991; Awasthi ef ai., 2003: Srinlstanl ef
uZ .. 2002).
Because of their pathophysiological relevance, attention has been focused during
the last dccade on the ability of mammals to metabolize aldehydes, including 4-HNE. 111

vitro, metabolic studies carried out with rat liver subcellular fractions showed that 4-1 fNF
,vas rcduced to 1,4-dihydroxy-2-nonene (DHN) by cytosolic alcohol dehydrogenase
(Estcrbauer el al., 1985) and oxidized by aldehyde dehydrogenases to 4-hydroxynol1cnoie
acid (I-INA). In addition to these products. the glutathione-IINE (GS-HNE) conjugates
were rapidly formed during incubation of 4-BNE with hcpatoeytcs. entcrocytes. and
tumor cells (Siems e/ 01., 1992; Ramana et al., 2(06). In a study carried out alkr
intravenous injection of 4-I-INE into rats, four mercapturic conjugates were characterized
in the urine, namely 1.4-dihydroxy-2-nonene mercapturic acid, 4-hydroxynollenal
mercapturic acid, 4-hydroxynonenoic acid mercapturic acid. and the corresponding
lactone mercapturic acid derivatives (Alary ct al., 1995); glutathione conjugates of 4HNF and 1,4-dihydroxy-2-nonene were also observed. These results were further
confirmcd by De Zwart e/ al. (1996) demonstrating that conjugation of 4-flNE with GSH
is a high capacity, first pass metabolic step in the elimination ofthis aldehyde.
Cytochromes P450 (P450) arc enzymcs that mctabolize xenobiotics and
endogenous and compounds. They arc integral mcmbrane-bound heme-containing
proteins. localized in the endoplasmic reticulum of hepatocytes (Black. 1<)92) and
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extrahepatic tissues as a complex with NADPH:P450 oxidoreductase (CYPOR) (Nelsoll
and StrobeL 1987). A number of reports have demonstrated that exposurc to high
concentrations of aldehydes. e.g. 4-HNE; inactivak these hCl11oproteins in a dircct or
mechanism-based reaction (Kuo et al., 1997). The sensitivity of P450s to 4-1 INE is
varied, with CYP2B4 and CYP2B 1 being inactivated to the greatest extent and 2C3, 1/\2,
2El, and 1A1 to a lesser extent. The

KinaClivatioll

for 4-IlNE is normally greater than 0.,

mM for these P450s. However, levels of lipid-derived aldehydes probably do not
normally attain suiIiciently high levels in vivo to cause extensiw inactinltion of thc
P450s. A rolc for cytochromes P450 in the metabolism of endogcnous and cxogcnous
aJI-unsaturated aldehydes has not been fully established. In this study,

\VC

dcmonstratc

thJt mammJlian cytochromes P450, namely, mouse Cyp2c29, humJIl CYP3A4 and
CYP2B6, and rabbit CYP2B4, catalyze the facile oxidation of a,0-unsaturated aldehydes
to their carboxylic acids at low 11M concentrations of aldehyde substrate, whilc some
enzyme inactivation occurs at higher conccntrations. Using mouse livcr microsol11cs and
primary hepatocytes in conjunction with selective P450 inhibitors, we show that. in
Jddition to aldehyde dehydrogenase, some hepatic P450s, such as CYP2B6, CYP3A4,
CYP2c29 and CYP2J2 participate signi ficantly in oxidative metabolism of these
aldehydes and display low KM values for these reactions. Interestingly, in additioll to the
oxidation rcaction, we observed that CYP3A4, CYP32B6, CYP31 A2, Cyp2c29 and
CYP32J2 also participate in the reduction of 4-HNE to 1,4-dihydroxy-2-noncne.

MATI,:RIALS AND METHODS

31

Chemicals and plasmids. The expression plasmid, pCW-Cyp2c29, with Cyp2c29 cDNA

cloned into Nde I and Hind III restriction enzyme site was provided hy lA. Goldstein,
National Institutes of Environmental Health Sciences, Research Triangle Park, NC
(Luo el af., 1998). The CYPOR expression plasmid was provided hy Mark Doll and
David Hein, Department of Pharmacology and Toxicology, University of I.ouisvillc
School of Medicine. All plasmids were restriction enzyme digested to confirm the
identity of the cDNA of interest. Preparations of Escherichia coli membranes containing
recomhinant CYPOR and CYPIA2, 2B6, 2EI, or 3A4 were prepared as described
(Guengl.::rich and Martin, 1999). In thesc preparations, the ratio of P450 to CYPOR

\VdS

noted to he between 0.8-2.0. Human CYP2J2 and CYPOR expressed in insect cells was
generously provided by Darryl Zeldin, National Institutes of Environmental Ilealth
Sciences, Research Triangle Park, NC. Anthracene-9-carboxaldehyde (()-AA), ()anthracene methanol (9-AMeOII) and anthracene-9-carboxylic acid (9-/\C/\) were
purchased {i'om Sigma-Aldrich Chem. St. Louis, MO and dissolved in DMSO bet(.)re usc.
3flIJ-4-ITNE was prepared as describcd previously (Srivastava £'1 a!.. 2(02). and 4-1 INI:
was purchased from Calbiochem, San Diego, CA. The HNA standard \vas gencrated by
incubating 4-HNE with yeast aldehyde dehydrogenase (Sigma

Chemic~ll

Co .. St. Louis,

MO) and, after monitoring NAD+ reduction for completion of the reactioll. the products
were extracted into ethyl acetate (Srivastava e/ af., 2002; Ramana el ul., 200()).

Escherichia coli growth conditions. Glycerol stocks containing dual expression
plasmids, pCW-Cyp2c29 and pACYC-l Duct CYPOR gene in E. coli BL21 (DL])

served as innoculum for the expression experiment. Cells vvere grown overnight \vith

32

vigorous shaking (250 rpm) at 37°C in Luria broth containing 54 mg/mL or ampicillin
and 34 mg/mL chloramphenicol. A 111 000 dilution of E. coli cells was made into 500 1111,
of Terrific Broth and grown at 37°C to an optical density of 0.6 at 600 nm. One hour prior
to induction, the growth medium was supplemented with 0.5 mM 6-aminolevulinic acid.
Enzyme expression was then induced with 1 mM isopropyl-~-D-thiogalactopyranoside
and the culture incubated at 30°C with orbital shaking at 190 rpm. After 48 h. the cells
werc harvested by centrifugation at 5.000 x g for 10 min. The cell pellet was suspended
in 100 mM Tris buffer, pH 7.8, containing 20% glycerol (v/v), and 0.5 mM EDTA to
achieve a volume equal to 15% of the original volume of culture. Membrane preparation
was carried out at 4°C as described (Richardson ef aI., 1995) with some modifications.
Lysozyme was added to a final concentration of 0.2 mg/mL, and an equal volume of icecold water vvith gentle stirring. After an additional 30 min of stirring, the resulting
spheroplasts were centrifuged at 8,000 x g for 10 min and resuspended in 0.05 volumc

or

TMK buffer (50 mM Tris-HCI, pH 7.3, 50 mM KCI and 10 mM MgCh). The cell i)cllct
was frozen at -80°C and upon thawing, a protease cocktail for bacterial cells (Sigma. St.
Louis Mo.) was added as recommended by the manufacturer. The spheroplasts were
lyzcd by sonication using six 1O-sec pulses at 40% power using a Branson 200 scries
soni tier fitted with a micro tip. Cell debris was removed by centrifugation at 5,000 x g Cor
10 min, and the supernatant was ultra-centrifuged at 143.000 x g for 60 min. The
resulting membranes were suspended in 10 mM potassium phosph,!te buffer, pH 7..t
containing 20% glycerol and 0.1 mM EDTA by homogenizing in a Potter-Elvehjcl11
homogenizer to form spherosomes and stored at -80

n

e until used.

Preparation of mouse liver microsomal fractions. Male C57BLl6J mice (22 g to 27 g:
Jackson Laboratories, Bar Harbor, MA) were fed ad lihitum for 1 week with AIN-76A
diet (Purina Test Diet, Richmond, IN) or AIN-76A diet supplemented v.ith 0.45% HIli\.
All procedures for handling the mice were approved by the University of Louisville
IACUC Committee and conformed to the Public Health Service Policy on Humane Care
and Use of Laboratory Animals. Animals were anaesthetized with CO 2 and euthenized by
spinal dislocation prior to harvesting the liver into icc-cold 0.9% NaCI solution. The
livers were cut into small pieces and homogenized in a Potter-Elvehjem homogenizer
(Sears Drill Press Stand Model 25921, Chicago IL) with 4 volumes of 50 mM potassium
phosphate buffer. pH 7.4, containing 0.25 M sucrose per gram of liver. Microsomal
fractions were isolated by differential centrifugation as described by Remmer

c(

01

(1966). Microsomal fractions were resuspended in 0.1 M Tris-HCI buffer (pIT 7.4).
containing 0.25 M sucrose and sedimented a second time. The final preparation was
resuspended in Tris-HCI bufTer containing sucrose and 10°;() glycerol and stored at -80°C,

Determination of protein and P450 content. Total protein concentrations were
determined by measuring formation ofbicinchoninic acid-eu+ complex at 562 nm (Pierce
Chemical Co., Rockville. IL). P450 content was determined by thc CO-differcnce
spectra of dithionite reduced P450 (Omura and Sato, 1964) using a Varian Model 50
spectrophotometer (Varian, Palo Alto, CA). Cytochrome P450 content was calculated by
assuming a molar extinction coefficient of91 mM'lcm'l. The p t50 content of liver
c

microsomal fractions from untreated C57BLl6J mice was 0.23 nmol/mg. The final

homogenization of membranes to obtain spherosomes resulted in significant Joss of
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Cyp2c29 activity. Volk et al. (1995) observed a remarkable tendency of this P450 to
dissociate from membranes during homogenization. It is possible that this results in the
loss of activity due to conversion to the inactive P420. The maximum amount of active
Cyp2c29 obtained in spherosomes was 1.52 nmollmg of protein.

NADPII:Cytochrome P450 oxidoreductase activity measurement. The co-expression
of each P450 of interest and the CYPOR was performed using E. coli BL21 (DE3). The
activity of CYPOR in spherosomes was determined by measuring the reduction of the
artificial substrate cytochrome c. The reactions were carried out at 37°C in 0.05 M
potassium phosphate buffer, pH 7.4 containing 40

~lM

cytochrome c. diluted aliquots of

the spherosome (contain the P450 and CYPOR), and I 00

~lM

NADPH. The absorbance

change was monitored at room temperature at 550 nm with a Cary 50 Bio UV-Visiblc
spectrophotometer. The CYPOR activity was determined assuming a mobr extinction
l

l

coefficient of 21 mM- em- (Masters et at., 1966). During the preparation of
spherosomes several fractions were tested and that with the highest CYPOR activity
(Figure 6) was then used in metabolism assays. Similar fractions were used for the
reconstitution experiments.

Primary hepatocyte culture. Male Sprague-Dawley rats (180 g-200 g: I-Isd:SD, I farlan
Indianapolis, IN) were used for liver perfusion as described by the method of Bayliss and
Skett (1996). Cell survival was determined by trypan blue exclusion (Berry et (II.. 1991)
and hepatoeytes having viability greater than 80% were plated at a density of 4 x 10

6

cells/dish onto 60-mm plastic dishes precoated with collagen in Williams E-Fl2 1: 1
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mixed medium described by Ferrini et al. (1998) and 1som e/ al. (1984). After allowing
the cells to attach for 4 h, the medium was changed and renewed every 24 h thereaHer in
the absence of serum. The cells were treated with 50 ~lM 4-HNE and the reactions
terminated at 0, 10, and 20 min with trichloroacetic acid (TCA) to achieve 7.5 TeA
concentration. The resulting samples were frozen at -80 nC prior to analysis by llPLC as
described below. The inhibitors (0.5 mM miconazole, phenytoin, or cyanamide) were
added just prior to 4-HNE. When 0.5 mM troleandomycin was added as an inhibitor to
the hepatocytes, the cells were pre-incubated with trolcandomyein 10 min prior to adding
4-HNE.

Purification of rabbit liver cytochrome CYP2B4 and NADPH :cvtochrome P450
oxidoreductase. CYP2B4 was purified from rabbit liver in the Prough Laboratory as
described by Dean and Gray (Dean and Gray, 1982) to a purity of approximately 1X nn101
hemoprotein/mg protein. Rabbit liver CYPOR was purified by the method oj' Yasukochi

and Masters (1976) to a specific activity of 38.2

~lln()l cytochrome

c reduced per

111 i n

per

mg flavoprotein. Both preparations displayed a single major protein band upon analysis
by SDS-PAGE.

Cvtochrome P450 activity assay. CYP3A activity was determined in mouse livcr
microsomes by measuring O-dealkylation of the benzyl ether or resorulin to the
fluorescent product, resorufin (Prough et al., 1978). Reactions were carried out at 37"e in

2 mL volume with 1 mM NADPH, and 0.25 mg/mL (50 nM P450) microsomal protein in
0.1 M potassium phosphate buffer, pH 7.4. The production ofresorufin was monitored at
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Figure 6. Determination of cytochrome c reductase activity in membrane fractions.

NADPH-cytochrome P450 oxidoreductase was expressed in E. coli and membrane
fractions called spherosomes prepared by sonication, centrifugation and homogenization.
CYPOR activity was then determined by measuring cytochrome c reduction using
enzyme-containing spherosomes, spherosomes from mock-transformed plasmid or the
pellet obtained from centrifugation. The reduction of cytochrome c was measured at 550
nm. Oxidoreductase activity was used to calculate the concentration of CYPOR llsing the
factor 1.360

~lmol

cytochrome c reduced per minute per

~lM

of oxidoreductase protein

CYasukochi and Masters, 1976). The data is the meanL SD of a triplicate incuhation.
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0.3

an excitation wavelength of 535 nm and emission wavclel1l'th of 586 nm with a
~

~'

luminescence spectrometer (Model LS50B, Perkin-Flmer, ]3oston, MA), i\ standard
curve for the product, resorufin, was constructed to calculate enzyme activity normalized
to microsomal protein concentration.

Anthraccnc-9-carboxaldehydc oxidation assay. The oxidation of anthracene-9carboxaldehyde (9-AA) by P450 enzymes was determined by measuring the formation of
anthraccne-9-carboxylic acid (9-ACA) as described by Watanabc el o/.. 2002 and :Vlarini

el al., 2003. In brief, the incubation mixture included recombinant 1>450s (50 nM) or
mouse livcr microsomes (0.25 mg/mL,
consisting of I 00

~lM

~50

nM P450), an NADPH-rcgcncrating system

NADPH, 4.25 mM isocitric acid, 50 mM MgCI 2 , and 1.3 Units/mL

isocitrate dchydrogenase, 25

~M

9-AA, and 0.1 M potassium phosphatc butkr. I'll 7.4.

The reaction was carried out at 30°C for 10-30 min and terminated with I Ill]

oro.s N

NaOH. Ethyl acetate (4 mL) was added to allow product separation between thc aqueous
and thc organic phase. The formation of 9-AMeOH was determined in the alkaline
organic phase at 255 nm excitation and 411 nm emission wavellength with a
spectrofluorimeter (Model LS50B). Aqueous phase (1 mL) was subsequently acidified
with 1 mL or 0.5 N HCl and 9-ACA extracted with 4 mL cthyl acetate. The Iluorescence

of 9-ACA in the acidic organic phase was measured at 255 nm excitation and 4SX

11111

emission wavelengths (Figure 7). The fluorescence excitation and emission spectra oj' the
metabolites was nearly identical to authentic anthracene-9-carboxylic acid and 9anthracene methanol. The 9-AA metabolism assay was used as an initial indicatioll
aldehyde oxidation or reduction by P450s.
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The 9-AA metabolism assay was also performed with reconstituted CYP2B~.
CYP2B4 and CYPOR were separately expressed in E coli and spherosomes containing
both enzymes used. The reconstitution was performed in 0.05 mM
dilauroylphosphatidylcholine, 86 nM pig CYPOR and 50 nM CYP2B4. The incubation
reaction was initiated by adding 100 ~lM NADPH and continued for 10 min at JO"( '. The
reaction was terminated with 1 mL 01'0.5 N NaOH and products extracted using 4 l11L
ethyl acetate as previously described.

Metabolism of 4-I1NE by cytochrome P4S0s. 4-HNE metabolism was performed by
incubating 50 ~M eHJ-4-HNE with either E. coli expressed P450 (50 nM) or mouse
microsomal protein (0.25 mg/mL,

~>50

nM P450). Incubations were carried out in 0.1 M

potassium phosphate buffer, pH 7.6, containing 0.5 mM NADPI-I in a 1 mL reaction
volume for 20 min in a 37°C-water bath with orbital shaking at 200 rpm. The NADPTf
regenerating system was not used with 4-HNE due to the formation of additional anaJytcs
associated with the isocitratelisoeitrate dehydrogenase mixture. Recombinant P450s (50
nM), purified rabbit CYP2B4 (200 nM P450 plus 600 nM CYPOR) or mouse liver
microsomcs (0.25 mg protein/mL) were analyzed for aldehyde oxidation activity. The
reaction was initiated by adding 50 ~M eH]-4-HNE. The reactions were terminated aner
20 min incubation by flash freezing sample tubes in liquid nitrogen. The frozen samples
were thawed upon adding TCA and the denatured protein sedimentcd at 13,000 x g for 5
min at 4°C. The supernatant was injected into the HPLC column after an aliquot \vas
removed to measure radioactivity in a Packard Tricarb 21 OOTR scintillation counter

(PackcmJ Instrument Co., Dovvners Grove, II,) with Ultimagold (Packard Instrument Co ..
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Figure 7. Procedure to measure 9-anthracene aldehyde metabolites. 9-Anthracene
aldehyde (25 ~lM) was incubated with P450 as described under methods. 9-anthracene
mcth:.Hlol was extracted into the organic phase of the basic incubation reaction and
measured at )cexeitation 255 nm and Aemission 411 nm. Aqueous phase (1 mL) was
acidi ficd with 0.5 N Hel, followed by extraction with 4 mL ethyl acetate, and 9anthracene carboxylic acid was measured in the organic phase at ),excitation 255 nm and
)~cll1ission

458 nm.
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Downers Grove, IL) as the scintillation cocktaiL prior to separation by high performance
liquid chromatography. The recovery of eII] radioactivity from the reaction mixtures
were >98°;() and the recoveries from I-IPLC were determined to be >95%. All ofthe P450s
displayed linear reactions to 20 min with 4-HNE.

Inhibition of aldehyde metabolism by cytochrome P450 inhibitors. Metabolic assays
with either 9-AA or 4-HNE were performed with either membranes containing expressed
P450 or mouse liver mierosomes as described above. except for the addition ofselcctiw
inhibitors. Phenytoin and troleandomycin (0.5 mM) were used to inhibit Cyp2c29 and
Cyp3a. while cyanamide (0.5 mM) was used as an inhibitor of aldehyde dehydrogenase.
Miconazole (0.5 mM) was utilized as a general inhibitor of P450. Trolcandol11ycin vvas
preincubated with microsomal or expressed P450 fractions and 0.5 mM NAOPl I for 10
min before 9-1\1\ or eHJ-4-HNE was added. Miconazole, phenytoin, and cyanamide
were added to the reaction immediately prior to the aldehyde substrate.

Anaerobic metabolism of 9-AA and 4-HNE bv mouse liyer microsomes. The
incubation reaction was prepared as described above for 9-anthraccne aldehydc and 4TI~F

in an Erlenmeyer flask fitted with a serum stopper fitted with syringes. First thc

bufTer was bubbled for 5 min with carbon monoxide or argon followed by addition of the

P450. A mixture of glucose (74 mM). glucose oxidase (0.33 mg/mL) and catalase (1400

U/mL) was also added. The headspace ofthc reaction mixture was i1ushed with cither
carbon monoxide or argon for 3 min and the reaction initiated with I 00 ~lM NADPH. The

reaction was conducted for 20 min and during this time, the headspace of the reaction
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\vas continuously flushed with either argon of carbon monoxide. The reaction Vias
terminated by adding NaOH (for the 9-AA incubation) or frozen in liquid nitrogen (the 4lINE incubation). Extraction of products was performed as described above.

Kinetic analysis of 9-AA metabolism bv Cvp2c29. The reaction contained prcpared

sonicated membranes (containing both 50 nM CYP2c29 and approximately 100 nJ\!
CYPOR), 0.1 M potassium phosphate buifer pH 7.4. and the NADNI-regenerating
system. The membranes were co-incubated with 25

~lM

or 50

~M

4-1 INE and increasing

concentrations of 9-anthracene aldeyde for 10 min at 30°C shakillg at 200 rpm. The
reaction was terminated with 0.1 M NaOH and product extracted with ethyl acetate as
describcd above. Fluorimetric measurements were performed as described above.
Analysis of the data was performed using the Kinetin program (Clark and Carol. 19R()).

High performance liquid chromatography (HPLC). The HPLC system consisted of a

Waters automated gradient controller with dual model 510 pumps (Vlilford. MA). a
Waters manual injector (2 mL loop) and a C 18 reversed phase column (5 pm, 250

111111

x

4.6111111 Varian. Walnut Creek. CA) connected to a radioactivity detector (Radiometric
Flo-one B model ;\-515 detector, Packard Instrument Co., Downers Grove, IL) or to a
fraction collector (Biorad Modcl221 0 BiOl'ad. Hercules. CAl. The mobile phasc v. as a
linear gradient ranging from 100% solvent A (0.1 % (v/v) TFA in water) to 1OO?Ic) solvent

13 (40% solvent A, 60% acetonitrile). Solvents were delivered at a 110w rate of I mL/min
for 75 min as follows: linear gradients from 100<% to 7M"o solvent l\ (0-15 min). ii'om
76(X) 1\ to 74°;() i\ (15-40 min). from 74(Yo to 40% A (40-45 min). from elm'i) to 0% j\ (45-
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GO min), and then eluted with 100% A (60-75 min). The conditions were changed to
100(0) A over 10 minutes prior to starting the next run. The incubation and J TPLe analysis

Were performed in triplicate.

Gas chromatography-electrospray ionization/mass spectrometrY of 4-HNE
metabolites. For GC- MS analyses, the samples were derivatized in 20 ilL of acetonitrile

with 20 ~lL ofN,O-bis(trimethylsilyl)-trifluoroacetamide (BSTFA) for I hat 60

0

e as

described previously (Srivastava et al., 2000). The mixture was cooled to room
temperature and 1 ~lL aliquots were used for analysis. The GC-EUMS analysis was
performed using an Agilent 6890/5973 GC/MS system (Agilet11 Technologies) under 70

tV electron ionization conditions. The compounds were separated on a bonded phase
capillary column (DB-5MS, 30 m x 0.25 mm IO x 0.25

~m

film thickness from

nw

Scienti tic Folsom, CA, US!\. The GC injection port and interface temperature were set

(0

280"C. with helium gas (carrier) maintained at 14 psi. Injections were made in the
splitless mode with the inlet port purged for 1 min following injection. The GC oven
temperature was held initially at 100ll C [or 1 min, and then increased at a rate of looe
min'l to 28(tC, which was held for 5 min. Under these conditions, the retention time ror
I1NA derivative was 9.67 min.

Statistical analysis. Experiments were conducted in triplicate and the means and

standard deviations (SO) were determined. Where appropriate a Student's I-Test was
used for statistical analysis with p:S 0.05 as the criterion for significance. Alternati\'c1y,

analysis of variance (ANOY1\) was performed when required.
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RESULTS
Flourescence spectra of the 9-anthracene aldehyde metabolites 9-anthracenc
carboxvlic acid and 9-anthraccne methanol. The method for measuring 9-anthraccnc

carboxylic acid, the oxidized product of 9-anthracene aldehyde. had been previously
described (Marini et al., 2003). The excitation and emission wavelengths 01"25511111 and
458 nm respectively were used to measure 9-anthracene carboxylic acid formation. 9anthracene methanol is a reduced product of9-anthracene aldehyde. Using the Perkin
Elmer model 50B spectroiluorimeter we determined the excitation and emission
wavelength of 9-anthracene methanol to be 255 nm and 411 nm respectively (Figure 8).
The emission wavelengths for both 9-anthracene carboxylic acid and 9-anthracene
mdhanol were strikingly different, thus enabling us to measure these products {"rom [>450
incubation reactions using appropriate standard curves for the two florescent metaholites.
9-Antbracene methanol was measured in the ethyl acetate of the organic phase after
raising the pH with base. The f1uorescence intensity of9-anthraccnc methanol was high
in this phase suggesting efficient extraction into the organic phase. 9-Anthraeene
carhoxylic acid was extracted into ethyl acetate following acidification of the aqueous
phase.
Evaluation of P450s capable of oxidizing anthracene-9-carboxaldchvdc to
anthracene-9-carboxylic acid. Watanabe et al. (1991) demonstrated that Cyp2c29 is an

aldehyde oxygenase utilizing a cannabinoid aldehyde at low ~ll\f concentrations as a
substrate. Therefore, we sought to evaluate the ability of a number of PLt50s ror their
ability to oxidize a synthetic aldehyde substrate, 9-AA (Watanabe et 01 .. 2002~ Marini el
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al., 2003). Several P450s rapidly metabolized the aldehyde compound, while others
apparently did not oxidize this aldehyde to its carboxylic acid Cfable 3). For example.

l)_

anthracene aldehyde oxidation activity for human CYP3A4. human CYP2B6. and mouse
Cyp2c29 was appreciable. while the ability of CYP 1A2, CYP2E 1 and CYP2.J2 to oxidize
this model aldehyde was negligible. There were also significant levels of activity seen
with liver microsomes from mice (1.5 nmollmin/nmol P450). We sought to determine the
kinetics of 9-AA oxidative metabolism by murine CYP2c29, as well as the human
CYP3A4 (Figure 9). The P450s were incubated with varying concentrations of 9anthracene aldehyde at 30°C and subsequently analyzed to determine the KM for
oxidation to acid. Recombinant mouse Cyp2c29 expressed with CYPOR in F. coli
membranes oxidized 9-AA to 9-ACA with a Kea! 01'7.4 min-! and a KM 01' 71- 0.9 ~lM
with apparent normal Michaelis-Menten kinetics. We observed a slight deviation

or

CYP3A4 from simple Michac1is-Menten Kinetics toward cooperativity. CYP3,\4
displaycd a Kea! of 7.6 min-! and an So.s of 15 ~lM. These rcactions wcre inhibited by
more than 98% by addition of either 0.5 mM mieonazole or by omission ofNADPI r fi'olll
the reaction mixture (results not shown). The KM values were in the pM r~l11ge. Therci'ore.
we assayed all P450s at a concentration of25 ~lM. since this value was at least 3-1 O-fold
higher than the Km for Cyp2c29 and CYP3i\4.
CYP2B4 was used in a reconstitution experiment to measure 9-/\;\ metabolism
(Figure 10). Reconstitution was performed in dilauroylphosphatidylcholine and pig
CYPOR. The reductase concentration (1.75 fold ratio of reductase to P450) that gave
highest activity for the P450 was used in the reconstitution. Maximum oxidation of
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Figure 8. Structure and fluorescence spectra of 9-anthracene aldehyde metabolites.

The spectra of (A) 9-anthracene aldehyde (9-AA), its oxidized form, 9-anthracene
carboxylic acid (9-ACA) and its reduced form, 9-anthacene methanol (9-AMeOH). (B)
Excitation and emission spectrum of9-ACA, excitation and emission spectra of9AMeOH. Y-axis = relative fluorescence intensity, X-axis = wavelength (nm).
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Figure 9. Concentration dependence of oxidative mctabolism of 9-anthraccne
aldchydc Cyp2c29 and CYP3A4. The concentration of 9-AA was varied and the initial
ratcs of metabolism measured in the presencc of an NADPII regencrating system,
NADPI L and either recombinant Cyp2c29 or CYP3A4. The P450 concentrations wcre 50

11M and both P450s were expressed into E. coli spherosomes with their flavoprotein
oxidoreductase, NADPH:CYPOR. The data were mean ± SD collected in triplicate and
analyzed using a double reciprocal plot. The Kill and

S05

50

valucs are shown.
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9-AA was observed when CYP2B4, the reductase and dilauroylphosphatidylcholine \vere
all present. Little reduction of 9-AA was observed for this P450.

Analvsis of 4-IINE metabolites generated bv CYP2B4. I [PLC and gas

chromatography-mass spectrometry were used to characterize the oxidative metabolites

of 4-HNE Cormed by recombinant cytochromes P450. r3H]-4-HNE at concentration

or 50

pM was incubated with CYP2B4 and CYPOR for 20 min in the presence of NADP[ f.
Preliminary experiments with the recombinant samples demonstrated that the rates of 4lINE metabolism were linear for this time period. A representative

~!lrol11atogram

or "~

ITNE and its metabolites separated by HPLC when oxidized in a reconstituted system
containing 200 nM purified rabbit CYP2B4, 600 11M CYPOR, 50
dilauroylphosphatidylcholine, 0.5 mM NADPI-L and 50

~lM

~lM

4-HNL is shown (Figure II).

Spontaneous decomposition of 4-HNE during the extraction and resolution procedurl'
was minimal, as shown by the limited formation of any analytes that Vvere retained
slIghtly longer than 4-UNE at the zero time point (Figure II A). Moreover, v"hen
NADPI-I-P450 oxidoreductase and dilauroylphosphatidyl choline were reconstituted in
the absence of P450, little product was formed (Figure II B). Identical results wcrc
obtained when the NADPI-I, the oxidoreductase, or P4502I34 was omitted (results not
shown). When all three components were reconstituted over a 20 min incubation period,
3% of the total

3

rHJ-4-HNE was converted to a product with a retention time (1/1)

or :'i()

minutes (Figure IIC, Table 3), indicating that this rabbit P450 cfTeetivcly metabolized 4lINE to one major product. Based on the co·-migration orthe authentic 4-

hydroxynonenoie acid standard generated with yeast aldehyde dehydrogena:ic, we
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Figure to . Metabolism of 9-Anthracene by reconstituted CYP2B4. The reconstitution
or CYP2B4 was conducted in 50 flM dilauroylphosphatidylcholine, 86 nM pig
NA])PlI:CYPOR and 50 nM CYP2B4. Incubation with 9-AA (25

~lM)

was initiated by

adding 100 flM NADPH and continued for 10 min at 30°C. Formation 01' 9-A(,A and 9AMeOI [ was determined by spectrof1uorometry. Data represent the mean ' S.D. or a
triplicate incubation. Statistical significance was determined using the Student's I test.

***

Significant increase in 9-AA oxidation in the presence ofCYP2B4, CYPOR and

eli laul"('),lphosphatidylcholine. p< 0.001.
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tentatively assigned the identity o[the product with a retention time generated hy
CYP2B4 to 4-hydroxy nonenoic acid. An unknown metabolite (3% conversion. putative
lactone) eluted slightly more slowly than the substrate 4-HNE (IF: 60 min lor the unknown
and If( 58 min for 4-HNE); this analyte was present at zero time with j)uri1icd.
reconstituted CYP2B4 and did not increase with timc. Inclusioll

or 0.5 mM mieOllll;:ole

as a P450 inhibitor with the fully reconstituted CYP2B4 system completely inhibited

I INA formation, but had little or no effect on the amount of unknown product gencrated
(Figure 11 D), suggesting that it may not be generated enzymatically. NADPJ I ~md~

lINE incubated alone for 20 min did not result in analytes other than the small amount () I'
an unknown metabolite (data not shown). These results demonstrate that reconstitution

or

purified rabbit CYP2B4 with CYPOR and lipid results in metabolism or 4-I-INJ·: to 4hydroxynonenoic acid. Similar results were obtained with other P450s tested using

1'111-

·+·IINI~, except that several P450s displayed products eluting in the region near that seen

with the unknown metabolite and several displayed products that \\ere more polar than 4hydroxynonenoic acid. These results demonstrate that CYP2B4 generates 4hydroxynonenoic acid from the oxidation or 4-HNE.

Evaluation of P4S0s in oxidative mctabolism of 4-HNE to 4-hvdroxvnoncnoic acid.

U sing a fixed concentration of 50 11M 4-HNE, we examined several P450s as catalysts

for oxidation orthis aldehyde to its carboxylic acid. After metabolism, the products werc
analyzed by HPLC with radiometric detection of product. The reactions with either
CYP2c29 or CYP3A4 were shown to be linear to 20 min with SO 11M 4-HNE substrate.

Using a flxcd concentration of 50 11M 4~HNE, we examined several P450s as catalysts
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Figure t 1. The reconstitution of 4-HNE oxygenation activity catalyzed by rabbit
CYP2B4. Purified rabbit CYP2B4 was used to catalyze the NADPH-dependcnt

oxygenation of [ltll-4-HNE in the presence of purified CYPOR and
dilaurylphosphatidylcholine at 37°C. The CYP2B4 concentration was 250 nM and the
amount ofNADPl-l:cytochrome P450 oxidoreductase was the amount that caused
maximal 7-benzyloxyresufin debenzylation in the prescnce of
dilaurylphosphatidylcholine (data not shown). The reaction was linear to 20 minutes and
after terminating the reaction with an equal volume of 1% TF A in water, 4-l-INE and its
products werc analyzed by HPLC with a radiochemical detector. A. Zero time sample.
B. 20-Minute time point with reconstituted P450 and oxidoreductase \\ ithout
dilaurylphosphatidylcholine. C. 20-minute incubation reaction with reconstituted
CYP2B4. oxidoreductase and dilaurylphosphatidylcholine. The arrow points to the
putati ve 4-hydroxynoncnoic acid peale D. 20-minute incubation reaction with
reconstituted CYP2B4, oxidoreductase and dilaurylphosphatidylcholine in the presence
of 0.5 mJ\1miconazolc. L is the tentative lactone peak, 1L = reconstitution in lipid alone,

R + L + E~' reconstitution in CYPOR, lipid and CYP.
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for oxidation of this aldehyde to its carboxylic acid. After metabolism, the products \\crc
analyzed by HPLC with radiometric detection of product. The reactions with either
CYP2c29 or CYP3A4 were shown to be linear to 20 min with 50 pM 4-HN}: substrate.
In addition to the reconstituted rabbit CYP2B4, some human and murine P450s also
catalyzed 4-HNE metabolism. The rates of 4-HNE oxidation shown in Table 3 wcrc ill
the order of CYP2B6>CYP3A4>Cyp2c29>CYP2J2>CYP2B4. CYP 1 A2 and CYP::E I
were analyzed and did not appreciably oxidize 4-HNE.

Mass spectral analysis of products of aldchvde oxidation hy J>450s. Based on thc
iluorcscence spectra of the products formed from 9-anthracene aldehydc, the products in
the aqueous phase of the reaction appear to be identical to that of 9-anthracenc carboxylic
acid. J fowevcr, in order to validate that the major product formed hom 4-I-INE is 4:lydroxynonenoic acid, we used HPLC to analyzc thc ability of Cyp2c2(), CYP3A"f.
CYP2B4, and CYP2BG to metabolize 4-HNE to its carboxylic acid. Thc product that comigrated on HPLC analysis with the ALDH-biosynthcsized carboxylic acid metabolite
was collectcd and derivatized with N-methyl-N-(t-butylidimethylsilyl)lritluoroacctamide prior to analysis by GC-MS. The mass spectra ofthc AIDIIhiosynthcsized product, !INA, was identical to that of the putative !-INA product formcd
by Cyp2c29 (Figure 12). A faint parent peak was noted at miz 316. and major ions at mil:
of 30 I (M-CH3 due to loss of a methyl group from the trimcthyl silyl group) and at m/z
245 (M-CIIII due to loss of the 5 carbon alkyl side chain to cleavage betwcen C5 and
of 4-HNE). The mass spectra of the products formed by CYP3A4 and CYP2BL+ vvere

nearly identical to that observed in the presence of' Cyp2c29 (dnta not shown).
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Table 3
Catalytic activities of mouse and human CYPs expressed in I,,'. coli

Cyp

9-AA Oxidation
Activity

4-HNE
Oxidation
Activity

DUN formation

Lactone
formation

(nl1lol/lllin/nnlOl CYP)

(nllloi/illin i nillol CYP)

(nlllol/illin i nll10 l ('YI')

(nJlloi:lllillilll1loi ('YI')

7.4

0.96

0.30

nn

Cyp2c29
- - - - - - . - ...-~---f__---

--------+--------- ----------

---

CYP3A4

7.6

2.39

25.1

CYP2B6

2.3

53.1

33.3

CYP2J2

<0.1

0.95

1.72

23.28

<0.1

(J.el.)

3Xl
--,-----~

--

20.63
-

---

--- - - - - - - - - - - - - - - . - - - - - - f - - - - - - - - - - - - -

CYP2B4
1- - -.

??

----------------.--~----r____---

CYP1A2
-

0.36
------------

<0.1

<0.1

7.39

<0.1

<0.1

<0.1

<0.1

<0.1

1.02

OAc;

-_.-

.

CYP2EI
- -I-

Microsomes

1.5

0.37

--11- ___

The enzyme activities are expressed as turnover number and were the average of 4 assays
with a standard deviation of less than 5% of the average. Mouse liver microsoll1al
(i'actions were prepared from animals fed AIN-76A diet containing 0.51% butylClled
hydroxyanisole for 7 days. The concentration of 9-AA used was 25 ~d\1 and of 4-f1NE
\vas 50

~lM.
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Figure 12. Mass spectra of authentic 4-hydroxynonenoic acid and product generated
from Cyp2c29-dcpcndent oxidation of ,3111-4-HNK After metabolism. the samples
were analyzed by HPLC and the fractions eluting with the same retention time as the 4hydroxynonenoic acid standard were collectcd and subjected to cleetrospray ioni;:ationmass spectral analysis. A. Authentic 4-hydroxynoncnoic acid. B. 4-hydroxynonenoic
acid produced by Cyp2c29.
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documenting that a primary oxidation product formed from 4-HNE by several P450s was
identified as 4-hydroxynonenoic acid, the expected oxidation product.

Kinctic analysis of 4-IINE-inhibition of 9-ACA metabolism catalyzcd bv Cvp2c29.

The observation that Cyp2c29 catalyzed the oxidation of both 9-anthracel1c aldehyde amI
4-I-INE to their carboxylic acids led us to measure the steady-state kinetic parameters for
Cyp2c29 oxidation of 9-anthracene aldehyde in the presence of increasing concentrations
of 4-HNE. Previous studies by Coon and coworkers (1995) established that (,YP2!': I is
inactivated at high concentrations of 4-lINE (J 40-400 flM). providing

(l

direct tool Cor us

to determine the mechanism of 4-HNE as an inhibitor of 9-anthracenc carboxylic acid
formation by Cyp2c29 at low. Since

(X,~-unsaturated

aldehydes may inactivate these

P450s, we incubated most of the P450s shown in Table 3 with 4-hydroxynonenaL
acrolein, and trans-2-hexenal to assess whether they are irreversible inhibitors (dal~~ not
shown). After 20 minutes incubation, the samples were diluted 1O-f'old and the 9-AC/\
f'ormation or other enzyme assay measured. Acrolein and lruns-2-hexenal had little or no
cirec! on any P450 tested (data not shown), but in the case of 4-HNE. there was some
inhibition. However, this inhibition was dependent on the initial concentration of'4-TII\I'
added. Enzyme kinetic parameters were determined hy fitting kinetic elate: llsing nonlinear regression analysis to various models using the enzyme kinetic analysis prog:'(lm
Kincti 77 (Clark and Carol, 1989). The best fit for Cyp2c29 was a mixed competitive
inhibition by of 9-AA metabolism by 4-HNE (Figures 13). The Villax for 9-AA oxidation
in the absence of 4-HNE was 130 ± 7. The apparent K, of 4-I-lI\L for Cyp2c29 \vas

approximately 32 J: 4 ~lM calculated from the double reciprocal plot ( l/V vs. 1II SI ill the
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presence of 4-HNE; see inset Figure 13A). In separate studies not shown, we detcrmined
an apparent Kill for 4-HNE oxidation to HNA by Cyp2c29 of ~ 15

~lM.

These results

suggest that at low concentrations, 4-HNE is a competitive substrate ror

Cyp:~c29

\vith 9-

AA (Figure 13B). At 4-HNE concentrations above 300 )1M. significant inactivation

many P450s occurs (Kuo et aI., 1997). There was no cifect of 4-HNE (100

oj'

,LlM) 011

CYPOR activity with up to 30 min incubation in the presence of NADPI-J (data not

shown).

Oxidation of 9-anthracene aldehyde by mouse liver mierosomes. The oxidation of 9-

AA by liver microsomal protein (0.25 mg/mL) from mice fed with O.5(j;) 1311/\ in I\IN7(lA diet was also determined (Table 3). The rate of formation of 9-ACA was 1.5

nmollmin/nmol P450. In order to deduce which P450s may be involved in this reaction in
mouse liver microsomes. we used selective cytochrome P450 inhibitors previollsly
established to be effective in primary hepatocytes. Miconazole (500

~tl\f)

eausd

approximately 50% inhibition. as expected (Figure 14). Lower concentrations of
miconazole (1 00

~lM)

caused 20-25% inhibition suggesting that Cyp3a enzymes may be

partially involved in 9-AA oxidation (data not shown). Phenytoin (500 ~lM) is a
ccmpetitive substrate for Cyp2c29 (Jackson c! al .. 2(04) and caused approximately 40 l Yt,
inhibition of 9-AA oxidation activity. On the other hand, trolealldomycin is a speci fic
mechanism-based inhibitor for CYP3A enzymes (Chaurct c/ (fl., 1997) and incubatioll
500 ~lM troicandomyein, 0.5 mM NADPH, and liver mierosomes ror 10 min prior to

l)-

AA oxidation assays. resulted in 40~;) inhibition of the reaction in mouse liver

mmicrosomes. The aldehyde dehydrogenase inhibitor cyanamide did not signiJic(lntiy
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or

Figure 13. Kinetic analysis of inhibition by 4-I1NE of anthracene-9-carhoxaldehyde
oxygenation by Cyp2c29. The concentration dependence of 4-HNE inhibition of 9-I\A
oxidation was performed by incubating increasing concentrations or 9-AA with O. SO or
I 00 ~lM 4-HNE in the presence of 0.25 mg/mL Cyp2c29-containing spherosomes and

100 ~lM NADPH at 30 0 e for 10 min in a shaking water bath. A.
~lM

0,

0 ~lM 4-HNE; L\, SO

4-HNL U, 100 IlM 4-I-INE. Data shows the mean activity±: SD ofa triplicate

incubation. Inset: double reciprocal plot of lIrate of metabolism vs. lIanthracene-9carboxaldehyde concentration. B. Scheme accounting for mixed competitive inhibition.
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inhibit microsomal oxidation of9-AA, suggesting that there was litlle or

110

contribution
l~oth

or ALDH in the microsomal preparation (Table 4). These results demonstrate that

murine Cyp2c29 and Cyp3all (or related P450s) likely catalyzed the oxidation of 9-1\/\
with liver microsomes from C57BLl6 mice. Further, the partial inhibition by the t\yO
compounds suggests the participation of multiple P450s in the microsomal reaction.
namely Cyp2c29 and Cyp3a Cfable 3).

Metabolism of 4-IINE by mouse liver microsomes. The oxidation of4-lINE by

mOLlSe

liver microsomal protein was also determined by HPLC as described previously
(Srivastava e/ al., 2002). The reaction was performed by incubating 50 flM r.llIl-4-11NL.
NADPH. and microsomes. 4-HNE was oxidized at a rate of 0.37 nmol/min/nmol P450
(Table 3). As with the E. coli-expressed Cyp2c29. the mouse liver microsomal fi'aetions
generated an unknown metabolite (tR

=

62 min). In addition, a polar mctabolitc (tR -~ 4

min) was observed near the bcginning of the gradient, which has not been characterized
to date. Miconazole, a general P450 inhibitor, caused approximately 40(X) inhibition of 4-

HNE oxidative metabolism to 4-hydroxynonenoic acid by mouse liver microsomal
protein fractions (Figure 14). The Cyp2c29 inhibitor phenytoin caused 70% inhibition oj'
total 4-HNE metabolism. while troleandomycin. a specific inhibitor or C:yp3,,- caused
40% inhibition. These data demonstrate the importance of the two murine P450s. ill the
oxidation of 4-HNE and suggest that multiple P450s are involved in the oxidati"e
metabolism of 4-HNE.
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Figure 14. The effect of specific inhibitors on mouse liver microsomal aldchyde
oxygenase activity for 9-anthracene aldehyde and 4-hydroxynonenal. Liver
l1licrosolTles from C57BLl6J mice fed AIN-76A diet supplemented with 0.45% BIlA was
used to perform the 9-AA and 4-HNE oxygenase activities. SpeciJic P4)0 inhibitors (0.)

111M miconazole or phenytoin) were added to the reaction mixtures or preineubated (0.5
mM troleandomycin) with liver microsomes and NADPH prior to adding aldehyde
substrate. The enzyme activities are the mean ± of a triplicate incubation. Statistical
significance was determined using analysis of variance.
llninilibi1l:d control, p

=

0.05.
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* Significantly difrerent II·om the

Figure 14
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Table 4
Effect of alcohol dehydrogenase, aldehyde dehydrogenase, and P450 inhihitors on
recombinant CVP3A4 activity.

Inhibitor (100 JlM)

% of control activity

Control

100

miconazole

15

3

troleandomycin
~

-

~----~~-~-~----

--

--~---

~--~-

-~----

--

--~-~---~--~~------~

~~-----

92

cyanamide
I

-~~~---

-

~

- - - - ------

benomyl

37

4-methylpyrazole

2

The activity of CYP3A4 was measured at 25°C using the 7-benzyl ether of resorufin as
substratc in the presence of 0.5 mM NADPH and E. coli membranes expressing both
CYP3i\4 and NADPII:cytochrome P450 oxidoreductase. The acti\'itics were

all C\\Cr;lgc

of three assays and the standard deviation was never more than 5-8% of thc avcrage
vJiue.
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Metabolism of 4-HNE in primary cultures of rat hcpatocytes. Studies by Peters'211 and
coworkers (Hartley et af., 1995) demonstrated that primary cultures of rat hepatocytes
metabolize 4-HNE to its carboxylic acids by oxidative reactions, its dihydroxy form
through reductive reactions and its glutathione adduct through GSIl conjugation
reactions. Based on thc use of inhibitors, they concluded that aldehyde debydrogenClses
were the major catalysts of the oxidative reaction. However, om results suggest that some
P450s are sensitive to the known inhibitors of aldehyde dehydrogenases For example.

I 00

~lM

benomyl caused 65% inhibition of CYP3A4 and 1 flM 4 methylpyrazole. alcohol

dehydrogenase inhibitor caused 98% inhibition of CYP3A4, Table 4. Miconazolc and
trolcandomyein are known to be potent inhibitors of CYP3A (Chamel e{ aI., 19(7). On I:
r:yanamide was shown to be a specific inhibitor of aldehyde dehydrogenase at SOO :d\1.
cll~d

did it not inhibit benzyloxyresorufin O-debenzylase activity of CYP3A4. Since two

major classes of enzyme catalyze the oxidation of aldehydes to carhoxylic acids. namely
aldehyde dehydrogenases and the P450s, we sought to test the relative participation 01'
these two systems in aldehyde oxidation in a cellular model. Specific inhibitors of ALDlI
(cyanamide) and P450s (miconazole and troleandomycin) ,vere utilized to determine 1he
relative participation of these enzymes in the metabolism of [3 11]-4-H\lE in primary
cultures of rat hepatocytes. Because CYP3A4 is inhibited by 4-methylpyr,l/ole and
hcnornyl (Table 4), we did not utilize these inhibitors previously believed to he specific

ror alcohol dehydrogenase and aldehyde dehydrogenase, respeetive!y. The HPLC profile
for the 4-HNE metabolites formed in rat hepalOcytes (Figure 15A). polar metabolites (tl,
5 min), GSH conjugates of 4-HNE (tR 4l.5, 45, and 49 min), DHN (tR 55 min), HNA (tR
57 min) and the slower eluting metabolite (tR 62 min), similar to that rcposted by Petersen
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Figure 15. Use of specific inhibitors of aldehyde dehydrogenase (cyanamide) and
P450 (miconazolc and troleandomycin) on 4-HNE metabolism in primary
hepatocytes from Sprague-Dawley rats. Primary rat hepatocytes were prepared as
described in Methods with a viability 01'>95(;10 and immediately treated with 4-IINE. The
reactions were quenched by adding 1% TF A and frozen at -80°('. The products were
measured by HPLC and radioactivity determined using a radiomatie detector. A. HPLC
elution profile for 4-HNE metabolized by rat hepatocytes. B. Effect of inhibitors (0.5
mM) of aldehyde dehydrogenase (cyanamide) or P450 (miconazole or trolcandomycin)
on formation of lIN A. Four preparations of rat hepatocytes was used to obtain statistical
signiticance compared with the absence of inhibitor. *, p ,~c O.05~ **, p= O.JOl.
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and coworkers (Hartley et aI., 1(95). We treated hepatocytes with an AL])II inhibitor
(cyanamide), a general P450 inhibitor (miconazole), or the speciiic CYP3i\ inhibitor
(troleandomycin) at 500 11M, concentrations shown to maximally inhibit aldehyde
dehydrogenases or P450s in microsomes or expressed recombinant P450s, respectively
(results not shown). The effect of these inhibitors on production of various ul1conj ugatecl
hepatocyte metabolites are shown in Figure 1513. Addition of the ALDII inhibitor
cyanamide caused a 55% inhibition of HNA production, while miconazole caused ~.. 25<%
inhibition of EN A formation. When cyanamide and miconazolc were added together.

IlNA formation was inhibited by 85%. Troleandomycin, the inhibitor orCyp3a.
stimulated JTNA formation by 175%. Mieonazole alone, or miconazole plus cyanamide
decreased formation of the polar metabolite, but increased GSI-l cOI~ugate formation
(data not shown). These results demonstrate that the increase in GSI-I conjugates whell
P·150 and ALDH are inhibited is most likely the result of all three pathv.ays of
metabolism being similar in their metabolic rate and affinity. ar,d that the glutathione ,r..,'transfcrases utilized the remaining free 4-HNE.

R~ducti()n

of 9-anthracenc aldehyde to 9-anthraccnc methanol by cvtochromcs

P450. Cytochromes P450 are mostly known to catalyze substrate monooxygenation. [n
studying aldehyde metabolism by cytochromes P450, we definitively observed oxidation
to the carboxylic acid. Interestingly, in addition to the oxidation reaction, a limited
number ofP450s reduced the aldehydes to their corresponding alcohols. Incubdtion
experiments were performed vvith either 50 nM recombinant P450 or 0.25 mg/mL mOllse
liver microsomes as described under materials and methods. Incubati@ with

1l101lSl:

liver

microsomes caused the reduction of 9-AA to 9-anthracene methanol at a rate of 0.25
nmollmin/nmol enzyme. Likewise, the incubation of human CYP3A4 with 9-anthracCllC
aldehyde caused reduction at a rate of 0.32 nmol/min/nmol CYP (Figure

1 ()).

This is in

comparison with 9-AA oxidation activity of ] .5 nmollmin/nmol CYP for microsoll1es and

7.6 nmol/min/nmol CYP3A4 Crable 3).

Reduction of 4-HNE by P450s and identification of metabolite by IIPLC-mass
spcl'tromctry. To study the reduction of 4-HNE by cytochromes P450, 50 nM of each
['450 was incubated with 50 ~lM [3Ifj-4-HNE and NADPH for 10 J1lin. The NADPI I
regenerating system consisting of ID} I was omitted hecause we observl'd a reactiop
between 4-HNE and components of the regenerating system. The incubation of 4-11011':
with P450 generated a product that migrated at a tR of 55 min by HPLC. The profile
shown in Figure 17 was obtained by incubating 4-HNE with CYP3A4-. The identity

or

this CJmpound was determined by gas chromatography electron impact-mass
spectrometry to be the reduced form of 4-HNE, namely 1,4-dihydroxy-2-nonene (D1-I[\)
(Figure] 8). The parent peak was not observed at mil: 3 J 8, but n:ajor ions were ohsened
at m/z of287 (M-CI-h due to loss of a methyl group from the trimcthyl sily! gr(iup) and ~lt

m/z 231 (M-CHII due to loss of the 5-carbon alkyl side chain by cleavage bctween C5
and C6 of 4-HNE). In addition, incubation of 4-lfNE with rat prinury hcpatoeytes

resulted in 4-HNE reduction to DHN.
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Figure 16. Reduction of 9-anthracene aldehyde to 9-antracene methanol by CYP3A4
and mouse liver microsomes. 9-AA (25 ~ll'v1) was incubated in 0.1 .'vI potassium

phosphate burfer. pH 7.4 with 50 nM CYP3A4 or 0.25 mg/mL mOllse liver microsomal
protein at 3011 C for 10 min in a tinal volume of 2 mL. The tTaction \vas terminated with I

1111,

or 0.5 N NaOI-f. Following extraction in 4 mL ethyl acetate, 9-AMeOI r was

measured by fluorescence spectroscopy

O~

excitation, 255 nm; Ie emission, 411 nm) in tbe

organic phase. The results are expressed as the average oflriplieate experiments of three
reactions in which the SO varied by

.:s SCYo.
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Figure 17. HPLe profile of metabolism of 4-HNE catalyzed by CYP3A4. The

metabolic assay was performed in triplicate with 2 mL of reaction mixture containing F
m/i expressed CYP3A4 (50 nM) and 50 11M [3 Hj-4-HNE and 100 ~lM at 37°C Cor 20

minutes in a shaking water bath. The reaction was terminated by flash freezing in liquid
nitrogen. The reaction was thawed upon adding TeA, centrifuged and the supernatant
injected onto the HPLC column. 1A-dihydroxy-2-noncne is duted at 56 minutes and 4hydroxynonenoic acid at 57 minutes.
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Figure 17

Retention time (min)

Figure 18. Mass spectra of 1,4-dihydroxy-2-nonene (DHN) generated from
CYP3A4-dependent metabolism of [3HI-4-HNE. After metabolism, the samples were

analyzed by IIPLC and the fractions that eluted with the same retention time as the DI-IN
standard at

tN 56

min were collected and subjected to mass spectral analysis. A.

j\uthentic ])JIN, B. DlIN produced by CYPJA4.
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\Ve have not been able to confirm the identity of the lactone. which may be due to its
re;lrrangemcnt to a more complex molecular (.I. Cai and W.M. Pierce. Ph.D .. Universit)
of Louisville School of Medicine. privileged communication).

The formation of DEN in rat hepatocytes was inhibited by the

P·~50

inhibitor

miconazole (57%) and troleandomycin (83%), the ALDH inhibitor cyanamide inhibited

DIIN formation (8°/c» (Figure 15). A combination of cyanamide and miconazo\c caused a
further inhibition of 73% of inhibition of DJ-IN formation. Taken togcther. this data
suggcsts that P450s participate in both the oxidativc and reductive mctabolism of4·JIi\'I':,
There is also a competition for 4-J-INE metabolism as seen vvith the increase in DI IN
('ormation following inhibition of the oxidation pathway by cyanamide,

Anaerobic conditions inhibit P4S0-depcndcnt oxidation but not reduction of
aldehvdes, To catalyze a monooxygenation reaction, cytochromes P450 require

molecular oxygen, CYPOR and NADPIl We developed a methcd

10

validatc the

oxidative and reductive metabolism of9-AA and 4-HNE by cytochrol11cs P450. This
method involves anaerobic metabolism in the presence of either argon or carbon
monoxide. The anaerobic environment was created by two differcnt mcthods In thc hst
mcthod.

\VC

bubbled the hcadspace or the reaction with argon and then addcd

to

the

incubation reaction glucose oxidase, glucose, and catalase. The glucose oxidase reaction
consumed molecular oxygen to catalyze glucose oxidation to glucuronic acid. a reaction
that generates hydrogen peroxide, The hydrogen peroxide \vas removed by its
conversion to 11202 and water by added catalase, The residual oxygen in the systcm was

mini mized hy continuous f1 ushing of thc headspacc of the illcuhation rcaction ,yi th argon.
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Figure 19. Lack of oxygen inhibits P450 dependent oxidation but not reduction of
aldehydes. The incubation reaction was prepared in an Erlenmeyer nask fitted with a
serum stopper fitted with syringes. Following initiation of the reaction, the headspace

or

the reaction was continuously nushed with argon (anaerobic) or carbon monoxide (CO).
The reaction was terminated with 0.5 N NaOH (9-AA) or by flash freezing ill liquid
nitrogen (4-1INE). 9-ACA and 9-AMeOH were extracted with ethyl acetate and
measured by f1uoreseence spectroscopy while 4-hydroxynoncnoic acid and 1Adihydroxy-2-nonene were measured by HPLC.
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DIIN

9-A-M cOli

file second method was by flushing the hcadspace or the reaction with carbon monoxide.
CO hinds to the sixth coordination position of heme in the P450 ])[cvl:nting the binding

or

oxygen. From these experiments, we observed that the oxidation of 9-;\;\ to 9-;\C/\ and
4-HNE to 4-hydroxynonenoic acid by mouse liver microsomes was signilicantly
inhibited by more than 90% (Figure 19). The P4S0-mediatcd reduction of 9-;\;\ to 9AMcOlI and 4-HNE to 1,4-dihydroxy-2-noncne vvas not affected by the anaerobic
environment. The reduction of 4-HNE to 1,4-dihydroxy-2-nonene was slightly elevated
by the presence of CO suggesting that while O 2 is required for oxygenation. it is not
required for the reduction reaction by the P450s. In addition. CO docs not inhibit tl~e
cytochrome P450 dependent reduction.

DISCUSSION
A typical reaction catalyzed by P450s is the hydroxylation of an un Il1l1ctionali:;ed ,llkyl
group. However, examples are also known in which P450s catalyze the oxidation nf
aldehydes to acids with the incorporation of molecular oxygen into the products
(CTuengerich, 2001). Several critical P450-catalyzcd reactions have been showll

iO

involve oxidation of aldehydes or hemiacetals. namely the aromatase and sterol 14udemethylase reactions. The formation of estrogen requires oxidation of the 19-111ethy1
gruup of 4-androslenedione to a methyl alcohol derivative. followed by two consecutive
oxidation steps to form an intermediate aldehyde and carboxylic acid derivative. The
thermodynamics of dehydration drives this reaction to produce aromati;:ation of the Aring

or 4-androstenedione.

A similar reaction also occurs during the removal of'the 1+(1-

l1ldhyl group of sterols via this same reaction pathway to form the esse!ltial sterol
ergosterol; inhibition of this P450 in microorganisms has been sh()\\ n tc, be an dTcctivc
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method to inhibit the growth offungi. Human liver microsomes possess the ability to
oxidize aromatic aldehydes such as 11-oxo-!\ 8-tetrahydrocannabinol to acids by the P450
system (Watanabe e/ of .. 2002). More recently, model substrates. 9-AA and 4biphenylaJdehyde, have been used to measure the activitv of several ]>450s (Marini el (/1..
2(03). These f1uorogenic substrates provide simpk methods to measure the acid products

formed from the P450-dependent oxidation of aromatic aldehydes.
Our studies addressed the possible role of various P450s in the metabolism of
aromatic <x,r)-aldehydes (e.g., anthracene-9-carboxaldehyde) and the aliphatic <x.0aldehydes (e.g., 4-HNE). Our initial observation of murine Cyp2c29-catalyzed oxidation
of4-HNE suggested that Cyp2c29 and other related P450s may also be involved ill 4-

fINE metabolism in the heart and liver in vivo, 'where it is reportedly expressed (Luo el
(f/ .. 1(98). Cyp2c29 was initially identified as a microsomal aldehyde oxygenase (P450

lv1 UT-2) by Yamamoto et al. (1991), who observed that Cyp2c29 was the primary
microsomal P450 responsible for oxidation of a cannabinoid aldehyde. We observed that
P450s of the 2B, 2J, and 3A subfamilies also catalyzed oxygenation of aromatic
aldehydes to their carboxylic acids. These results collectively demonstrate that [>450s
also contribute to aldehyde oxidation. as suggested by Marini e/ al. (2003).

l-!O'v\l'\'CL

t\\O

other P450s. P4501;\2 and 2E 1 were analyzed and appear to be poor catalysts uf 4-1 INL
oxidation Crable 3). Our studies suggest that some of the P450s pruduce products in
addition to lINA. Furthermore. we provide data showing that 4-11NEis a competitive
substra1c for 9-AA metabolism by Cyp2c29 and suggests that other short chain alck-hydes
may he substrates for the P450. The Kill values were in the range or 1-20
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~lM.

To evaluate the relative participation of P450s and aldehyde dehydrogenases ill
oxidation of aromatic and aliphatic (X,p-aldehydcs, we studied their activity in murine
liver microsomes or with expressed recombinant P450s and its flavoprotein
oxidoreductase. The oxygenase activity ofliver microsomes was found to be inhibited>
50<% hy 0.5 111M miconazole, an inhibitor of most P450s. Using spccilic inhibitors,

\\C

also showed the participation of Cyp3a (troleandomycin) and Cyp2c29 (phenytoin)
activity in mouse liver microsomes. We observed the presence of an apprcciahle
NADP"-dependent oxidation of9-A/\ to 9-ACA in the cytosolie fi·actions of mouse liver
microsomes that was inhibited by cyanamide (data not shown).
Studies wcre performed to evaluate the specificity of known inhibitors of
aldehyde metabolizing enzymes using cyanamide (ALDI-I), 4-methylpyrazole (alcohol
dehydrogenase), and benomyl (ALDH). CYP3A4 was shown to hc potently inhibited by
heth

i~-methylpyrazone

~)pecific

and benomyL suggesting that cyanamide was the ollly ALDII

inhihitor that can be used to distinguish ALDHs from P450s.These inhibitors

were utilized in experiments with primary cultures of rat hepatocytcs to cvaluatl: the
relative participation of ALDH and P450s in 4-HNE metabolism. Cyanamide illhibitcd
HNA formation by > 55% and miconazole only inhibited HNA formatilln around 2530<Y;). Troleandomycin actually stimulated formation ofHNA, sLlggl~sting thal CypJa

enzymes may be involved in formation of other products from 4-1 TN]:. As a result,
inhibition of the Cyp3a reactions apparently increased the steady-state concentration oj" 4fINE and led to higher levels of formation ofl·INA through other P450s, as well as
/\LDlI. The production of polar products derived hom 4-11NL in :1Cpatocyles was

inhibited by miconazole, suggesting that these products arc formed bv P450s. I IO\\c\cr.
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these polar metabolites may also be due to tritiated water released during oxidative
metabolism. We observed a slight difference in the retension time of the mdabolites
between the different HPLC profiles (Figure 15 and Figure 17). We believe that this \vas
due to difTercnces in the room temperature arc the time of separation of the difTerellt
mc~tabolite

fractions by HPLC.

The GSH-conjugates were increased by P450 inhibitors. suggesting that upon
blocking the P450 reactions. more substrate is available for GSI-I conjugation of 4-1 INF
(data not shown). These results demonstrate that in hepatocytes the three pathways
involving glutathione S-transferases, aldehyde dehydrogenases and cytochrome P450s
apparently function at similar rates. Cytochromes P450 account Cor a signilicant portion
\)1'

the oxidative metabolites of 4-HNE in hepatocytes at the concentration studied.

I)etcrsen and coworkers (1995) may have underestimated the role of P450s in rat hepatic
mclabolism due to the sensitivity ofP4503A to the ALDH and alcohol dehydrogcnase'
inhibitors used.
During the study of the mouse liver microsomes and the diCkrcnt P450s that
metaholized 9-AA and 4-HNE, we found that some P450s are able to reduce these
compounds to the corresponding alcohol. We developed a method lor screening P'4S()'
involved in aldehyde reduction by using a fluorescence measurement of 9-AMcOII.
DitTerential extraction sepal'ates the carboxylic acid and the alcohol, allowing us to
measure the two metabolites in the two organic phases. Human CYPJAt dnd mouse liwr
microsomes were able to reduce 9-AJ\ to 9-AMe01-1. CYP3A4 is the major adult human
\i,er P450 and metabolizes the most xenobiotics. We also observed that this P450
catalyzed the reduction of 4-HNE to DHN. The magnitude or 4-IlNE reduction by the

individual P450s analyzed was CYP2B6 > CYP3A4 > CYPIA2 > CYP2.12> Cyp2c29.
Mouse liver microsomes also catalyzed 4-HNl: reduction. The observation or reductioll
of 4-IINE with the different P450 was further confirmed by using the P450-specilic
inhibitors.
Reductive catalysis by cytochromes P450 is uncommon cxc...:pl Cor a

re\\

substrates at low oxygen tension. Some reduced products JTlay not be stable as i -ekctronand 2-elctron-reduced intermediates in the presence of molecular oxygen. Azo dyes arc
,\idely used in cosmetics, food, textiles and drugs. The azo compound sulfollazo III and
aral1lanth are reduced by rat hepatic microsomes (Peterson ef al., jl)gg). The
hcpatocarcinogen dimethylaminoazobenzene is reduced by rat liver microsomes in an
oxyg...:n- and CO-insensitive manner (Levine and Raza 1988). The bioreductive activation
(lfthe quinine 2,3j,6-tetramethy-lA-benzoquinonc is catalyzed by CYP2B 1 (Cocptm ('/
(Ii., 1992).

P450s require NADPH and oxygen for oxidative metabolism. Therefore, in tl1'-:
absence of eitheL the P450-dependent l11011ooxygenation reaction is inhibited.

)11 ~1ddi:i0i1

to 1he usc of chemical inhibitors, we were able to demonstrate that the lac k () t' oxygel1
inhibited the P450-dependent oxidation of both 9-AA and 4-HNL but !lot the reduction

or either compound. An anaerobic environment was created by bubbling the readiol1
mixture with argon or CO, Argon lowers the p02 to zero thereby creating a relative
anactObic environment residual oxygen is removed by the glucose oxidase/catalasl:
reaction. CO binds to the sixth coordination position o1'hel1\e irol1.

prc\'\.~l1tillg

oxygen

binding. By using chemical inhibitors, CO and argon, we successfuily demonstrated tile
role of P450s in lipid aldehyde metabolism.

gg

Figure 20. Proposed pathway for the metabolism of 4-HNE by P450s with the
involvement of the oxyferryl (Fe(V)=O) and the ferrous (Fe-II) species of the P450.
Fe depicts the iron in the heme of the P450. The Fe-O v, Fe-O lv and Fe 3+ oxidation states
contribute to 4-HNE oxidation to HNA. The Fe2+ oxidation state contributes of 4-HNE
reduction to DHN.
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The proposed pathway [or 4-HNE metabolism by CYPs iis shown (Figure 20).
During the metabolism of substrate, P450s exist in different oxidation states.
These oxidation states can influence the product generated by the: P450 (Figure 3). The
oxidation state of the P450 that generates HNA is the perferryl (Fe-O v) or oxyferryl (FeOIV), requiring oxygen, electrons and NADPH. Hydrogen is abstracted from 4-HNF
forming a carbonyl carbon radical, which can then react with the iron-bound hydroxyl
radical generating 4-hydroxy-2-nonenoic acid. The HNA may then undergo further
reactions involving electron rearrangement, protonation and oxidation to

tcmll a lactone.

The cytochrome P450-dependent reductions are catalyzed by the ferrolls (Fe (II)) stateP450, the electrons being transferred from NADPH to the P450 by NADPIlCYPOR
(Mansuy, 1994).This may be the oxidation state of the P450 that generates 1,4dihydroxy-2-nonene. It has been noted that the P450 Fe(IT) state can occur during
conditions of low oxygen tension.
in conclusion, our results demonstrate that several P450s are efficient catalysts ill

the oxidative and reductive transformation oflipid-derived aldehydes to carboxylic acids;
l·hydroAynonenoic acid, and alcohols; 1,4-dihydroxy-2-nonene, and add a 1\e\\ Llcd to
the biological activity of these metabolites. P450s are expressed in hepatic and
extrahepatic tissue. By metabolizing 4-HNE, CYPs convert this reactive lipid aldehyde
to a less reactive product. which could either be excreted of sUbjc:ctcd to further
metabolism. Our studies suggest that P450-mediated metabolism operates in paralkl \\ ith
other metabolic transformations of aldehydes; hence, the P450s could serve as reserve
compensatory mechanisms when other high capacity pathways

or aldehyde elimination

are compromised due to disease or toxicity. Finally, hecause 4-HNE like unsdturated
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nl"

aldehydes. such as acrolein. trans-2--hcxenaL and crotonaldchyde. are also food
constituents or environmental pollutants. P450s may be significant regulators of toxicity
due to xenobiotic aldehydes as welL
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CIIAPTERIII
INDUCTION OF

G~=NE

EXPRESSION IN MOUSE HEART AND UVI(R BY

BUTYLATED HYDROXY ANISOLE AND ACROLEIN
INTRODUCTION
To determine the changes in gene expression related to chemical cxposure,
disease, toxicant and hazard prediction, researchers have extensively used the technique
o/' DNA microarray analysis. By analyzing global gene expression changes, it i:-; possible
to prcdict rcgulatory pathways for action of specific chemical compounds, as \vell as,
mcchanisms for environmental disease progression. In this study. we used C57f3L,o mice
to imestigate the role of butylated hydroxyanisolc (BIIA) and Hcrolcin in the rcguLttiol1
()(" gene expression. Based on the hypothesis of Paul Talalay (Prestera and Talalay, 19(5).
there is a paradigm that phase I enzymes are not generally induced

i))

electrophilic agents

like HHA and tBHQ or even 4-HNE and acrolein. We therefore sought to identi fy
changes, if any, of P450s expressed in the liver and the cardiovascular system. In
addition, we veritied a number of phase I and phase II xcnobiotic metabolizing enzymes
whose gene expression is altered after exposure to B1IA and acrolein.
The detoxification of many chemicals proceeds through a three-step enzymatic
process, commonly referred to as phase I, phase 1I and phase III metabolism. In the first
step, phase I enzymes such as cytochromes ]>450, dehydrogenase's, reductlses aJ1d
oxidases modify lipophilic compounds. This allows for subsequent moditieation by
conjugation to water soluble compounds by phase II enzymes like glutathione S-

transferases (OSTs), NADPH quinone oxidoreductase 1 (NQORI), and UDP
glucuronosyl transferases. Phase II reactions consist mainly of glucuronidation. sull~ltion.
glutathionylation, methylation, or conjugation with amino acids. In addition, estcrascs,
amidases, imidases. epoxide hydratase, or other hydrophilic processes increase the
hydrophilic nature of these compounds. Lastly, transporter proteins, also known as phase
III enzymes, localized in the sinusoidal and the apical membranes of hepatocytes,
intestinal, and kidney cells, regulate the intracellular levels of these compounds by
transport and excretion (Jakoby and Ziegler, 1994). The interaction of phase

t

phase II

and phase 1lI enzymes and proteins ensures the metabolism and disposition of
xcnobiotics, thereby regulating their levels in l'ivo.
The aim of this study was to investigate the regulation of gene expression b)! lipid
aldehydes, particularly, to determine the role of lipid aldehydes. in the regulation

or gene

expression of lipid aldehyde metabolizing enzymes, including cytochrornes P450.
Humans are exposed to a number of aldehydes, two of which we have studied,

L~-Il\JI':

and acrolein. These aldehydes are generated in vivo predominantly generated during the
process of oxidative stress. Exposure can also occur via ingestion of foods containing
these carbonyl compounds. Acrolein. a key component of cigarette smoke. is associated
with a variety of diseases. It has been determined that the amount of carbonyl compounds
obtained during the combustion of a regular size cigarette ranges from 1.92 to 3.14
mg/cigarette. Of these, acrolein represents 0.22 to 0.47 ~g/cigarette (Fujioka and
Shibamoto 2006).
By their chemical nature. acrolein and 4-HNE arc highly rcactiv\~
clectrophiles. Several studies have demonstrated that these lipid aldehydes regulate gene
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expression through the activation of transcription factors. These transcription f~lctorS.
generally referred to as oxidative stress-sensitive transcription factors. include \'hl'2. ;\P-1
and 1\'F-KB.
High acrolein concentrations cause GSH depletion. In addition, acrolein reacts
with nucleophilic groups such as the amino group oflysine. the sullhydryl of cysteine
and with the imidazole group of histidine (Uchida et al., 1993). These reactions modi 1\
the function of macromolecules. These actions of acrolein, especially the depletion of
glutathione, result in oxidative stress. Cells respond to this stress by activating the
mitogen-activated protein kinases (MAPKs) such as ERK 1 and the c-.Tun N-terminal
kinase JNK I 12 (Yuan et al.. 2(06). The downstream cifects of JNK 1 activation on
oxidative stress-sensitive transcription factor activation are two- fold. First,
phosphorylation and activation of .Tun results in the induction of gene expression by the

A P-1 transcription factor through binding to the 12-0-tetradecanoylphorbol 13·-acetatcresponse clement or TRE (Angel el al., 1987). Second, activated ERK and JNK can
phosphorylate Nrf2 at serine residue 40, causing Nri2 release fr0111 Keap-l and
subsequent translocation to the nucleus. In the nucleus. Nrf2 binds to the antioxidallt
response clement as a heterodimer with other proteins, small Mafs, c/EBP and Jun,
resulting in an increase in gene expression.
BIlA is a phenolic antioxidant widely used to study the induction ol'Phase II
xenobiotic metabolizing enzymes. In addition to its antioxidant property. BHA is used to
study the induction of gene expression resulting

ji'Ol11

oxidative stress (Pinkus ef aI.,

1996: Yuan et al .. 2006). In vivo, BlIA is O-demethylated to tertiary-butyl hydl'OC]ulnolle
(tBI lQ: Figure 21) by phenobarbital-induced microsomal enzymes (Cummings e{ ul.,
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1985). Both BHA and tBHQ induce gene expression through the oxidative stresssensitive transcription factors. Since BI-IA. tBIlQ and acrolein all induce gene expression
through similar set of transcription factors, we hypothesize that P450s of interest may he
regulated by Nrf2. Therefore, we used BHA as a control for acrolein treatment of mice
fo!' the analysis CYP P450 gene expression by reactive lipid aldehydes.
In order to achieve our goal of identi fying genes regulated by acrolein, we
submitted RNA samples from treated mice to the Bradfield Laboratory for microarray
analysis of gene expression using the environment, drug and gene expression (LDCE)
data base program. This program was developed by the Bradf~eld laboratory at the
McArdle Laboratory for Cancer Research, University of Wisconsin Medical Schoo!. This
resource is a public database that allows two modes of research.?r interaction. First.
investigators can query a large and growing database of toxicant induced transcriptional
profiles generated using a common microarray protocol and platform. Second, the EDCiE
resource accepts RNA sample submissions from laboratories interested in developing
novel toxicant-induced transcriptional profiles for inclusion in the open access database
(Hayes el al., 2005).
In addition to the mieroarray analysis, we performed quantitative real-time PCR
(qRT-PCR) analysis to verify the results of the microarray analysis. From the same
tissue, we prepared liver mierosomes and used these in metahol ism assays to investigate
changes in microsomal P450 activity following treatment with BHA Finally, WcsL:m
blotting was performed with the same microsomes for Cyp2c29, to verify changes in
protein level following treatment of mice with BllA.
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Figure 21. Chemical structure ofbutylated hydroxyanisolc (BHA: hutyl-4h~'dr()xyat1is()le)

and tertiary-butylated hydroquinone (tBlJQ). In vivo, I3IIA is

oxidativciy dcmethylated by microsomal P450s to generate tBHQ.
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Figure 21
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MATERIALS AND METHODS
Treatment of Animals. Mice (C57BL/6, 22 g to 27 g; Jackson Laboratories. Bar llarbor.
MA) were divided into two groups based on the chemicallreatmcnt they received. (JrOLIp
1 was fed ad libitum for 1 week with either AIN-76A diet (Purina lest Diet, Richmond.
IN) alone (control) or AIN-76A diet supplemented with 0.45% I3l-IA. Group 2 was
divided into two subgroups. Subgroup I received a daily dose of either saline or acrolein
in saline (5 mg/kg acrolein, Sigma, St Louis MO) by gavage for 7 days. The animals
were fed Purina mouse chow (Richmond, IN). The second subgroup was exposed for 6hrs daily to 5-ppm acrolein by inhalation for 5 days. Thc control group was exposed to
normal air for the same amount of time. The entire trcatment and e:\pcriment scheme is
summarized in Figure 22. Thc mice were sacrificed and the liver and heart harvested and
stored at -SO°C until used. All proccdures were approved by the University 01" l.ouisville
IACUC Committee and conformed to the USPHS Policy

011

Hummle Care and Usc

or

! .aboratory Animals. The exposurc of mice to acrolein by inhalation was per\emlled at the

inhalation core facility of the Program Project Grant PO I ES directed by Aruni
Bhatnagar, Ph.D. The duration of exposure was selected based on their toxicological data
following exposure at different time intervals.

Total RNA isolation and purification. For total RNA preparations. about 0.1 g 01'
frozen liver tissue or an entire mouse heart was homogenized in I 111L of TRlzol@
(Invitrogen, Carlsbad, CA). The mouse heart is fibrous and required maceration in

:l

mortar and pestle containing liquid nitrogen prior to homogenization with a pellet
pestlc@ motor (Fischer Scientific, Pittsburg, PA). The supernatant was transferred to a
sterile tube and incubated for 5 min at room temperature to permit the dissociation 01"
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Fi~un'

22. Schematic representation of experimental design fiJr analysis of gene

,:':pr('.'ision in male C57BLl6 mice following treatment with either BlIA or acroleill,
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nucleoprotein complexes. Chloroform (0.2 m1, per I mL TRIzcl reagent) was added to
each tube. the sample shaken vigorously for 15 seconds. and then incubated at room
temperature for 2 min. The samples wcre sedimented at 12.000 x g for 15 min at 4()C.
Thc colorless aqueous phase containing the R"JA was furthcr extracted by mixing with
O.S mL isopropyl alcohol followed by incubation at room temperature for 10 min and
sedimentation at 12.000 x g for 10 min at 4°C. The RNA pellet was washed with 1 mL of
75°;() ethanol, followed by centrifugation at 7,500 x g at 4°C. The R,\JA pellet vvas air
dried for 5 min and dissolved in 60°C RNAse free water. The RNA was purified u.'-)ing
silica membrane spin columns (RNeasy® reagent; Qiagen, Valencia. CA). RNA integrity
\\as then assessed using the 600 LabChip(g) kit with a 2100 8ioanalY7er (Agilent
Technologies. Palo Alto, CA) and quantified Llsing the Nano Drop spectrophotometer.
The RNA was aliquotcd and stored at -80 n C until used.

Sample preparations for microarray analysis. RNA samples ror mieroarray analysis

of gene expression were prepared according to the requirements oj"the j':nvironmenL
Drugs and Gene Expression (EDGE) program. RNA quality (Figure 23) and quantity \\as
determined as explained above. At least 60

~lg

of RNA per sample was provided I'll!·

analysis to the Bradfield Laboratory. The samples were analyzed using the Ccnispherc
3]) Array 50 kit protocol adapted from Genisphere, Inc (Hatfield, PA). The detailed
protocol for microarray analysis can he found at the EDGE program website
11.!.!g://edge.oncology.wisc.edu.

102

Figure 23. Verification of RNA quality used for microanay and quantitative realtim.e peR analysis of gene expression. Aliquots of independent RNA samples extracted
('rom mice heart and liver were analyzed with the RNA 6000 Nano-Labchip on the
/\[',ilenl 2 I 00 Bioanalyzer. (A) The gel picture shows the RNA ladder (lane 1) and four

SCllllples (lane 2 -5). (B) Representative eleetrophorcgrams depict two peaks for the

und i 8S rRNA in the RNA samples.
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Microaarray data analysis. The Bradfield Laboratory performed microarray
construction, image and data analysis and the detailed protocol has been published
(Thomas et at., 2001). Gene expression was measured using a microarray chip that
contained approximately 1,200 minimally redundant cDNAs from an expressed sequence
tag (EST) project executed by the Bradfield laboratory, as well as, a public EST effort.
The results for the genes were first collapsed into a fully non-redundant set by averaging
the results from multiple copies of the same gene. After collapsing, the data set was
screened for genes that did not respond to the treatments used in the study. A threshold of
2-fold change in gene expression was typically used as the cut-off value. Only genes that
showed greater than a 2-fold change in response to treatment were selected for further
analysis. Finally, the gene expression values were discretized such that mRNA induced
greater than 2-fold were given a value of one, mRNA decreased greater than 2-fold were
given a value of minus one, and mRNA expressed with less than a 2-fold change were
given a value of zero. A How chart for the data reduction scheme adapted from a
Bradfield Laboratory publication is shown (Figure 24).

Principle Component Analysis of Microarray data. The data are plotted in a 3D PCA
map with Principal Component 1 (PCI) the x-axis representing 100% of variation in the
data, PC2 the y-axis representing 2.62··0.06% of the variation. Control housekeeping
genes used to nommlize the data, center around coordinate 0,0. Gene sets predominantly
affected by BHA treatment (blue) and those predominantly affected by acrolein (red),
map to different coordinates suggesting they are differentially affected by the two
treatments. We wish to thank Amir Singh and Thomas Knudsen, Ph.D., for their
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assistance in the analysis of this data through the resources of Birth Defects Center in the
Department of Molecular, Cellular and Craniofacial Biology, University of Louisville,
School of Dentistry.

Quantitative real-time PCR (gRT -PCR) for micro array data validation. To verify
the results of the microarray analysis, qRT-PCR was performed on mRNAs from control
or mice that were treated with either BHA or acrolein. Quantitative RT-PCR was also
performed on 5-ppm acrolein heart and liver samples from mice that were exposed to by
inhalation. We seilected eight genes for verification based on our interests in lipid
aldehyde metabolism. cDNA was synthesized from total RNA using the Advantage RTfor-PCR kit (Invitrogen, Carlsbad, CA). RNA (I Ilg), 20 pmol random hexamer, 5X
reaction buffer (50 mM Tris-HCI, pH 8.3, 75 mM KCI, 3 mM MgCh), 0.5 mM dNTP, I
unit/ilL RNase inhibitor and 200 units/Ilg MMLV reverse transcriptase were used in a 20
ilL reaction. Residual RNA was digested with 1.5 U of RNase H at 37°C for 20 min. The
cDNA was then diluted 5-fold with nuclease-free water and stored at -80°C until used.
Quantitative real-time PCR was performed using the ABI 7900HT Sequence Detector
System according to the manufacturer's instructions (Applied Biosystems, Foster City,
CA). FAM dye-labeled primers for Cyp2c29, Cyp3all, Cyp2a5, GST mul, nQOR-I,
CYPIA2., HO-I and ALDHIAI were designed by the Prough laboratory at
wwwoinvitrogenllux and purchased from Invitrogen (Carlsbad, CA). The qRT-PCR
reaction was prepared as follows: TaqMan® Universal PCR Master Mix No AmpErase®
UNG (Applied Biosystems, Foster City, CA; half the reaction volume), 50 nM of each
primer, 2 ng/IlL cDNA and water in a final volume of 15 ilL. All qRT -PCR experiments
were performed in triplicate using cDNA samples from independent RNA sets. For each
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Figure 24. Flow chart outlining the method for microalTay data reduction and

classification analysis for gene expression. Copied II'OIll Thomas

1'1

(II.. (2002).

i\,kliJods in b1Zymology. Vol. 357: Pages 19X-205. (Bradliclel lahoratory publication).
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gcne. a serial dilution of eDNA was Jlerformed to establish a standard

CllrVC.

All gene

e>.;pression kvels were normalized to ISS rRNA. Primer specificity fnr the dilTerelll
genes was veri lied by melting temperature (Till) analysis and bv performing

;In

agdrnsc

gel electrophoresis. The curves obtai lied follO\ving "1m analysis sh()\\ cd a single peJk /"m
e~leh t~el1e

(Figure

=~5i\).

In addition. agarose gel electrophoresis

or

the qI<."I-P(·R

j),'Ot!llC(

Jc\'ealed a single band per gene per sample (Figure :)513). These ohsendti·.)ns indicltcj
tInt the primers used for the qRT-PCR analysis \'vere highl) spl·ciJic.
Gene expression was calculated by determining the cycle threshold (( 'I) obtailled
li'olll the fluorescence emission recorded in the geometric phase of gene ~llllP 1i licat iOJ,.
The /\C 1 value was then calculated by subtracting the

('lor

the LUTet

fr;)1ll

thlt 01 :ts

respective ISS rR1\A. After determining the 2 6C1 , the ('old changes in the level of gene
e':pression of treated samples over cuntrol samples \\ere calculated by as:-;iglling a llnit
value to the control samples.

\Vestern hlot analysis of Cvp2e29 rxpr('ssion in mouse liver. Mierosoml's \\ere

prepared ii'om the liver of mice that wcre ICd AIN-76i\ diet only or

(H:,\<j,)

Bl 1.'\-

supplemented AIN-76A diet. Total microsomal protein was dekrl1lin<.:d by the !W!\
assay as previously described. Liver microsomal proteins (20

~lg)

\\ere re,ul\nj on

Ci

sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (PAGE: !t)%
]Jnlyacrylamide) and transferred to a polyvinylidene dil1uoridc

1l1~Il:b!·al1e.

The

memhranes were incubated with antibodies against ('yp2e2() (antibm:y I X4 7) or (': p2d\)
(antibody 1549). After incubation wi,h the secondary antib(ldy. the :mmu!loreacti\l' bamb

were \'isualized with enhanced chemiluminescence Westclli hlouin'
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SySll'lli (\IllC:':-;\1Wll

f;';gm·l: 25. Analysis of the specificity of quantitative real-time peR primers. (i\) The

'",Jelling cune (Tm) analysis was performed for each gene and primer sp'.:cilicity \LT:lil:d
[;\ :t

:iingle amplified peak.. A representative melting curve is shcm n t(:r Cyp2c2().

)R

1. Cyp3all and ISS rRNA. (B) !\ 1% agarose gel electrophoresis of the prcllillcts

or tiL: qRT-PCR analysis shows a single band for each sample well loaJed.
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Figure 25
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Biosciences). The Western blotting experiments wen: performed by the laboratory nj' \)1'.
Joyce!\. Goldstein (Laboratory for Pharmacogenomies, NfEHS. Research Triangle Park.
NC).

Cytochrome P4S0 enzyme activity assay. Mouse liver microsomes were prepared hom

mice !Cd with AIN-76A diet only or 0.45% BI lA in AIN-7()A diet and used to perl()]"Ill ()anthracene aldehyde metabolism assays. The P450 content orthe llJierosol11es

("rolll

each

mouse liver was determined by CO-difference spectra of dithionite reduced 1>450 (Omura
and Sato. I (64). Microsomal protcin hactions containing 50 ntv1 were llsed to I1lcasure 9anthracene aldehyde oxidative and reductive metabolism as previously described.

IU~SULTS

Changes in gene expression following exposure to xenohiotics. An important objectivc
nt' the EDGE program is to create a public-access database of gel1e expressiol1 in rl'SpO!1Sl'

to different chemicals. Figure 26, adapted from the EDGE database. shows projjles
obtained by feeding mice with 2,3.7,8-tetrachlorodibenzo-p-dioxin (TCDD.

,111

aryl

hydrocarbon receptor ligand), pregnenolone 16a-carbonitrilc (peN. a pregnane X
receptor ligand), phenobarbital (PHB. a constitutive androstane receptor activator). and
our test compound,

BIIA ( Nrf2 and AP-I activator). As observed. different gcnes vvele

induced or repressed by the four compounds. However. some genes were regulated (up or
down) in a similar fashion between the four compounds. suggesting t11at these genes
maybe regulated by more than one signaling mechanism. These gene') include Cyp2e2()

(PB, TCOD and BI-IA), Cypla2 (PB, TCDO, and BITA) and Cyp2a4, GSTml (PB.
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BHA). These four compounds also individually regulated unique subsets of genes. thus
resulting in a divergent response to exposure to these compounds: Hsd 17b2 (TCOD).
Cyp3a25 (PCN) and Ugp2 (BHA). The genes that were uniquely regulated can serve as
characteristic markers for TCDD, PCN, PHB and BI-IA, thereby assisting in the
prediction of outcome of exposure and the receptor or transcription factor involved.

Determination of the changes in gene expression following the exposure to acrolein
or BHA. C57BLl6 mice were exposed to BHA or acrolein for 7 days prior to sacrifice,
and RNA extracted from the heart and liver. The duration of exposure was chosen based
on prior studies demonstrating that the maximum expression of genes for foreign
compound metabolizing enzymes occurred in rats between 5 and 8 days following
exposure to phenobarbital or dehydroepiandrosterone (Rem mer, 1958, 1972; Canney

ef

al., 1960; Prough et al., 1994).

From the electronic data provided following microarray analysis, we generated a
heat map for genes responding to our treatments. A condensed heat map (Figure 27) was
generated by assuming a cutoff for minimum induction of2-fold and a minimum
repression of minus 2-fold of gene expression in response to BHA or acrolein. A color
scheme is used to show the expression pattern: red indicates induction; green indicates
repression and black signifies no change in gene expression. From this analysis, we
observed a difference in the absolute fold change in gene expression level in the liver
between the two control groups of mice, acrolein vs. BHA, per as.

Principal component analysis of gene expression between acrolein and BHA treated

113

Figure 26. Heat map of microanalysis obtained from treating mice with different
chemical compounds. 2,3,7,8-tetrachlorodibenzo-p-dioxin CTCDD; an aryl hydrocarbon

receptor ligand), pregnenolone 16a-carbonitrile (PCN; a pregnane X receptor ligand),
phenobarbital (PHB; a constitutive androstane receptor activator), and BHA ( a Nrf2
activator and AP-l activator and inducer of oxidative stress).The PHB, TCDD and PCN
data are from the database located at http://edge.oncology.wisc.edu.
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Figure 26
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mice liver. Since our initial evaluation of the data from BHA exposure per as and

acrolein exposure by gavage or inhalation demonstrated differences between the control
mRNAs, we assumed that the two diets differentially affected expression of the control
mRNAs used to normalize the results of the two data sets. Unfortunately, we could not
control the differences in diet, since the samples for acrolein exposure pel' os and by
inhalation required use of chow diet for the inhalation facility at the University of
Alabama Birmingham (E. Postlewaithe, Ph.D., personal communication). Therefore, we
consulted with Amir Singh, Birth Defects Systems Manager
(http://systemsanalysis.louisville.edu) who recommended we compare the genes induced

by either BHA or acrolein (increase by 2.0 or more) and normalize those two sets of data
using the control mRNAs utilized by the EDGE system to scale the results. The data was
then plotted in a principle component map. As shown in Figure 28, one can see that the
control (housekeeping genes) map to position (0,0), and the two sets of genes induced by
either BHA or acrolein are very different sets of gene products. In addition, the
magnitude of change was much less for acrolein than BHA. We interpret these data as
indicating that BHA and acrolein at the concentrations used regulate different sets of
targets genes. In addition, the responses for acrolein administration by gavage were
much lower in magnitude, raising the concern that the dosage of acrolein used (5 mg/kg
body weight to avoid death of the mice) might not be sufficient to achieve dosages
necessary for induction of the set of genes regulated by BHA. From results in the
literature, acrolein is toxic to cells. When assessing target gene expression, cell death
becomes a significant feature of the experiment, before significant induction of gene
expression is seen (Winner et al., 1997).
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Figure 27. Heat map showing changes in gene expression in male C57BLl6 mice
liver following treatment with BHA or acrolein. The first column represents control
AIN-7oA-fed mice, the second column represents mice fed diet containing 0.45% BHA
od lihilum for 7 days, the third column corresponds with mice treated with saline by

gavage while the fourth column represents mice administered 5 mg/kg acrolein in saline

hy gavage while on chow diet. The hierarchical clustering of genes is a total of four
arrays generated using a condense clustering assuming a minimal induction of 2-fold and
a minimal repression of minus 2-fold. The color scheme is used to show the expression
pattern: rcd indicates induction, green indicates repression and black represents no
change in mRNA in response to BHA or acrolein treatment. Circle shows changes in
GSTm 1, Cyp2c29 and Cyp2a4 in the different samples.
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Figure 27
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Changes in gene expression following exposure to BIIA. Lipid aldehydes produced

during oxidative stress are metabolized through conjugation to GHS by the GSTs
(Esterbauer et aI., 1975). BHA caused the induction ofmRNA expression ofGSTa3,
GSTml and GSTtl. The aldehyde dehydrogenases catalyze NAD(P)H- dependent
oxidation of aldehydes including 4-HNE to their respective acids. The aldehyde
dehydrogenase ALDH1, ALDHla7, ALDH4 and ALDH5 were all induced by BIll\. The
aldo-keto reductases (AKRs) are a family ofNADPH-dependent enzymes that catalyze
the reduction of aldehydes to alcohols (Jin and Penning, 2007). BH/\. caused induction of'
the mRNA level ofaldo-ketoreductases AKRlc6, AKRlcl3 and AKRlc19 Crable 5).
Enzymes of the GST, ALDH and AKR (Ellis, 2007) family are known to be induced by
compounds that activate Nrf2. Our data has demonstrated that BHA, aN rf2 activator
induces the expression of these enzymes and therefore correlates with previous
observations (Nair et al., 2006, Purdon-Dickinson et al., 2006) ..
P450s are induced by a variety of compounds including substrates and nonsubstrates of this superfamily of enzymes. From the microarray analysis data. some CYPs
were induced in response to BHA. These include Cypla2, Cyp2a4, Cyp2c29. Cyp2c37.
Cyp2c40, Cyp2c50 and Cyp51 (Table 5). The 5'-promoter sequence of the P450 genes
do not contain an apparent antioxidant responsive element. Therefore the induction of the
CYPs most likely is not directly mediated by Nrf2 binding to the ARE. This suggests the
involvement of a different transcription factor, most likely AP-l, also known to be
activated by BHA.
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Figure 28. Principle component analysis of data from BIIA and acrolein controls
and treatments. C57BLl6 mice were fed with AIN-76A diet only (control) or

supplemented with 0.45% BHA in AIN76A diet for 7 days. A second group of mice was
fed with chow diet only (control) or administered 5 mg/kg acrolein by gavage daily for 7
days. RNA was extracted from the mice lever and changes in gene expression determined
by microarray analysis. The two sets of data for the genes induced by either BHA or
acrolein (increase by 2.0 or more) were normalized using the control mRNAs utilized by

the EDGE system to scale the results. The control (housekeeping genes) map to position
(OJ)). and the two sets of genes induced by either BHA or acrolein are different sets of

gene products.
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Figure 28
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Acrolein treatment altered gene expression in mouse liver. Microarray analysis was

was also conducted to verify ehanges in gene expression in C57BLl6 mice liver, to
identify xenobiotic metabolizing genes induced by acrolein. Table

CJ

shows a set of genes

of interest that were induced or repressed in response to acrolein treatment. Some
aldehyde dehydrogenases, aldo-ketoreductases, as well as glutathione S-transt'erases were
induced by acrolein (Table 6). Interestingly, like BIIA, some cytochromcs

P~50

were

induced in response to acrolein. These include Cyp2c29, Cyp2c44, Cyp2el. and Cyp2.i6
Crable 6). The mechanism through which cytochromes P450s arc regulated by
compounds known to activate Nrf2 like BHA and acrolein are still'JnknO\vn.
For most of these genes of interest the fold-change in gene expression caused by
acrolein was lower than that observed for BIlA. It should be noted that the mice ,vere
treated by gavage with only 5 mg/kg of acrolein. Trcatment with a higher dose

or acrolein

resulted in the death of the mice. Therefore, the low level of change ofmR:',L\ :mluetiol1
observed with acrolein could be because of insufficient levels of acrolein reaching the
liver and therefore robust induction was not observed. Also, there arc several xenobioticmc!abolizing enzymes expressed in the gastrointestinal tract and the liver thal could
mc!abolize the acrolein before its induction effect is initiated. Most importantly, cells
contain the non-protein peptide GSH. GSH can spontaneously or enzY111mically conjugate
with acrolein, causing a further reduction in acrolein levels. Acrolein is a highly reacti\c
elcctrophile. It may have reacted with proteins and other macromolecules in thc gastro
intestinal tract, thereby reducing the amount of acrolein reaching the hcpatocytcs.

Quantitative real-time peR confirmation of microarray results. To verify the
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Table 5. BHA-regulatcd xenohiotic-mctabolizing enzyme genes in mouse liver
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results from the microarray analysis, quantitative real-time PCR (qRT-PCR) was
performed to examine the effects of acrolein and tBIlQ on gene expression. The genes
selected for analyses were Cyp2c29, Cyp3aJ L Cyp2a5, Cyp 1a2, GSTm L ALDII 1Al
and nQORl. RNA samples from individual mice were reverse-transcribed using random
hexamer primers to eDNA and then used for the qRT-PCR experiments. The C, value for
the expression of each gene was normalized to 18S rRNA and the fold induction \vas then
calculated. The RNA samples were not pooled; the data represent mRNA expression
levels of livers from an individual mouse. The results are presented as box and whiskers
plots. The box plots extend from the 25 th to the 75 th percentile. The line across the box
shows the median distribution of samples (n

=

5) for each gene. For each point. a single

mRNA was analyzed in triplicate and the average is shown.
The average fi:)ld change in gene expression was Cyp2e29. 6-fold; Cyp3a II. 1fold; ALDHIAI 16-fold; Cypla2, 3-fold; GSTml, 22-fold; Cyp2a4, 33-fold. and
nQORI, 47-fold in the liver of mice fed AIN-76A diet supplemented with OAYY<l BIJA
for 7 days relative to AIN-76A diet alone (Figure 29A). The average fold change in gene
expression in the mice heart following BHA treatment was Cyp2e29, 2-fold; GSTm 1.
1.4-fold; ALDHIAL 1.4-fold and. nQOR-I, 1.5-fold (Figure 29B).Quantitative RT-PCR
was also performed on samples from mice liver and heart that had beell treated with
saline or 5 mg/kg acrolein daily for 7 days in the mouse chow diet. Gene expression was
verified for Cyp2e29., 1.6-fold; GSTmL 0.96-fold; ALDBI A L O.n-fold; Cyp2aS.

O.9'~

fold and Cypla2, 0.93-fold in the liver (Figure 30A). Genes verified in the heart were
Cyp2c29, 0.94-fold; GSTml, O.78-fold; ALDE1 A 1. O.81-fold and nQOR 1. O.CJ6-J"old
(Figure 30B). Like with the previous samples, RNA samples used in this study
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Table 6. Acrolein-regulated genes in C57BLl6 mouse lin"
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pooled. We observed a lower level of induction ofCyp2c29 mRNA in the heart and liver
samples from mice that were exposed of 5 mg/kg of acrolein by gavage; there was no
change observed for Cyp3aIl in the same samples. Even though the expression of
Cyp2c29 was lower in acrolein-fed mice heart and liver compared with HIlA. the
experimental levels were higher than for GSTml and ALDIIl A 1. Since these compounds
normally acting through Nfr2 typically regulate GSTml and ALDI [IA 1, it is likely that
Cyp2c29 is regulated differently from the Nrf2 target genes. We speculate that Cyp2c29
is regulated by the oxidative stress-sensitive transcription factor, AP-l.

Analysis of gene expression following acrolein administration bv inhalation.
Acrolein is a major environmental pollutant. The sources of acrolein include cigarette
s11l0ke, smoke from car exhaust and wild fire (Beauchamp cl al.. 198R). We performed a
preliminary study to determine if the exposure to acrolein hy inhalation (.5-ppm. 6 1m per
day for 5 days) affects gene expression in the heart and liver of mice. We sc\eelcd :;
genes based on our previous observation that the expression of these genes were changed
following oral administration of acrolein or BHA. The average fold induction of gene
Expression was Cyp2c29, no change: GSTml, 1.2-fold; ALD1-Ilal, l.S-fold: nC)ORL
2A-fold and HO-I, 2.3-fold in mice liver (Figure 31A). In the heart. we observed no
change in gene expression for Cyp2c29. ALOHlal, nQOR-l. A minimal fold change
was observed for HO-I, lA-fold and GSTml, 1.3-fold; in mice heart (Figure 31 B). These
low levels of induction of mRNA suggest that either the level of acrolein in the inhalation
chamber was not high enough to cause induction through Nrf2 and AP-I or. the inhaled
acrolein is not reaching the heart and liver at concentrations high enough to cau;-;c a
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Figure 29. Quantitative real-time peR analysis of gene expression in C57BLl6 mice
heart and liver following treatment acrolein. Mice were treated by gavage with saline
(control) or 5 mg/kg acrolein by gavage daily for 7days. RNA was extracted II'om the
heart and liver. reverse transcribed to cDNA and uscd for qRT-PCR analysis of genc
expression. The fold induction is shown in a box and whiskers plot. The boxes cxtend
1h
I.rom tIlC 'l5
~
to t11e 75 th percent!'1 e, t I1e I'me aeross rcpresents t I1e me(i'Ian (i'Istn'1'
,utlOn

0 t.

sampks (n= 5) for each gene. For each point. mRNA sample fr0111 a single mouse liver
was analyzed in triplicate and the average is shown.
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Figure 30. Quantitative real-time peR analysis of gene expression in C57BLI(, mice
heart and

liv~~r

following treatment acrolein. Mice

wen~

treated by gavage with saline

(control) or 5 mg/kg acrolein by gavage daily for 7days. RNA was extracted fioom the
:leilrt and liver. reverse transcribed to eDNA and used for qRT-PCR analysis of' gene
expression. The fold induction is shown in a box and whiskers plot. The hoxes extend
'rom tile 25 th to the 75 th percentile, the line across represents the median distribution of'
samples (n

ccc

5) for each gene. For each point, mRNA sample from a single mouse liver

\\ilS analyzed im triplicate and the average is shown.
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robust induction in gene expression.

BIIA induces 9-anthracene aldehyde metabolism in mousc liver microsomes. We

demonstrated by microarray and qRT-PCR that feeding of C57BU6 miee with 0.45°;()
BIll\. or 5 mg/kg of acrolein for 7 days caused an induction of Cyp:~c29

I~y

\lsi ng Iivcr

mierosomes from BI-IA-fed mice liver, we performed metaholism studies using 9-J\/\ as
substrate. We observed that BHA-f(xi mice liver microsomal oxidation of9-/\./\ was
induced 3-fold compared with the control. This induction was statistically signilicant at p
n.005., There was also a small but significant increase in the reduction

or 9-/\;\ to 9-

anthracene methanol (p < 0.05. Figure 32). This suggests that BIl/\ induced the
expression of microsomal P450s responsible for 9-AA metabolism. In our published
study (Amunom et al., 2007), we demonstrated that mouse liver microsomes oxidi/,e hoth
()-/\/\ and 4-HNE and that this oxidation activity was inhibited by several [>450
inhibitors~

mieonazole (general P450 inhibitor), phenytoin (Cyp2e29 inhibitor) and

troleandomycin (Cyp3a inhibitor). Taken together. these data suggest that the treatment
of mice with BHA induced the expression of hepatic P450s like C:yp2e:~9 (6A-fold;,
which we have shown to be capable of metabolizing 4-HNE. The expression ofCyp2c29
\vas also induced 1.6-fold by acrolein indicating the possibility ,)1' substrate-dependent
transcriptional regulation. It is possible that during oxidative stress, when acrolein ~l11d 4-

fINE levels increase, some P450s are induced and contribute to the further mctahol ism of
these lipid aldehydes.

BIIA induced Cyp2c29 protein levels in mouse liver. In addition to measuring the
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Figure 31. Quantitative real-time peR analysis of gene expression in C57BLl6 mice

following treaitment acrolein by inhalation. Mice fed chow diet \\'eIT treated with
acrolein hy a 6·-hour daily dose of normal air (control) or air containing 5-ppm acrolein
for 5 days. RNA was extracted from the heart and liver. reverse transcrihed to cDNA and
lIsed for qRT-PCR analysis of gene expression. The fc)ld induction is shown in a box and
\vhiskers plot. The boxes extend from the 25 th to the 75 th pereentile_ the line across
rcprcsL'nts the median distribution of samples (n = 4) for each gene. For each point.
mRNA sample from a single mouse liver was analyzed in triplicate and the average is
:-;I1O\"In. Fold induction for Cyp2c29, GSTmL ALDHIA L nQORI and 110-1 ill A.l\licc
Ii \L:l" alld B. Mice heart following exposure to air containing 5-ppm acrolein.
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Figure 31
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mRNA levels in mice liver (control vs. BHA), we measured Cyp2c29 (52 kDa) protein
level in liver microsomes. A Western blot analysis of mierosomes from C57BU6 mice
liver with antibodies generated against Cyp2c29 (Goldstein .lA., PhD, NIEI IS, Triangle
Park, NC), revealed a 2.5-3.0-fold increase of this P450 in BHA-fcd mice (Figure 331\).
The Cyp2c29 antibody cross-reacted with the Cyp2c39. However, Cyp2c29-specilic
change could be distinguished from Cyp2c39, because the Cyp2c39 antibody did not
cross .. react with Cyp2c29 (Figure 338). The Cyp2c29 antibody did not cross-react \\?ith
othcr members o[the Cyp2c class ofP450s that included Cyp2c37, Cyp2c.38. Cyp2ccJO,
Cyp2c44, Cyp2c50, Cyp2c54, Cyp2c55, Cyp2c65, Cyp2c6CJ and Cyp2c70. This is
important because the mouse Cyp2c class has about 75 % identity the results conlirmcd
the specificity of the Cyp2c29 antibody used (Figure 33C). I-Iaving previollsly
demonstrated that Cyp2c29 metabolizes 4-HNE and that Bl fA induces this P!l50 by both
microarray and qRT-PCR, taken together, the results suggest that BH/\ and acrolein
induce Cyp2c29 expression. It is possible that the protein level or other

P'~50s

were

induced in the microsomal samples; however, they were not individually determined.

Discussion
To identify genes that arc induced following exposure to Bl IA and acrolein.
Jllicroarray analysis was performed on 1200 genes and the expression pattern compared
between the control and acrolein- or BHA-fed C57BLl6 mice. Bascd on our analysis,
several genes were induced by either acrolein or BlI/\ in mouse liver: v,,'e observed a
higher induction of gene mRNA in the BHA-fed mice than acrolein-fed mice.

Cytochromes P450 constitute a superfamily of enzymes that metabolizl.: lipophilic
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Figure 32. Induction of cytochrome P450 activity in mouse liver microsomes by

BIIA treatment. Mice were fed with AIN-76A (control) diet or AIN-76A diet containing

OAY!';) BIlA (treated) for 7 days and microsomal fractions prepared frot1l the liver.
Cytochrome P450 (50 nM) activity in the mierosomes were analyzed by measuring the
oxidation of9-AA to 9-ACA and reduction to 9-AMeOH in the presence ofNADPIJ
regenerating system at 37°C.

**

Significantly different from controL p'-O.OOS;

"significantly different from control, p<0.05.
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Figure 32
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compounds. Some CYPs also function as biosynthetic enzymes. While humans have 57
P450 genes, mice have 102. In this study, we observed that some P450s were induced in
the BlIA- or acrolein-fed mouse liver samples. Most importantly Cyp2e29, Cyp I a:2. and
Cyp2a4 were strikingly induced. Cyp2c29 is a murine P450, abundantly expressed in the
liver and other extra hepatic tissue including the heart. lungs, brain and intestine

(I ,uo el

(II .. I (98). We have previously demonstrated that this P450 metabolizes 4-J INL. Cyp:2a'~

(C)g (Ytl sequence identity with Cyp2a5) is expressed in the liver and

olt~lctory

mucosa

~ILlt

not in the heart (Su and Ding, 2005). BIIA induced this P450 in ll1uuse li\'Cl". \\hich we
demonstrated was also able to metabolize 4-HNE. Induction of P450s hy HilA and
acrolein were of interest to us since these compounds arc predomin:.mtly associated with
the induction of the expression of genes that encode enzymes invoh'ed in phase II
xcnobiotic metabolism. BHA and acrolein inducc gene expression by utilil'.ing a group
t!"(inscription factors referred to as oxidative stress-sensitive transcription

f~letors

or

as

mediators. Acrolein activates the .INK signaling pathway (Ranganna e/ al., 20(2). [n
vivo. RHA is O-demethylated to tBHQ and tBHQ can undergo redox cycling generating
hydrogen peroxide (oxidative stress) causing the activation of JNK. The activation of
.INK can either result in the phosphorylation and activation of c-JUI1 or the
phosphorylation and activation ofNrf2. Activation of these transcription

l~H.:t\)J"s

result in

the induction of expression of target genes.
The involvement ofNrf2 in cytochrome P450 gene regulation has not been
extensively documented. Some studies have suggested a possible wic orNrf2 in P:150
gene expression. For example, Bu et al. (2004 and 20(6) performed microarray

an~dysis

of gene expression by sulforafane (SFN, a compound known to induce gene expression

137

Figure 33. HilA induces the expression of Cyp2c29 in mice live!". MOllse

li\l~r

lIlicrosomalfi-actions from AIN-76A controls and OAY% BHA supplemented AIN7()-fccL
\'vcrc electrophoresed on a 10% SDS-polyaerylamide gel. Resolvecl proteins were
transCcrred to nitrocellulose membrane and immunoblotted ror the presence of
cytoehromes P450. A. The membrane was immunoblotted llsing antibodies against
('\,p:2c:29 and immunoreactive bands detected by enhanced chemiluminescence: I ~al1es I
~lIld

14. protein standard (2 ilL); lanes 2 and 13. E. coli expressed Cyp2c29; lanes 3 U 6.

("y]12c29 in control microsomes; lanes 7 to 12, Cyp2c29 in HI lA-treated microsomes.

HIIA-CL, BlIA-controlliver; BHA-TL, BHA-treated liver. B. The membrane was
i!11il1Llt~ohlottcd

with an antibody against Cyp2c29. C. Members of the mouse Cyp2c

Lll1lily were immunoblotted with an antibody against Cyp2c29 to check for erossr\~activity. Twenty micrograms of protein was loaded per sample well.
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:Figure 33
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through Nrf2). In these rat studies, several P450s were induced: CYP 1/\, CYP:lA.
CYP28, CYP4A and CYP39A. This observation led these authors to suggest a possible
role ofNrf2 in the regulation of expression of the above-mentioned P450s. [n addition.
studies have shown that Nrt2 regulates the induction of Cyp2a5 in DBAI2 mice (J\buBakar et af., 2004; 2007).
GSTs are a family of cytosolic enzymes that mainly function to detoxify by
conjugation through Michael addition of GS} [ to electrophilic compounds. Bf-{;\ or
acrolein induced GSTml. GSTn:, GSTr by at least 2-fold. ALDI-I was also induced

at

least 2-fold. GST and ALDH are known acrolein and 4-HNE mctabolizing el1zvmes.
,
~

Recently. we also demonstrated that some P450s (CYP2c29, CYP3A4. CYP2J2.
CYP2B6) are good oxidativc and reductive catalysts for 4-IINF. It is possible that the
induction of these genes by BHA and acrolein serves as a protective role against th,; toxi

i
':

effects of these lipid aldehydes.
In addition to treatment of mice with acrolcin by gavage, we analyzed RN!\
samples from the heart and liver of mice that had received acrolein by inhalation. The
rcsults from this study suggested that 5-ppm acrolein failed to robustly induce gene
expression in mice heart and liver. This may be due to insulfIcicnt amounts

or acrolein in

the smoke or insufficient amount of acrolein reaching the targct orgalls to inducc genc
expression.
As a follow up to the microarray analysis and qRT -PCR, we performcd 9-1\/\
metabolism assay with microsomes from BIIA-fed mice liver and observed a 3-/old
induction of 9-AA oxidation activity compared with the control. Phenytoin. a high
aflinity substrate for Cyp2c29 was a potent inhibitor of this enzyme reaction. This
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confirmed the observation that BHA-induced P450 gene expression in mouse liver,
specifically Cyp2c29. Additional verification of the induction of P450 expression was
conducted by Western blot analysis of liver microsomes prepared from Bf-IA-treated
mice liver. The results revealed a 2- to 3-fold average induction in the level of ('yp2c2()
in HI lA-fed mouse liver compared with eontrolmicrosoma\ samples. Taken together.
thcse results demonstrate that BHA and acrolein induce xenobiotic mdaho\i:;.ing
cnzymes, including Cyp2c29, which metabolizes the lipid aldehydes. suggesting the
occurrence of substrate-dependent transcriptional regulation of this gene.
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CHAPTER IV
TRANSCRIPTIONAL REGULATION OF THE MOUSE CYP2C29 GENE

INTRODUCTION

Alteration in the regulation ofP450 expression is a major sou:"CC

orvariabil~ty II1

the mdaholism of xenobiotics and endogenous compounds. Induction of P450 expression
can lead to alterations in drug efficacy and create the potential for drug-drug interactiolls
(Sucyoshi and Negishi, 2001). In our study using the microarray analysis or ~'.enc
c);pression, we observed that Cyp2e29 was induced following treatment of l11iCI~ \\ ilh
either BHA or acrolein for 7 days. This observation was further confirmed by

qRT-PCi~

and Western blotting. This result is particularly interesting since we have prcy'ic;usly
shown that this P450 is capable of metabolizing 4-HNE to 4-hydroxyno!1eno:c dcid ami
to

a lcsser extent l,4-dihydroxynonene. The induction of Cyp2c29 gene

expres~~ion

hy

BJ Ii\ and acrolein suggests substrate-depcndent regulation of gene ':);pre~sioi1 lhn'ug 1l

the participation of the oxidative stress-sensitive transcription factors such as AP-l and
Nrf2. ('yp2c29 is the first mouse Cyp2c to be sequenced and characterized (Matsunaga
e{

(If" 1994). Its complete coding region contains 490 amino acids. The deduced amino

acid sequence ofCyp2c29 exhibits 83% identity with that of the rat CYP2C7, and it is a
homolog of the human CYP2C9 (Guo et (fl., 2006). Cyp2c29 is expressed at high levels
in mouse liver (Matsunaga ct al., 1994) and extra-hepatic tissue inclt:ding the heart. small

intestine (Zhang et al., 2003) and mOLlse brain (Volk
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el

oL 1995\. Cyp2:J9 cal,11Y/cs tl1l.:

metabolism of several structurally diverse compounds; the oxidation of /11- and /)tolualdehyde to toluic acids (Watanabe et af., 1994), the metabolism of the anti-epileptic
drug, phenytoin (Volk et af., 1995) and the oxidative hydrolysis of the coumarin
derivative scoparone (Meyer et af., 20(1). Reccntly we demonstrated that Cyp2c29 is
capable of metabolizing aldehydes namely, 4-HNE and 9-anthraccne aldehyde (Aniunolll
e{ aI., 20(7).
The mechanisms governing the regulation of hepatic cytochrome P450 gene
expression are diverse. The use of gene promoters in transfection studies has facil itatcd
the understanding of these mechanisms of regulation. The study by Jackson

e{

01. (2004)

has documented transcriptional regulation of Cyp2c29 by the constitutive active
androstane receptor (CAR). In this study, it was determined that ph..;nytoin. acting
through CAR, increased Cyp2c29 mRNA and protein levels in mouse liver.

Cyp2c~~<)

e:'-.pression in the liver is decreased in hepatocyte nuclear factor I -alpha (lINF I (f.) null
mice (Cheung et ai., 2003) implicating HNF I a in Cyp2c29 basal expression.
AP-l family members include Fos, lun and activating transcription factor (AlF).
The AP-l transcription factors bind to the DNA sequence known as thc TP A (12-0tetradecanoylphorbol 13-acetate)-response elcment (TRE), as different dimcric
combinations of basic leucine zipper proteins from the Jun (c-Jun, .TunB. and JunO) and
Fos (c-Fos, FosB, Fra-l, and Fra-2).The TRE sequence was originally described in the
human collagenase gene promoter and has the sequence 5'-TGA(CG)TCA-3' (Angel ct
(//., 1987). The activity of the AP-l transcription factors is regulated by components 01'
the mitogen-activated protein (MAP) kinase cascade. The MAPKs arc cvolutionari;y
conserved proteins that allow cell-surface receptors to act upon several regulatory targets
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within the cell. Three cascades composed of a MAPKK kinase or MEK kinase. a MAPK
kinase (MEK) and a MAPK regulate the activity of MAPKs. Mammals express at least
four groups ofMAPKs; ERK1I2, JNK1I2/3, p38 and ERK5. The targets of the stressactivated kinase, lNK, include lunD, c-Jun, ATF and ELK-I. These proteins are
activated following exposure to oxidative stress or other cell stresses.
Transcription factor Nuclear factor erythoid-2 related factor 2 (Nrf'2) is a
basic leucine zipper (bZip) protein. Nrt2 binds to is canonical antioxidant response
clement (ARE) as a heterodimer with other bZip proteins notably small MaL Jun. and
ATF. The ARE consensus sequence initially described by Rushmore e/ of (1991) is 5'GTGACNNNGC-3'. It was later observed that the bases flanking the core ARE sequence
also influence the function of the ARE. The sequence was therefore expanded to 5'TMAnnRTGAYnnnGCRwww-3'; M represents A or C, R reprcser:ts A or G. Y
represents C or T, W represents A or T, S represents Gore (Wasserman and FahL 19(7).
By performing point mutation studies, it was determined that the "OC" in the ARF core
sequence is an absolute requirement of a functional ARE (Rushmore

e/

ill., 199 J). It l~as

also heen demonstrated in the human c-Ha-ras gene that in addition to the nanking
sequence, the trinucloetide "NNN" within the core ARE also intluenees the recruitment
of proteins to the ARE (Miller and Ramos, 2005).
Compounds that cause oxidative stress in the cell have heen shown to activate
both AP-l and Nrfl. Treatment of cells with 4-HNE results in the depletion of GSl r, the
production of peroxide and the activation of the JNK (Uchida et al.. 1998). Acrolein
activates the MAP kinase signaling cascade resulting in the activation of JNK, p38 and

ERK1I2 (Ranganna et al., 2002). Several studies have also shown that BHA alld its
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metabolite tBHQ activate AP-l. BHA induced the rat glutamate-cysteine ligasc and
glutathione synthetase, two enzymes involved in thc synthesis of GSIl through the
activation of AP-l (Yang et al., 2002).
In addition to activating AP-l. acrolein, 4-HNE and BHA also cause the release
ofNrf2 from Keap-J and allow translocation ofNrf2 from the cytoplasm to the nucleus.

BIIA is the prototypical Nrf2 activator and has been used by several groups to induce
gene expression via Nrf2. A study by Yuan et al. (2006) demonstrated that BflA
regulated the ARE-mediated induction of heme oxygenase-l gene expression through
Nrf2 coupled with ERK and JNK signaling pathways in HepG2 cells. Upon activation .
.INK phosphorylates Nrf2 at Serine-40 causing the release ofNrf2 from Kcap I. Thl~sc

ohservations imply that in addition to AP-l activation, the MAP kinase cascade can also
activate Nrt2.
The core ARE sequence strikingly resembles the consenSLlS TRI·:. implying lh~lt
sequcnces that resemble these response elements have to be tested lor their functioll b:
determining which transcription

t~lctorS

are recruited to these cis-elements. As stated

above. we observed that Cyp2c29 is induced by BIIA and to a lesser extent by acrolein.
We also confirmed by Western blotting that Cyp2c29 protein levels were 2-fold higher in
liver microsomal fractions prepared from mice treated with BEA compared with
untreated mice. We therefore hypothesize that Cyp2c29 gene expression is regulated by
HilA and acrolein through the oxidative stress-sensitive transcription Cactors. To test this
hypothesis, we cloned and analyzed the 5'-flanking sequence ofthc ('yp2e29 gene for
transcriptional regulation by the oxidative stress-sensitive transcription

MatInspector (http://www.genomatix.d~) and TFSEARCH
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i~lctors.

Using

(bttp:l/www.cbrc.jp/research/db/TFSEARCH.html). we scanned 3000 hases of the
Cyp2c29 promoter for putative transcription factor binding sites. A putative TRE \\as
observed at -1249 bp, upstream of the Cyp2c29 transcription start site. This sequence
strikingly resembles the TRE and contains the consensus ARE described by Rushmore

ef

al in 1991. We subsequently analyzed the 3000 bp 5'-tlanking sequence, as well as the

TRE for regulation ofCyp2c29 gene expression. We observed that induction oCCyp2c29
is mediated by transcription factor AP-l.

MATERIALS AND METHODS
Chemicals. Tert-BHQ, SP60012S (JNK inhibitor), and okadaic acid (phosphatase

inhibitor) were purchased from Sigma Chemical Co, Inc. (St. Louis, MO) anll dissol\ cd
in dimethyl sulfoxide (DMSO). Acrolein was purchased from Sigma Chemical Co and
diluted to the required concentrations in phosphate buffered saline. The luciferasc assay
reagent and cell culture lysis reagent (SX) were purchased from Promega (Madison, WI).
When reagents were prepared in DMSO, the maximum concentration orDMSO Pc!' 111101'
media on treated cells was 0.4 % (v/v).

Plasmids used for transfection. Plasmid GL-3 basic vector was purchased frolll

Promega (Madison, WI). Cyp2c29 promoter constructs were prepared by a similar
method as described by Jackson et al., 2004. Mouse genomic DNA was purchased from
Promega (Madison, WI) and used in PCR experiments to generate :103 t bp of the
c

(~vp2c29 S'flanking sequence. This region contains 123 bp ofthc (yp2c2Y gene, as well

as, 301 J base pairs of the Cyp2c29 S'-flanking sequence. The downstream primer: 5'T'GGATCTGGTCGTGTTCCTAGC- 3' introduced an Nco! site. \\hilc the upstream
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primer: 5' --ACACAATTTGGTTTTGGTTA- 3' introduced a Kpn ! site to the upstream
region of the 3034 bp PCR product. A 600 bp fragment ofthc Cyp2c29 5'-FS was also
generated. The upstream primer, 5' -CCCGGGGATAGTGGTTATCACTGAATAG-3'
introduced a Smal site and the down stream primer 5'CTCGAGCTGTACTGGGGCATATAAAG-3'introduced an Xhol restriction enzyme
C,j

site. The amplicons were recovered into pCR;J<4Blunt-TOPO ; "ector
(Invitrogen, Carlsbad CA). After sequence verification by comparison with genomic
DNA sequence data, the Kpnl and Neal sites were used to remO\'e the Cyp2c29 -3043 bp
promoter region and inserted it into the pGL3-Basic vector to generate the reporter
plasmid pCyp2c29-3.0Luciferase reporter plasmid (pCyp2c29-3.0Lue). Dr. .IA.
Goldstein (NIEHS, Triangle Park NC) provided the pOL3 luciferase rcporter plasmid
containing 1500 bp of the Cyp2c29 promoter (pCyp2c29-1.5Luc). Plasmid O_lMGSTYaLuc (pO.164GSTYa-Luc) containing 164 bases of the rat GST Ya minimal prollloter
cloned in front of the luciferase reporter gene was generated by Dr. K. C"meron Falkner
(University of Louisville). This construct has been extensively used in the Prough
Laboratory to drive the expression of genes by various enhancer clements. The plasmid
pO.164-GSTYa Luc was used to generate the shorter Cyp2c29 fragments lacking the
Cyp2c29 native promoter. The restriction enzymes SmCi I ancLU70 / \'/ere used to remove
a 600 bp region of the Cyp2c29 5'flanking sequence and inserted into

pi),

164-GSTYaLuc

upstream of the rat GST Ya promoter to generate pCyp2c29-600Luc, Dr. ('B. Pickett
and T. Nguyen (Schcring-Plough Research Institute, Kenilworth. New Jersey) provided
the expression plasmids for c-Fos (pRSV-cFos) and c-.Tun (pRSV-c-.Tun). Dr. KS, Ramos

(University of Louisville) provided the Nrf2 expression plasmid (pCI-Nrf2nco), Plasmid
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O.I64GSTYa-ARELuc (O.I64Ya-ARELuc) containing 164 bases orthe rat GST Ya
minimal promoter and the consensus antioxidant response clement cloned upstream of
the luciferase reporter gene was used as a positive control for Nrf2-dependent regulation
of gene expression.

A luciferase reporter plasmid containing 30 bp fi'agment of the Cyp2e29 promoter
region (pCyp2c29-TRELuc) or mutants of the TRE (pCyp2c29-AP I Mut L pC'yp2c2()GCMutJ) were generated by the technique of primer annealing. We also generated a 30
bp fragment containing the human collagen TRE. The 30 bp oligonucleotides were

obtaim:d from Integrated DNA Technologies. Inc. (Coralville. IA) and the scqucnces arc
shown in Table 7. For each fragment a Kpnl restriction enzyme site was included at the
5' -end and a Nhe 1 site at the 3' -end. The olignucleotides were re-suspended in 10 1l1l\1
Tris-EDTA (pH 8) and phosphorylated using T4 polynucleotide kinase according

to

tll(:

manufacturer's instructions (Promega, Madison WI). Phosphorylated oligonucleotides
were cleaned with the QIAquick nucleotide removal protocol (Qiagell. (JermantO\vn MD)
according to the manufacturer's instructions. The primers were annealed in bufler (1 mM
Tris pH 8, 50 mM NaCl, 10 mM EDT A, Sigma Chemical Co, St Louis !'vIO) by heating
at 95°C for 2 min and gradual cooling to 25

°c (room tempcraturc) for 45

min in the

Amplitron@ II Thermolyne thermocycler. Each double-stranded DNA was ligated into

Kpnl- and Nhel-digested p0.164Ya-Luc (Figure 34) using T4 DNA ligase. according tll
the manufacturer's instructions (Prom ega, Madison WI).

Transient transfection of HepG2 cells and measurement of luciferasc actiyity. The

human hepatoblastoma cell line HepG2 (HB8065. American Type Culture CollectioJl,
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Table 7
Oligonucleotides showing the Cyp2c29 putative TPA (12-0-tetradecanoylphorhol
13-acetate)-response clement (TRE), wild (vpe and mutant sequenccs, and th{~
human collagenase TRK

Oligonucleotide

Sequence

Cyp2c29TRE
Forward
Reverse

5'-A TCACTGAATAGTGACCTAGCACATAC;TCi\-3'
5'-CTAGCTGACTATGTGCTAGGTCAC'TATrCAGTGGTAC'-]'

Cyp2c29-Mut-TRE
rorward

5'- ATCACTGAATAGGAGACTAGCACATAC;TCA-]'

Cyp2c29-Mut-GC
Forward

5'-ATCACTGAATAGTGACCTAAAACATAGTCA-] ,

Collagenase TRE
Forward
Reverse

5' -CAAAGCATGAQTCAGACACCTCG-3'
5' -CTAGCGAGGTGTCTGACTCATCiCrITCJGTAC'-]

The underlined nucleotides in Cyp2c29 TRE were mutated to determine their rule in the
induction of reporter plasmid in response to transfected Fos and

Jlli1

expression pl'lsmids.

The underlined sequence in the collagenase TRE is the core sequence. Thesc
oligonucleotides were cloned in front of the lucifcrase gene in pO.164GSTYa-Luc to
generate recombinant reporter plasmids. and used in transfection e:-: pcrimcnts.
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Figure 34. The modified pO.164-GSTYa Luciferase plasmid showing the luciferase
gene, the minimal rat GST Ya promoter (164 bases) and the Cyp2c29-TRE (-30
bases). The Cyp2c29-IRE was replaced with mutants of the IRE (pCyp2c29-APIMut or

pCyp2c29-GC-mut), 600 bases of the Cyp2c29 promoter (pCyp2c29-0.6Luc), or the
human collagenase TRE (pCol-TRELuc).
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Figure 34
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Transient transfection of HepG2 cells and measurement of luciferase activity. The
human hepatoblastoma cell line HepG2 (HB806S, American Type Culture Collection.
Rockville, MD) was maintained in Eagle's minimal essential media with 10% fetal
bovine serum (HyClone, Logan UT), antibiotic-antimycotic solution (1 X, contains
penicillin, streptomycin and fungizone; Invitrogen, Carlsbad CA) and nonessential amino
acids (IX; Mediatech Inc. Herndon VA). For transfection experiments, cells were plated
at a density of IS0,000 cells per well in 12-well plates. Twenty-four hours after plating,
cells were transfected using 4 Ilg/mL LipofectAMINE (Invitrogen, Carlsbad, CA) with
either the reporter plasmid pCyp2c29-3.0Luc, pCyp2c29-1.SLuc, pCyp2c29-0.6Luc and
pCyp2c29-TRE and its mutants, p0.164GSTYa-ARELuc, or pCol- TRELuc (100 ngiI11L).
The cells were also cotransfected with pRSV-cfos (3.S-S0 ng/mL), pRSV-cJun (3.5-50
ng/mL), and a

~-galactosidase

expression plasmid (pCMV-~Gal) in 1 mL of serum frec

medium. After an overnight incubation at 37°C, the cells were overlaid with 1 mL media
containing 10% FBS and then treated with 4 ilL of 12.S mt\l tBHQ in DMSO. The
trcatment of cells with acrolein (0.2 nM and 0.4 nM) was performed in normal and serum
li'ce media. Seventeen hours later (overnight) the cells were harvested with 100
lysis buffer (Promega, Madison, WI). The

~-galactosidase

~lL

of cell

and luciferase activities were

determined as described by Falkner et at. (1998). The data are expressed as luciferasc
activity relative to ~-galactosidase activity to correct for transfection efliciency. All
transient transfection experiments were performed in triplicate, and experimcnts wcre
repeated at least twice to confirm rcsults.
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Statistical Analysis. Experiments were conducted in triplicate and means

.1:

standard

deviations were determined. Statistical comparisons among treatment groups were
determined using analysis of variance (ANOVA) or a Student's t test.

RESULTS
Cloning and sequencing of the 5'-flanking sequence of Cyp2c29. The sequence of the
3.0 kb product of the Cyp2c29 5'-flanking sequence (5'-FS) is shown (Figure 35). This
sequence was generated by PCR and analyzed for transcription factor binding sites using
MatInspector Version 3.2 and TFSearch.html. The phenytoin-responsive module
(PHREM), characterized by the Goldstein Laboratory (NIEHS, Triangle Park NC) is
located at -l.3 71 Kb upstream of the Cyp2c29 translational start site. This module
contains a CAAT enhancer binding protein (C/EBP) binding site. The PHREM is
responsible for the constitutive androstane receptor-dependent induction of Cyp2c29 by
the anti-epileptic phenytoin (Jackson et al., 2004). The 3.0 kb 5'-FS ofCyp2c29 also
contains putative binding sites for AP-l, NF -kB, the coactivator p300, signal transducer
and activator of transcription (STAT), specificity protein (SP-I), pregnane X receptor
(PXR), myeloid zinc finger protein (MZF) and heat shock factor (HSF) (Figure 35).

Functional analysis of the 5'-flanking sequence of Cyp2c29. Microarray analysis,
qRT-PCR and Western blotting analysis demonstrated that treatment ofC57BLl6 mice
with BHA or acrolein resulted in the induction of Cyp2c29, both at the mRNA and the
protein level (Chapter III). To determine the oxidative stress-sensitive transcription
factors responsible for Cyp2c29 induction, we co-transfected HepG2 cells with luciferase
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Figure 35. The 3.43 Kb of the Cyp2c29 5'-flanking sequence. The sequence shown is
the -t3 to -3043 bases of the Cyp2c29 5'-FS. The underlined nucleotides represent
putative transcription factor binding sites identified by MatInspector and TFsearch
software. The phenytoin responsive module (PHERM) is shown. The box shows
nuclcotides that were cloned into the pO. 164Ya-Cyp2c29-TRE-Luc. The transcription
~;tart

site is italicized.
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reporter plasmids containing different lengths of the Cyp2c29 5' -FS generated by
deletion, and Fos and lun (AP-l) or Nrf2 expression plasmids. Luciferase activity from
the pCyp2c29-3.0 reporter plasmid gradually increased with the increase in cotransfected AP-l. However, the levels were lower than the basal activity seen in the
absence of AP-l (Figure 36). There was a 2-fold increase in luciferase activity from the
pCyp2c29-600 luc:iferase reporter plasmid in the presence of 50 ng and 100 ng of Fos and

lun suggesting that this sequence is regulated by AP-l. The luciferase activity returned to
control levels when the cells were transfected with 150 ng of AP-l expression plasmids.
The reporter plasmid pCyp2c29-TRE contains a 30 base pair fragment of the
Cyp2c29 promoter. The highest fold induction (6-fold) was obtained when HepG2 cells
were transfected with this reporter plasmid in the presence of 50 ng ofthe Fos and lun
expression plasmids. Luciferase activity then decreased with increased amounts ofFos
and lun expression plasmids (Figure 36). The decrease in luciferase activity with
increasing cotransfection of the Fos and lun expression plasmids was unexpected. This
may have been caused by limiting coactivators or the formation of nonproductive protein
complexes at higher AP-l concentration. Unlike Fos and lun, Nrf2 did not induce
luciferase activity even when the cells were treated with tBHQ (data not shown).

Transcription factor AP-l induced reporter activity through a Cyp2c29 TRE. As
shown in Figure: 36, the pCyp2c29-TRE reporter plasmid showed maximum induction in
the presence AP-l transcription factor. According to the results of MatInspector and
TFSEARCH result, this fragment contains a putative AP-l binding site (TRE, 89 %).
However, this site also closely resembles the consensus ARE (Table IV). We therefore
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Figure 36. Deletion analysis of the 5'-flanking sequence of the Cyp2c29 gene.

1.1Icikrase constructs were prepared \vith different length Il'agmcnts of the 5'-FS oCthe
Cyp~c2c)

gene. A. Schematic representation of the different deletion constructs of the

(':p2c29 5' -nanking sequence. B. The constructs were tested by transient cotransfection
\"illl Fos and .Tun expression plasmids in HepCr2 cells. The normalized lucifcrase activity,

l'.,\pressed as relative light units divided by the i)-galactosidase activity. is the mean

I

Sf)

\)f!!Jree wells. Data was analyzed by Anova followed by a Dunnett test. *** Signilicantly
dil"i"crcnt ii'ol1l controL p< 0.001; **Significantly different Il'om controL p<0.05.
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Figure 36
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Fos+Jun
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pCyp2c29-T ;{F L

IIC

subjected this fragment (pCyp2c29-TRE) to further analysis in the presence of AP-I alld

Nrf2.
In the previous experiment, we observed the highest reportcr gelle expression
when IIepG2 cells were co-transfected with the lowest combination of Fos and Jun
expression plasmids (50 ng). We therefore decided to transfCct cclls with

10\\ cr

alllounts

or AP-l: Fos (3.5 -60 ng) and Jun (3.5 -60 ng) expression plasmids. Thc highcst
induction of luciferase activity (8-fold) was observed when the cells were cotransfCcted
with Fos (3.5 ng) and Jun (3.5 ng) expression plasmids (Figure 37). In addition to
responding to AP-I, the Cy2c29 TRE sequence of interest resembles the consellSLlS /\I\Y.
Therefore, to determine ifNrf2 contributes to Cyp2e29 induction. I Iep(J2 cells wcre
transfected with the Cyp2c29-TRE Luc rcporter plasmid and the NrQ and AJ>-1
cxpression plasmid, and luciferase activity measured (Figure 37). Surprisingly. Nrl2 did
!wt alfect luciferase activity even in the presence ofFos or .Tun (data not shown). This
obscrvation indicates that the induction orIucifcrase activity is in response to an /\J>-I-

:'I<.F and not an Nrf2-ARE interaction.
A positive control for AP-l-mediated induction of gene expression was per!'onm:d
by transfecting HepG2 cells with a Col-TRE lucifcrasc reporter plasmid. This plasmid
contains the human collagenase TRE Crable 7). Luciferase activity incl'L'ased by J.5 to 2fold in the presence of 15 -- 60 ng the Fos or .Tun expression plasmid (Figure 38). j\ cotransfection of the Fos and Jun expression plasmid caused an increase ill luciferase
activity with the highest induction of2.75-fold observed in the presence of 3.5 ng Fos
and 3.5 ng Jun expression plasmids. The collagenasc TRE thercf~m' interacts with a I'os
.run heterodimer to mediate the induction of luciferase activity obscn cd.
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Figure 37. Differential activation of the Cyp2c29-TRE Luciferasc reporter in
HcpG2 cells by AP-l proteins. HepG2 cells were transfected with pCyp2c29-TRELuc

reporter plasmid and the expression plasmid for Fos (3.5-60 ng) and .fun (3.5-60 ng).
Twenty four hours after transfection, the cells were harvestcd and the lysate assayed for
(I-galactosidase and luciferasc activity. The data represent the mean j SD of three wells.
i~:'\pcrimcnts

were repeated at least three times with similar results. Statistical

signilicance was determined using Anova followed by the Dunnett post-test. ***
Significantly different from controL p<O.OOl; **significantly di1ferent from control.
p'O.OOI.
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Figure 37
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Figure 38. Induction ofCollagenasc-TRE Luciferasc repol"ter activity folJowing
cotransfcction of Fos and Jun in lIepG2 cells. HepG2 cells were trans1Cctcd with pCol!RU ,lIC reporter plasmid and the expression plasmid for 1"os (3.5-60 ng) . .lUll (J.5-60
llg).

and Nrf2. The eells were maintained for 24 hrs and harvested. The celllysates \\ere

assayed for

~-galaetosidase

and lueiferase activity. The data represent the mean:1

s]) or

thn.T wells. Experiments were repeated at least three times with similar results. Statistical
,i:'Jlificanee was determined using Anova followed by the Dunnett post test, *p< O'(lOl
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Figure 38
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In a similar experiment, IIcpC;2 cells were transfected with pCyp2c2-rl~E Luc
and treated with 0.2 nM or 0.4 nM acrolein. There was no change in lucifcrase acti"ity at
0.2 nM acrolein. However at 0.4 nM acrolein treatment. thcre was a modest but
inconsistent increase in luciferase reporter activity (data not shown). The tn~atment of
I kpG2 cells with higher concentrations of acrolein caused cell death as detl~rmined by a

decrease in the p-galactosidase activity in the acrolein-treated cells.

The core and proximal nuclcotides of the TRE contribute to AP-l-dcpcndcnt

induction of Cyp2c29. To determine the contribution of the lluc]cotidcs in the Cyp2c29
TRF sequence in the induction of luciferase acti\'ity. HepG2 ce:ls were transiccted 'v\itll
the Cyp2c29-TRE (wild-type) or the AP-I mutant reporter plasmid Crable 7).
In the presence of AP-I, we observed a 2.S-fold incrcase in luciferase activity
from Cyp2c29-TRE (Figure 39). This activity was modestly increased when the cells
were treated with 50 ~lM tBHQ. There was no effect of co-transfcction ofNr!,2 alol1e.
e\en when the cells were treated with tBHQ. This suggests that Nrf2 may not interact
with the Cyp2c29 TRE. The core TRE sequence within the Cyp2c29-TRE-Luc \vas
mutated to generate the Cyp2c29AP-1 Mutl luciferasc plasmid. This lllutatioll obliterates
the Fos/Jun binding site. The increase in luciferase activity as seen with the \\ild-type
TRE in the presence of AP-I was lost when the cells were trans1Ceted with the
Cyp2c29AP-IMutl reporter plasmid. As expected. there was no change in lucijcrase
activity in the presence Nrf2, Fos/JunlNrt2, Jun alone or Jun/Nrf2 expressioll p!aslllids.
In addition to the AP-I mutation. the "GC" dinucleotide which is proximal to the

J '-end of the Cyp2c29 TRE was mutated to determine its elTecl on 1\[>-1 mediated
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Figure 39. Mutation of the core TRE results in the ablation of AP-l-depcndent

transcriptional induction of Cyp2c29. IlepG2 cells were transfected with pCy]12e:29-

11<1<: LLie (wild type), or pCypp2c29-AP I MUTl (mutant)

n~porter

plasmid ami the

l'xpression plasmid for Fos, lun and NrC. The cells \vere trcated with DMSO or 50 pivl
tlillQ In DMSO for 16 (overnight) hrs and then harvested. The eelllysates were assayed
Cor lucifcrase and

~-galactosidase

activity. The data shown is the mcan ± Sf) of three

\\elk Lxperimcnts were repeated two times with similar results. Statistical significance
was determined using the Students {-test.

***significantly di tlerent from

in the absence oftBHQ treatment. p<O.OOI.
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induction of luciferase activity. This "GC" is an obligate requircment for

:1

functional

A RE (Rushmore et a!.. 1991). There was no si gnificant di fterence in basal Iuci !Crase

activity between the wild-type Cyp2c29 TRE and the GC-mutant (Figure 40). J\ cotransfection of the AP-I expression plasmids caused an 8-fold increasc in luci fcrase
activity from the Cyp2e29-GC-mut plasmid compared with 2.S-fold increase from the
wild-type TRE plasmid. This suggests the presence of the "GC" cis-acting clement
results in negative regulation of induction of the Cyp2e29-TRE luci ferase activity hy API. but mutation of the element results in even higher inducible expr'2ssion of the gene.

Over-expression ofNrf2 had no effect on luciferase activit}. but these cells e:-.:press I\'rJ'2.
Induction by BEA in Nrf2 null mice is actually increased significantly ovcr wild-type
mice suggesting that Nrf2 may ameliorate AP-I signaling in the expression

or this gene.

In order to compare the response from the Cyp2e29 TRE to tha: or the:on.:CIlSLlS

ARE. HepG2 cells were transfected with the pO.164-GSTYa-ARELuc reporter plasmid.
This plasmid contains the antioxidant response clement of the rat G ST Ya promoter ane!
has been extensively used in the Prough Laboratory as a positive c(lntrol ror the ARL··
~rf2-dependent

induction of gene expression. Luciferase activity vvas measured

t()llowing cotranst'ection orthe Fos, Jun or Nrf2 expression plasmid (Figure 41). First,
there was a significant increase in basalluciCerasc activity following eo-transCcctioll of
the .fun (p <0.05), Fos and Jun. Nrf2 or Nrf2 and .Tun (p <0.(1) and the Fos express:on
plasm ids (p>O.OS). Second. following trcatmcnt with tBlIQ. wc

ob~erved

a Curther

increase in luciferase activity; II-Cold (.lun; p <(J.O I). 21-fold, Fos and .fun (p <0.(1). 2Sfold. Nrf2 (p <0.01) and 38-fold. Nrf2 and Jun (p <0.01) compared with

tlK

pO.l (l"j y~,-

J\ RE alone treated with tBH Q. These data confirm previous observati OllS that Fos or .I un
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Fi~ure

40. Mutation of the "GC" dinucloctidc rcsults in the induction of AP-t-

dcpendcnt transcriptional induction of Cyp2c29. I-lepG2 cells were transfccted with

pCyp2c29-TRELuc (wild type), or Peyp2c29-GCMlrn (mutant) reporter plasmid and
the expression plasmid for Fos, Jun and Nrf2. The cells were treated with I )[v1S0 or 50
~l\ltBI

[Q in DMSO for 16 (overnight) hrs and then harvested. The eelllysates were

a:;sayed for lueiferase and

I~-galactosidasc

activity. The data shown is the meal1

J

Sf) or

three vyells. Experiments were repeated two times with similar results. Statistical
sit',l1iticance was determined using the Students I-test.

***

Signiticantly dirferent h'oI1l the

Cvp2e:29-TRE Lue activity in the absence oftBHQ treatment. p < 0.00 I.
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Figure 40
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+
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Figu re 41. Effect of Nrf2 and AP-l on

ARI~-dependent

activation of pO.164GST Va-

A RE-Lucifcrase activity. HcpG2 cells were transfcctcd with pO. I M-CiST Ya-A RL Luc
,cpul'ter plasmid, Nrf2 and AP-I expression plasmids. Lucifcrase activity in I IcpG:2 cells
\v~IS

measured after treatment with DMSO or 50

relative

lucifcrase!~-gal

~lM

tBI IQ in DMSO. The data is the

activity for three wells. Experiments were

repca~ed

at least rnur

times \\ith similar results and statistical analysis performed by Anova i'olloV\cd by the
Dunl1elt post test.* (p<O.05) and
treatmcnt. -i-t And

***

(p<O.Ol) significantly different from basal "chicle

ttt significantly different from the basal tBIIQ treatmellt. p<O.01.
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Figure 41
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j.

can synergize with Nrf2 to potentiate the GSTA2 reporter gene expressil)l] undcr control
of this ARE (Nguyen et al., 2003).

The effect of MAP kinase inhihitors and phosphatase inhihitors on AP-l-dcpcndcnt
~lctivation

ofluciferase activity. AP-l (Yang el a/., 2(02) and Nrf2. (Yuan el a/" 19%)

an: activated by components of the MAP kinase cascade. To determine which kinases arc
involved in AP-l activation resulting in the induction ofluciferase activity, I TcpG2 cdls
were transfected with pCol- TRE Luc, the Cyp2c29-TRE Luc or pO.164

Ya-J\RI~

I.ue.

The transfected cells were then treatcd with the JNK inhibitor SP600 125 (Bennett el u/.,
2.(01), the protein phosphatase inhibitor okadaic acid (Takai et a/., 1(87) or the ERK
inhibitor PD098059 (Dudley et al., 1995). SP600 12.5 functions to inhibit .INK-mcdiated
phosphorylation of Jun, thereby inhibiting .Tun activation. Treatment of the
1 kpG2

tral1~Jeeted

cells with the JNK or the ERK inhibitor caused a 40-50(% inhibitinl1 of iuci fCr~uc

activity ufthe Cyp2c29 TRE luciferase reporter plasmid and a 50-60% inilibitinn in the
collagenase TRE reporter activity (Figure 42). The protein phosphatase inhibitor. oi<adai':
acid caused an increase in luciferase activity, 4-fold for Cyp2c29-TRE and 3-fold for
collagenase TRE. The GST Ya antioxidant response clement was also inhibited by 50 %
by the JNK inhibitor SP600125 or the ERK inhibitor PB098059, and induced 1.4-fold by
lhe protein phosphatase inhibitor okadaic acid. These data support the observation that
Cyp2c29 induction is mediated by AP-l and that this transcription factor requires
phosphorylation for activation.

Regulation of the cyp2c29 5' flanking sequence in mouse primarY hepatocytcs.

172

Mouse primary hepatocytes were transfected with luciferase reporter plasm ids contJillin,U
the different Cyp2c29 5'FS fragments, and the cells treated for 1G hrs with tBI ro. We
observed a 3-fold induction of luciferase activity with the reporter plasmid containing
3.0 kb of the Cyp2c29 5' -FS (Figure 43). In addition, we observed a 5-fold increase in
luciferase activity with pCyp2c29-0.6Luc compared with the basal pCyp2c29-3.0 lue
activity. In a separate experiment, treatment with tBHQ also caused induction of the
Cyp2c29-TRE in mouse primary hepatocytes (data not shown). We observed that
induction of the luciferase activity was more robust in mouse primary hepawcytes than in
llepG2 cells (Figure 39). Tert-BEQ is proposed to induce gene cxpn.:ssion by
undergoing redox cycling in the presence of enzymes capable of one-electron reductioll
ortBI IQ (Kahl et al., 1989). This reaction produces reactive oxygen species (oxidative
stress) which activate the MAP kinase cascade subsequently activating Nrf2 and AP-l. It
is possible that the enzyme system required for this process is absent in HepC;2 cells.
thereby causing the reduced induction of AP-1-mediated reporter activity observed.
Alternatively, there might be other transcription factors required to mediate the induction
ofCyp2c29 by tBHQ and acrolein, which are absent in IIepG2 cells.

Cvp2c29 is induced by RHA in Nrf2+/ and NdT /- mice liver. We have so I~ll' madc till'
t

fpllowing observations for Cyp2c29: 1. Its expression is induced by HIlA

an~1

acrolein in

ll1iee liver. 2. The Cyp2c29-TRE is induced by Fos/Jun and not by Nri2. 3. There is a
further induction of the Cyp2c29-TRe reporter activity following mutation ofthc

"ne"

dinucleotide at the 3 '-proximal region of the Cyp2e29-TRE. To further investigate till:
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Figure 42. Effect of protein kinase and phosphatase inhibitors on Cyp2c2lJ-TRE

lucifcrasc reporter activity. HepG2 cells were transfected with collagenase TRE,

('vp7.c29-TRE or GST Ya ARE luciferasc reporter plasmids. Cells were treated for 16 h
with 25

~tM

acid dr 50

of JNK inhibitor SP600125, 40 nM protein phosphatase inhibitor okadaie

~tM

ERK inhibitor. PD098059. Cells \vere harvested and Iysates assayed for

r)-

galactosidase and luciferase activities. The relative luciferase activity was calculated by
normalizing the change in luciferase activity following treatment to the vehicle treated
control:;. Data represent the mean
fo\i\)\\,~d

± S.D. of three wells and was analyzed by ANOVA

by the Dunnett test.* p>0.05; ** p<O.OI, significantly different froril ltw \ chicle
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Figure 42

o
DMSO

15 f11V[ SP600125

40nMOA
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50.uMPD98059

Figure 43. Lueiferase reporter activity in response to tBJlQ in mouse primary

hcpatocytes. Mopse primary hepatocytes were transfected with pCyp2c29-3.0 Iuc.
pCyp2c29-1.5 Lu¢ or pCyp2c29-604. After 24 hours. the cells were treated for 16 hours
with vehicle or 50 ).lM tBHQ. Cells were then harvested and Iysates assayed l'or

r)-

t'alact()sidase and luciferase activities. Data represent the mean ± S.D. of three \yells.
Statistical analysis was performed by ANOYA followed by the Dunnett post test. ***
Sit'nirlcantly different from the vehicle treated pCyp2c29-3.0Luc, ]1<0.001.
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Figure 43

o

pCyp2c 29-3.0 L uc pC yp2c29-1.5 L uc pC yp2c 29-604 L uc
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role of Nrf2, we conducted qRT-PCR with RNA from wild-type and Nrf2-'- mice liver red
BlIA.

C57BLl6 wild-type and Nrf2-'- mice were treated with BHA for 7days and RNA
extracted from liver samples of the same animals. Following cDNA synthesis, the mouse
liver sampiles were analyzed for changes in gene expression by quantitativc real-time
PCR. The following observations were made (Figure 44): GSTml was induced on
averagel0-fold; heme oxygenase 1, 3-fold: NAJ)PH:quinone oxidorcductase. 17-i'old and
Cyp2c29. 6-fold. In the Nr12

-1-

animals, GSTml and quinone oxidoreductase were

induced only 2-fold and no induction was observed for heme oxygenasc 1. Interestingly.
a further increase in induction was observed for Cyp2c29 (17-fold) in the Nd2 -I-mice
liver. The Hayes laboratory has conducted studies looking at Nrf2-dependent regulation
of gene expression. They have observed that administration of isothiocyanates which are
activators ofNrf2, to nrj2+ 1+ and nrj2

1
-

mice produced a ~ I.S-fold inercase in

NAD(P)H:quinone oxidoreductase 1 (NQO I) and glutathione 51-transferase (CST)
activities in stomach, small intestine, and liver of wild-type mice but not in l11utantmice.
The increase in transferase activity was associated with elevated levels of GSTA 1/2,
GSTA3, and GSTMl/2 subunits (McWalter ef al., 2004). This is in agreement with the
induction ofGSTml and NQORI caused by BHA in wild-type mice. Unlike the other
genes, Cyp2c29 was further induced in Nrf2-I -mouse liver supporting thal this enzyme is
regulated by a different transcription factor, most likely AP-l. Taken together, \ve
cOllcl ude that while N rf2 induces the expression of GS Tm 1, I 10-1 and nQO R-1 .
Cyp?'c29 is induced by transcription factor AP-l.
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Figure 44. Quantitative real-time peR analysis of gene expression in wild-type and

:'1'12-/- miee liver following treatment with RHA. Wild-type mice
7();\

WLrc

fed with AIN-

diet only (control, n=c4), or supplemented with 0.45% HHA (treated, 11=7) Cld lihitum

for 7days. Nrf2- I - mice were fed with chow diet only (control, n==3),

Of

supplemented with

O.:l5% HI IA (treated, n=3) for 7 days. RNA was extracted from the liver, reverse
lr~ll1scribed

to cDNA and used for qRT-PCR analysis of gene expression. The fold
th

induction is shown in a box and whiskers plot. The boxes extend from the 25 to the 75

1h

percentilc, the line across represents the median distribution of samples for each gene.
For each point, a single mRNA was analyzed in triplicate and the average is shmvl1. The
l::bk s!lmvs the average fold induction for each gene in the liver of wilLI-type or :~rf"::InICl'.
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Figure 44
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DISCUSSION
Cytochromes P450 play an important role in the metabolism of xenohiotics as
well as endogenous compounds. P450s also function in the synthesis of important
endogenous biomolecules. Cytochromes P450 arc expressed in severed organs and tissllcs
including the liver, heart, brain, lungs, and kidneys. The regulation of P450 expression is
a major source of variability in the metabolism of xenobioties and endogenous
compounds. Cyp2c29 is a major mouse P450, expressed in hepatic, as well as extrahepatic tissue. It is among the P450s recently demonstrated to be able to metabolize 4lINE. This P450 was also induced following the exposure of mice to HI IA or acrolein in
liver.
Analysis of the 5-t1anking sequence ofCyp2c29 revealed several putative
tl,mscription factor binding sites including a putative TRE located at-1249 bp upstream
df the Cyp2c29 transcription start site. This observation prompted us to examine 'v\bether

the transcription factors Nrf2, Fos or .Tun are capablc of regulating Cyp2c29 induction in
response to tBHQ and acrolein.
We examined the induction of several Cyp2c29 5'-FS-derived lucifcrase reporter
plasmids in the presence of exogenous Nrf2. Fos and Jun. Thc lueifcrase activity \\as
induced in the presence of .Tun alone or to a higher extend by Fos and Jun expression
pbsmids, suggesting that a Fos-Jun heterodimer and a .lun homodimcr may be
responsible for Cyp2c29 induction. Even though the Cyp2c29 lRE resembled the
consensus ARE, it did not respond to the presence of over-expressed Nrf2 or treatment
with tBHQ. We therefore concluded that the induction of Cyp2c29 in response to BIL\
and acrolein is mediated by the oxidative stress-sensitive transcriptio111~lCtor AP-I.
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We used a mutation strategy tn determine the role of the oligonucleotides within
and close to the Cyp2c29-TRE in the induction of gene expression. We also mutated the
core TRE from "GTGAC" to "GGAGA". This mutation resulted in the complete
ablation of the FoslJun-mediated luciferase activity. By mutating this sequence. the
binding of AP-l to the TRE is most likely inhibited. thus resulting in the jack of changl'
in luciferase activity in the presence of Fos and Jun. Conversely. we ohser\ed that
mutation of the dinucleotide "GC" to AA resulted in a higher inductiul1 or lucikrase
activity by Fos and Jun. suggesting that the "GC" dinucleotide is not the optimal
sequence for the AP-l mediated response.
Analysis ofmRNA levels from wild type and NrfXI - miee liver demonstrated a
further induction ofCyp2c29 in Nrf2-I - mice following treatment of mice with B1 IA. This
:~l\ggests

that Nrf2 might be acting indirectly to induce Cyp2c29 inductioll. III future

:;ludies. an enzyme mobility shift assay (EMSJ\) will be conducted to

\l~ril~v

Fos anJ .iul1

hinding to the Cyp2c29 TRE and the role of Nrf2 in protein-DNA complex formation.
This is necessary in light of the study published by Ngueyn e{ al .. 1994. In the study
lo()king at antioxidant response element-dependent regulation of GST /\ 1 gene
expression, the authors observed that deletion of the "GC" in the

ARJ~

found in 1he OS!'

Ya promoter resulted in a further induction ofluciferase activity by TPA. The authors did

not comment on this observation.
Substrate-dependent induction of cytochrome P450 gene expression is common.
Phenytoin. a substrate for Cyp2c29, has been shown to be able to induce the expression
of this P450 (Jackson et al .. 2004). \\'e have shown that acrolein is also able

~o

induce

Cyp2c29. It is likely that 4-IINE whieh is a lipid aldehyde as is acrolcill may also be able
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to induce Cyp2c29 gene expression. Since we observed that acrolein induced tbe
expression of several genes involved in lipid aldehyde metabolism (Figure 29, lO, 32;\),
it is possible that acrolein could regulate its level in vivo by inducing the expression of
enzymes responsible for its metabolism. This could hold true for

4-I{NI~:

which is also a

lipid aldehyde.
Cytochromes P450 metabolize xenobiotics, endogenous compounds, as well as
synthesize important metabolic and/or signaling molecules. making the regulation

or

('yp expression critical. Only a few P450s have been shown to be regulated by AP-I: for

example CYP2J2, which is an arachidonic acid epoxygenase. is induced hy c-Jun and
inhibited by Fos in HepG2 cells (Marden el ai., 2003). Cyp4a2 is all arachidonic acid

(1)-

hydroxylase. More recently, the promoter of this P450 has heen determined to be upFrl;gulated by Jun in HepG2 cells (Fiala-Beer e{ 01., 2007). We have shown that Cyp2c29
IS

also regulated by AP-l.
In our microarray analysis of gene expression (Chapter III). BIL\ and acrolein

induced several P450s. These include Cyp2c29, Cyp2c40, Cyp=:c50 and Cyp3a23. fn
addition, CYP39Al is induced 6-fold following 6 hours oftreatment of human colorectal
cancer cells with 60

~M

4-HNE (West and Marnett, 20(5). The l11echanism of inductioJ]

nfthese P450s by these compounds is unknown. But. for Cyp2c29, we have at least
ckmonstrated that this appears to be regulated by AP-l.
In conclusion, by using cell-hased assays, we have determined that

th~

inductil)!1

of Cyp2c29 expression by compounds that activate oxidati\e stress-sensiti\e
transcription factors is mediated by AP-l acting at a TRE located at -1249 bp upstream of
the Cyp2c29 transcription start site.
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CHAPTER V

DISCUSSION AND CONCLUSIONS

Prior to this study, the role ofP450s in the metabolism of lipid aldehydes
had not been clearly defined. A study in PPARa knock out mice demonstrated that the
Cyp4a class ofP450s is capable of metabolizing 4-HNE to 4,9-dihydroxy-2-nonenoic
acid, the omega-hydroxylated metabolite of 4-hydroxynonenoic acid (Gueraud el ul.,
1999). No other reports have been published for P450s in lipid aldehyde mciabolism. We
incubated 4-HNE with rat primary hepatocytes and observed rapid metabolism of ,1- I IN r:.
Several different P450 inhibitors inhibited this metabolism. Based on this observati,m. \\ e
hypothesized that P450s are lipid aldehyde metabolizing enzymes capable of
metabolizing 4-HNE. Metabolic studies were then designed with individual P4.50s
expressed in E. coli and 4-HNE or 9-anthracene aldehyde in the prl~senee ofN/dWIJ or
an NADPH regenerating system. An NADPH regenerating system was not used in the cllINE incubation reactions because we observed non-specific interactions

or 4-1 INE \\ i:h

components of the NADPH regenerating system. The use of! IPLe allowed for the
separation of 4-HNE metabolites that wcre then identified by gas chromatography and
ckctrospray ionization -mass spectrometry. In addition to residual 4-HNE. three major
metabolites were generated by P450s. These metabolites were eluted "itb a retention
time of 56 minutes, 58 minutes and 61 minutes hom the I1Pte column. J\ very polar
metabolite was eluted from the column

(tR =- 5 min). This metabolite is believed to be
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eH]-H 20. The metabolite peak corresponding to our authentic HNA standard (tR 58
c

minutes) was positively identified as 4-hydroxynonenoic based on common retcntion
time in gas chromatography and mass spectrometry. CYP3A4. Cyp2c29.

CYP2i~6

ami

CYP2B4 generated the 4-hydroxynonenoic acid. Interestingly, the metabolite that eluted
just prior to 4-hydroxynonenoic acid (tR

c

56 minutes) was identified as 1A-Llihyliro:xy-

2-noncne, a reduced product of 4-HNE. The 1A-dihydroxy-2-nonene was gencrated b)
CYP3A4, CYP2B6, CYP2J2 and Cyp2c29. While some P450s \\ere able to

ge\lera~e

both

4-hydroxynonenoic acid and 1A-dihydroxy-2-nonene, others such as CYP2B4 only
generated 4-hydroxynonenoie acid. CYP2E 1 did not metabolize 4-1 INE. These reactions
were confirmed by the inhibition of metabolite formation in the presence of 1>4:')0
inhibitors (Amunom et af., 2007). Furthermore, we observed metabolism

of4-IINl~

mouse liver microsomes, a process inhibited by different chemical inhibitors

oj'

by

P450s.

namely miconazole, phenytoin and troleandomycin. The metabolisll1 01'4-1 Il'\r in
microsomes was not inhibited by cyanamide, an aldehyde dehydrogenase inhibitor
(Figure 14). Aldehyde dehydrogenases are typically located in the cytosol or
mitochondria (Vasiliou et uf .. 2000). Failure to inhibit microsomal ,+-HNI: metabolism
with the aldehyde dehydrogenase inhibitor implies that the microsomes were not
contaminated with the cytosol fraction.
Primary cultures of rat hepatocytes also metabolized 4-IINL to 4hydroxynonenoic acid by oxidative reactions. 1,4-dihydroxy-2-noncne through reducti \e
reactions and glutathione-conjugated 4-HNE through GSH conjugation reactiolls (Ilartley
e{ al., 1995). Based on the usc of inhibitors, the authors concluded that aldehyde
dchydrogenases were the major catalysts of the oxidative reactioll, hut
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OUi'

results suggest

that some P450s are sensitive to the known inhibitors 0 f aldebyde dehydrogenascs ( 1()O
~lM

benomyl caused 65 % inhibition of P4503A4) and alcohol dehydrogenase

mcthylpyrazole caused 98

o;()

(I ~l:v1

4--

inhibition ofP4503A4, Table 2). Previous researchcrs may

have under-estimated the role that P450s play in 4-IINE metabolism in past studies.
Mercapturic acid conjugates oflINA and DlIN have been identified in rat urinc
(Alary et af., 2003) indicating that these are detoxitication metabolites of 4-IINE. P450s
therefore contribute to the metabolism and disposition of 4-HNE. to less reactivc
intermediates which can then be subjected to further metabolism. On the other ham!.
acrolein is metabolized in rats to several metabolites including oxalic acid. malonic acid.
3-hydropropionic acid and other N-acetyl-conjugatcd species (Parent

el

01.. 1998). In

addition, acrylic acid, glycidol and glyceraldehydes have been ohserved in rat liver
microsomal fractions (Patel et al., 1980). These are phase lmetabolie products of
acrolein. It is possible that P450s contribute to acrolein metabolism by generating these
products. However, we have not investigated this possibility.
In addition to 4-HNE, we determined that the (x,r)-unsaturated aldehYlk.

l)-

anthracene aldehyde, is also metabolized by cytochromes P450 to generate 9-anthracene
carboxylic acid and 9-anthracene methanol. the oxidized and reduced metabolites of 9anthracene aldehyde, respectively. In metabolic studies, Cyp2c:29 nletaholizcc\ hotb 9anthracene aldehyde and 4-HNE with a pattern of mixed competitive inhibition indicating
that 4-HNE and 9-anthracene aldehyde are alternate or competitive substrates of
Cyp2c29. Cyp2c29 is a mouse P450 expressed in hcpatic and extra hepatic tissuc that
\\<\s previously reported to oxidize a cannabinoid aldehydc to its acid ('r'amal11()to c{ ul..
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\995). In my dissertation research, we showed that this P450 can also metaho\i/e h<)th ~
lINE and 9-anthraeene aldehyde.
Cardiovascular tissues including heart. smooth muscle and endothelium express

d

variety of P450 enzymes that in humans include two gene famil ies of epoxygenases

(CYP 2C8, 2C9, 2C 10, 2J2) which generate the regio- and stereo-spccillc
cpoxyeieosatrienoie acids (EETs) and co-hydroxylascs belonging to the CYIl-fA t~\I11il)
v;hieh form subterminal and co-terminal hydroxycicosatetraenoic acids (lIFTh).
Together the products of these enzymes play an important role in regulating \'ascuiar
and homeostasis (Fleming, 2001). In these functions, the role

0

r l1Ul11an C Y P2C l)

tOIll'

appears

to be particularly critical since sulfaphanazole, a selective inhibitor of CYP2C9. inhibits
responses attributed to the endothelium-derived hyperpolarizing factor (EDIlF) and
potentiates nitric oxide mediated relaxation (Fleming, 2001). On the basis of these
',)hservations it has been suggested that CYP2C9 is the EDHF generating (,YP. I kl:CC.
our observation that mouse Cyp2c29 metabolizes 4-HNE suggests that in addition to
mediating or regulating NO/PGl2-indcpendent vasodilation, CYP2C9 and related forms
of P450 may have an important role in preventing oxidative injury. Altcn;ali\'ely.
competitive inhibition ofCyp2c29 by 4-HNE suggest that conditions associated wilh
high levels of oxidative stress and the gencration of lipid peroxidation products could
prevent or attenuate EDHF generation and thus compromise endothelium-depcndent
relaxation in coronary. mesenteric, and renal arteries. where ED! [}<'-mediakd responses
arc particularly critical. I-Ience, 4-HNE-dependent inhibition of CYP2C Corms could link
the development ofhypcrtcllsion with oxidative stress such as that associated with

atherosclerotic lesions formation. Clearly further physiological stu(Jics arc vvarrantcd to
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or reacti ve

understand fully the role of this and related CYP isolorms in the mctabolislll
carbony Is.

In addition to the metabolism of 4-HNF, we investigated the rok of lipid
aldehydes in regulating the expression ofxenobiotic metabolizing enzymes ill mouse
heart and liver by microarray and quantitative real-time PCR. Acrolein

lS

generated

ill

vivo from lipid peroxidation and is a prevalent environmental pollutant. C57BI./6 mice

were treated with acrolein by gavage or inhalation to mimic the natural routes

or acrolein

exposure in humans. A separate group of mice was also treated with HIlA for comparison
with the: acrolein exposure. In our micro array analysis of gene expression. we obserVl'd
differences in the magnitude of basal gene expression between control animals Crom
acrolein-treated group (chow diet) and the: BlIA-treated group (AIN-76/\ diet). It

ti1~

i~

possible that the diets caused the differences observed. To address this ambiguity. \Ve
conducted a principle component analysis ofthe two control groups. The control data
ii'om both sets of controls were normalized to a coml11on group of diagnostic genes and
then compared with the chronic acrolein and BH/\ treatments (Figure n). The genes ill
the BHA and acrolein treated groups separated into two difCerellt groups suggesting that
different genes were affected by the HIlA and acrolein treatment.
Several P450s were induced by 13HA in mouse livcr: Cyp I a2. ('yp7a l. ('yp2c2()
c

Cyp2c37. Cyp2c44, Cyp2c50 and Cyp5 L and acrolein: Cyp2c29, Cyp2c44. Cyp2c I and
Cyp2j6. Other studies have also shown that compounds that induce Nrf2 induce the
expression of some P450s. For example, in the study ofGST induction in CD-1 micc. P

1-

450 and P3-450 mRNA were induced 3-5-fold in the liver and intestine after 1311/\
treatment (Pearson et ai., 1(88). In addition. the cxpression o/" ('YP I :\. CYP3!\, CYP2B.

185

CYP4A and CYP39A was induced by the Nrf2 activator sulforafanc: (JIll e/ a/., 2004L
and Cypla2, Cyp2a4, Cyp2a12, Cyp3a13, and Cyp4aJO by 3H-L2-dithiole-3-thi(1I1e in
Nrf2- wild type, but not Nrf2 knock out mice (Kwak et 01.,2003). More recently. 4-1 INt·:
caused a 6-fold induction of CYP39Al in human colorectal carcinoma cells (West and
Marnctt, 2005). Even though these P450s are induced, it is widely known that the
promoter sequence of P450s does not contain an antioxidant element. the cis clement that
binds Nrf2 to induce gene expression. It is therefore evident that a ~eparate mechanism
exists for P450 induction by these compounds.
The glutathione S-transferases catalyze the conjugation of (~SI-I to elcctrophilic
compounds. BHA induced GSTa3. GSTmJ and GSTtL while GSTmi was induced by
acrolein. This corresponds with other studies that have determined this family of enzyme
to be induced by Nrf2-activating compounds (Thimll1ulappa et ClI., 20(2).
NADPH:quinone oxidoreductase L Heme oxygenase J and some members oCthe
aldehydle dehydrogenase and aldoketoreductasc f~lmily \\'ere also induced by both HI IA
and acrolein. Just like GSTs, these enzymes arc believed to be regulated by NrC? (Kvvak

et al., 2003: Thimmulappa et al., 2002).

My studies have provided the following observations related to Cyp2c29. (i) It
metabolizes 4-HNE; (2) Cyp2c29 mRNA is induced in mice liver by BHA and acrolein;
(3) Cyp2c29 protein is induced in mouse liver microsomes after 7 days of' HI !/\

treatment, and (4) BHA induced expression ofCyp2c29 in Nrf2 null mice. TransfCction
experiments with Cyp2c29-promoter luciferase reporter constructs indicated that
Cyp2c29 transcription was regulated by AP-l and not by the Nrfl tt'anscriptic)Jl j~lct()r.
Through a computer-based search of putative response elements and deletion analysis.
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the AP-l-dependent regulation of Cyp2c29 was mapped to a 30-hase pair region of the
Cyp2c20 promoter containing an AP-l response clement (TRE) li'om -1.23 8 to

-1.2~~(J.

This TRE responded to the expression of exogenous Fos and Jun as indicated by an
induction ofluciferase activity. Mutation of the core nucleotides of thc

TRI~

resulted in

the loss of luciferase activity. Surprisingly. when we mutated the '"OC" dinucleotide
which is immediately 5' of the Cyp2c29 TRE, we observed a 3-fold increase in lucifcrase
activity. This implies that the "GC" dinucleotide is not required f()r optimal induction of
Cyp2c29 by the AP-l transcription factors; in lact, they serve to negatively regulak
Cyp2c29 gene expression. Furthermore, qRT-PCR analysis was performed on samples
obtained from wild-type and Nrf2 ./. mouse liver. NADPH quinoJle oxidoreductase. hellle
oxygenase 1, and glutathione S-transferase were induced in the liver Ii'om B1IA-ICd llild·
fype mice liver and not in the liver from Nrf2'/' mouse liver. Conversely. Cyp2c.29 was

induced in the liver of wild-type BI-Jl\-fcd mice liver and further induced in BIIA·jed
Nrf2'/' mice liver. We conclude that while NAOPII quinine oxidoreductase. i1ellle
oxygenase 1, and glutathione S-transfCrase are predominantly regulated by the NrC-/\R!':
system. Cyp2c29 is most like regulated by AP-I. accounting for the further induction of
Cyp2c29 observed in Nrf2'/' mouse liver. As we have demonstrated. the cxpr.?ssioll
P450s in the liver is altered in response to compounds that cause the

ac~ivati()11

or

dr

transcription factor AP-l. During oxidative stress. when the levels of lipid aldehydes are
reported to be increased. this may also alter the levels or P450s being expressed. by
activating AP-l. Consequently, there could be differences in P450 acli\'ities in dilTcrent
organs resulting in alterations in the biosynthesis of biomolecules by the same P450s or
dit1erences in xenobiotie metabolism.
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In conclusion, P450s are lipid aldehyde metaholizing enzymes capable of
oxidative and/or reductive metabolism of 4-HNE and

9-antlm:lcl~ne

aldehyde. HilA am!

acrolein induce the expression of some P450s. For Cyp2c29, this induclion is t1lediated

by AP-I transcription factors, a mechanism not yet reported for any other P450s.

188

REFERENCES
Abu-Bakar,A., Satarug,S., Marks,G.C., Lang,M.A., and Moore.M.R. 2004. Acutc
cadmium chloride administration induces hepatic and renal CYP2A5 mRN A,
protein and activity in the mouse: involvement of transcription f~lctor NRF2
Toxicology Letters 148: 199-210.
Abu-Bakar,A., Lamsa,V., Arpiainen.S., Moore,M.R .. Lang,M.A .. and I Iakkola..l. 2007.
Regulation of CYP2A5 gene by the transcription factor nuclear factor (erythroid·
derived 2)-like 2. Drug Metabolism and Disposition 35: 787-794.
Alary) . , Bravais,F., Cravedi,.T.P., Debrauwer,L., Rao,D .. and Bories,G. 1995.
Mercapturic Acid Conjugates As Urinary End Metabolites of the LipidPeroxidation Product 4-Hydroxy-2-Nonenal in the Rat. Chemical Research in
Toxicology 8: 34-39.
Amunom,L Stephens,LJ., Conklin,DJ., Srivastava,S., Bhatnagar.A .. and Prough.R.A.
Several cytochromes P450 Are aldehyde monooxygenases. 12. 118-123. 2005.
Layafette, IN , U. Purdue Press. Enzymology and Molecular Biology of Carbonyl
Metabolism. Weiner, H.

Amunom,I., Stephens,L.J., Tamasi,V., Cai,J., Pierce. W.M .. Conklin.D.l. llatnagar,/""
Srivastava,S., Martin,M.V., Guengerich,F.P., and Prough,R.A. 2007.
Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes
I. Archives of Biochemistry and Biophysics 464: 187-196.
AngeLP., Baumann,I., Stein,B., Delius,H., RahmsdorLH.1., and lIe'TlichY. 1987. 12-0Tetradecanoyl-Phorbol-13-Acetate Induction of the Human Collagenase Gene Is
Mediated by An Inducible Enhancer Element Located in the 5 '-Flanking Region
Molecular and Cellular Biology 7: 2256-2266.
Awasthi,Y.C., Sharma,R., Cheng,J.Z., Yang,Y., Sharma.A., Singhal,S.S .. and AwasthiS
2003. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Mol.
Aspects Med. 24: 219-230.
Axelrod). 1955. The enzymatic deamination of amphetamine (benzedrine) . .r BioI.
Chern. 214: 753-763.
Beauchamp,R.O., Andjelkovich.D.A., Kligerman,A.D., MorganX.T., and Heck,H.D.
1985. A Critical-Review of the Literature on Acrolein Toxicity. ere Critical
Reviews in Toxicology] 4: 309-380.

189

Bcncdetti,A., Comporti,M., and Esterbauer,H. 1980. Identification of 4-Hydroxynoneal
As A Cyto-Toxic Product Originating from the Peroxidation of Liver T\'ticrosol11al
Lipids. Biochimica et Biophysica Acta 620: 281-296.
Berhane,K. and Mannervik,B. 1990. Inactivation of the Genotoxic Aldehyde Acrolein b)
Human Glutathione Transferases of Class-Alpha, Class-Mu, and Class-Pi.
Molecular Pharmacology 37: 251-254.
Black,S.D. 1992. Membrane topology of the mammalian P450 cytocilrol1lcs. F ASLB J. 6:
680-685.
Boon,P.J.M., Marinho,H.S., Oosting,R., and Mulder,G.J. 1999. Glutathionc conjugation
of 4-hydroxy-trans-2,3-nonenal in the rat in vivo, the isolated perfused liver and
erythrocytes. Toxicology and Applied Pharmacology 159: 214-223.
Boor,P.J. 1983. Allylamine Cardiotoxicity - Metabolism and Mechanism. Advances in
Experimental Medicine and Biology 161: 533-541.
Chauret,N., Gauthier,A., Martin,J., and Nicoll-Griffith,D.A 1997. In vitro comparison oj'
cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
Drug Metab Dispos. 25: 1130-1136.
Cheung,C., Akiyama,T.E., Kudo,G., and Gonza]cz,F.J. 2003. Hepatic expression of
cytochrome P450s in hepatocyte nuclear factor I-alpha (l INF I alpha)-deficient
mice. Biochemical Pharmacology 66: 2011-2020.
Chun,Y.J., Shimada,T., and Guengerich,F.P. 1996. Construction of a human cytochrome
P450 lAl: rat NADPH-cytochrome P450 reductase fusion protein cDNA and
expression in Escherichia coli, purification, and catalytic properties oCthe cnzyme
in bacterial cells and after purification. Arch. Biochem. Biophys. 330: 4g-Sg.
Cummings,S.W., Ansari,G.AS., Guengerich,F.P., Crouch,L.S .. and ProLlgh,R.A 1985.
Metabolism of 3-Tert-Butyl-4-Hydroxyanisole by Microsomal Fractions and
Isolated Rat Hepatocytes. Cancer Research 45: 5617-5624.
Davis,R.J. 2000. Signal transduction by the JNK group of MAP kinascs. Cell 1ll3: 230252.
de Zwart,L.L., Hermanns,R.C., MeermanJ.H .. CommandeurJ.N., and Vcrmeulen,N.J>.
1996. Disposition in rat of [2-3H]-trans-4-hydroxy-2.3-nonenaL a product of lipid
peroxidation. Xenobiotica 26: 1087-1100.
Dean, W.L. and Gray,R.D. 1982. Hydrodynamic properties oC monomeric cytochromes P450LM2 and P-450LM4 in n-octylglucoside solution. Bioehem. Biophys. Res.
Commun. 107: 265-271.
DeLozier,T.C., Tsao,C.C., Coulter,S.J., Foley,J., Bradbury,J.i\., Zeldin,D.C" and
Goldstein,l.A 2004. CYP2C44, a new murine CYP2C that metabolizes

arachidonic acid to unique stereospecific products. J. Pharmacol. Exp. Ther. 310:
845-854.
deZwart,L.L., Hermanns,R.C.A., Meerman,lH.N., Commandeur,J.N.M .. and
Vermeulen,N.P.E. 1996. Disposition in rat of [2-H-3]-trans-4-hydroxy-2,Jnonenal, a product of lipid peroxidation. Xenobiotica 26: 1087-1100.
l':ckl,P.M., Ortner,A., and Esterbauer,H. 1993. Genotoxic properties of 4-hydroxyalkenals
and analogous aldehydes. Mutat. Res. 290: 183-192.
EngeLK.H., Ramming,D.W., Flath.R.A., and TeranishLR. 1988. Investigation ofVolatilc
Constituents in Nectarines .2. Changes in Aroma Composition During Nectarinc
Maturation. Journal of Agricultural and Food Chemistry 36: 1003-1006.
Fstcrhauer,H., Schaur,R.J .. and Zollner,H. 1991. Chemistry and Biochemistry of 4HydroxynonenaL Malonaldehyde and Related Aldehydes. Free Radical Biolog:.'
and Medicine 11: 81-128.
Feng,Z.H., Hu,W.W., and Tang,M.S. 2004. Trans-4-hydroxy-2-nonenal inhibits
nucleotide excision repair in human cells: A possible mechanism for lipid
peroxidation-induced carcinogenesis. Proceedings of the National Academy of
Sciences of the United States of America 101: 8598-8602.
Fiala-Beer,E .. Lee.A.C.. and Murray.M. 2007. Regulation of the ral CYP4A2 gene
promoter by c-Jun and octamer binding protein-I. International Journal of
Biochemistry & Cell Biology 39: 1235-1247.
Fleming,I. 2001. Cytochrome P450 enzymes in vascular homeostasis. Circltlation
Research 89: 753-762.
Fraiser,L.H., Kanekal,S., and Kehrer).P. 1991. Cyclophosphamide ToxicityCharacterizing and Avoiding the Problem. Drugs 42: 781-795.
Fry,lR .. Fentem,lH., Salim,A., Tang,S.P.A., Garle.M.J., and Whiling.i).A. 1993.
Structural Requirements for the Direct and Cytochrome-P450··De)Jcndent
Reaction of Cyclic Alpha,Beta-Unsaturated Carbonyl-Compounds \vith
Glutathione - A Study with Coumarin and Related-Compounds. Journal of
Pharmacy and Pharmacology 45: 166-170.
Fujioka.K. and Shihamoto,T. 2006. Determination of toxic carbonyl compounds in
cigarette smoke. Environmental Toxicology 21: 47-54.
GJover,lN.M. and Harrison,S.c. 1995. Crystal-Structure ofthc IIeterodimcric Hzip
Transcription Factor C-Fos-C -Jun Bound to Dna. Nature 373: 257-261.
Goeptar,A.R., Tekoppelc,J.M., VanmaanenJ.M.S .. /oeternclk,C.E.M .. and
Vermeulen,N.P.E. 1992. One-Electron Reductivc Bioaetivmioll of2.3.5.(i-

191

Tetramethylbenzoquinone by Cylochromc-P4S0. Biochemical Pharl11ac()lo~y
343-352.

Ln.

GrahamLorence,S.E. and PetersonJ.A. 1996. Structural ali~~nments of P450s and
extrapolations to the unknown. Cytochromc P450, P', B 272: :115-:126.
Gregory,R.B. and Berry.M.N. 1991. On the thyroid hormone-induced increase in
respiratory capacity of isolated rat hepatocytes. Biochim. Biophys. ;\cta 1098: () J67.
Grune,T., Siems,W.G., and Petras,T. 1997. Identification of metabolic pathways of the
lipid peroxidation product 4-hydroxynoncnal in in situ perfused rat kidney.
Journal of Lipid Research 38: 1660-1665.
Cluj., Zhang,Q.Y., Genter,M.B., Lipinskas,T.W., Negishi.M., Nebcrt.D.W., and Ding.X.
1998. Purification and characterization of heterologously expressed mOllse
CYP2A5 and CYP2G 1: role in metabolic activation of acetaminophen and :2.6dichlorobenzonitrile in mouse olfactory mucosal microsomes. l Pharmacol. Exp.
Ther. 285: 1287-1295.
Guengerich,F.P. and Martin.M. 1999. Expression of P450s. Methods in Fnz)l11ology IOf):

x-yo
Guengerich.F.P. 2000. Pharmacogenomics of cytochrome P450 and other enzymes
involved in biotransformation of xenobiotics. Drug Devdopment Research 49: 4
16.
Gucngerich.F.P. 2004. Cytochrome p450: What have we learned and \\hat arc thc future
issues? Drug Metabolism Reviews 36: 159-197.
Guengerich,F.P. and Martin,M. V. 2006. Purification of cytochromcs P450: products oj'
bacterial recombinant expression systems. Methods Mol. Rio!. 320: 31-37.
Gueraud,F., Alary)., CosteeP., Debrauwer,L., Dolo,L., Pineau,l., and Paris,A. 1999.111
vivo involvement of cytochrome P450 4A f~lmily in the oxidative metabolism of
the lipid peroxidation product trans-4-hydroxy-2-nonenal. llsing PP AR :dphadeficient mice. Journal of Lipid Research 40: 152-159.
Hartley,D.P., Ruth)./\., and Petersen,D.R. 1995. The Hepatocellular Metabolism of 4Hydroxynonenal by Alcohol-Uehydrogena~;c. Aldehyde Dehydrogenase. and
Glutathione-S-Transferasc. Archives of Biochemistry and Biophysics 316: 1<)7205.
llartlcy,D.P., Ruth,lA.. and Petersen,D.R. 1995. The hepatocellular metabolism of' 4hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase. and
glutathione S-transftrase. Arch. Biochem. Biophys. 316: 1SO-205.

192

I [auptlorenz,S., EsterhauerJl, Moll, \V" Pumpel.R .. Schaucnstcin,E.. and PuschcnclorLB.

1985. Effects of the lipidpcroxiJation product 4-hydroxynonenal and related
aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells.
Biochem. Pharmacol. 34: 3803-3809.
Hayes,J.D. and McLellan,L.I. 1999. Glutathione and glutathione-dependent enzymes
represent a Co-ordinately regulated defence against oxidative stress. Frce Radical
Research 31: 273-300.
I layes,K.R., Volirath,A.L., Zastrow,G.M., McMilian,B.J., Craven.M" JO\'anovich.S ..
RankD.R., Penn,S., WaIisserJ.A., ReddyJ.K" Thomas,R.S., and Bradfield.C.;\.
2005. EDGE: A centralized resource for the comparison, analysis. and
distribution of toxi co genomic information. Molecular Pharmacology 67: 13601368.
I Ienly,D.C., PhillipsJ.W .. and Berry.M.N. 1996. Suppression of glycolysis is associaled

with an increase in glucose cycling in hepatocytes from diabetic rats . .r. Bioi.
Chem. 271: 11268-11271.
IIu,R., Hebbar,V., Kim,B.R., Chen,C., Winnik,B., Buckley,B., Sotcropoulos,P., ToliasY ..
Hart,R.P., and Kong,A.N.T. 2004. In vivo pharmacokinetics and regulation of
gene expression profiles by isothiocyanate sulforaphane in the rat. Journal or
Pharmacology and Experimental Therapeutics 310: 263-271.
llubatschJ., Ridderstrom,M., and Mannervik,B. 1998. Human glutathione lral1slCn~se
A4-4: an Alpha class enzyme with high catalytic eniciency in the conjugation or
4-hydroxynonenal and other genotoxic products of lipid peroxidation.
Biochemical Journal 330: 175-179 .
.iacksol1,J.P., Ferguson,S.S .. Moore,R., Ncgishi,M .. and Goldstein) .A. 200..1.. The
constitutive active/androstane receptor regulates phenytoin inductinn or Cyp2c2C)
Mol. Pharmacol. 65: 1397-1404.
Jaeksnn).P., Ferguson,S.S., Moore,R., Negishi,M., and Goldstein,.) .;\. 200"L The
constitutive active/androstane receptor regulates phenytoin induction of ('y]12c::9
2. Molecular Pharmacology 65: 1397-1404.
Jakoby,W.B. and Ziegler,D.M. 1990. The Enzymes of Detoxicatioll. Jound of
Biological Chemistry 265: 20715-20718.
Jurgens,G., Chen,Q., Esterbauer,H., Mair,S., Ledinski,G ...and .Dinges,Il.!)~ 1993.
Immunostaining of human autopsy aortas with antI hodles to moth fled
apolipoprotein Band apoprotein(a). Arterioscler. Thromh. 13: 16~9-16()c).
[(ahLR., Weinke,S., and KappusJI. 1989. Production of Reactive ()xyg~n Species Due to

Metaboiic-Activation of But'ylatcd Hydroxyaniso1c. Toxicology 59: 170-1 cn.

193

Karin,M. 1999. Tbe beginning of ,he end: I kappa 13 kinase (/KK) 'lOll NF-knp)Ja 1l
actIVatIOn. Journal of B iologi cili Chemistry 2 74: 27339-27342.

KliD, C. L., Vaz,A. D. N., and Coon,M, J. I 997. M elabo lie ae ti va 'ion of 'ran.H_ h vdro.w..'_
nonenal, a toxic Product of membrane lipid peroxidlltion lind inhihl'or ';('1'-15;)
cytochromes. Journal or !Jio/ogical ChcmislJy 272.- 22611-22(, Iii.

KWak,M.K., WakabayashiN, Itoh.K,

Motohas1Ji,H., Yamamoto,M., and KellsierJ. W.

2003. Modulation Orgene expression by cancer chemopreventive til'hiolelhlones
through the Keap I-Nrf2 pathway -Identification nf novel gene dusters fnr cell
survival. Journal of Biological Chemistry 278: 813 5-8145.
Lauren t,A., Perdu-DUrand,E., Alary J, Debrauwcr,L., and C ra\' edd.)'. 2(100. Meta ho Ii""

Of4-hYdroxynonena/, a cytotoxic Product of lipid peroxieiatioo, In rat prcei.sinll_
cutli ver slices. Toxicology Letlers J J4: 2 OJ -2 J4.

Levine, W.O. and Raza,H. 1988. Mechanism of AzorcJuction of
Dimethylammoazohenzclle y a - lVel
.

_"
. _,
,'d'
' R t L' . Nadph-Cy
to c1m)me_P_4) 0 RedUctdSl:
and Partially 'Punfied Cytoc b
11 ome_
' and Stimulation
,
,
1,
. and
P-450
- OXygen and Carboll-Monoxl C
Sensitivity
by~a~
Fmn

2, Drug Metabolism and DiSPOSitIOn 16: 441-448,

a,lO~.

I.I1C as, D. T.

. L. I. 1999. De>clines
during
c:mJi,:e.
and Szweda,
' , 'in mitochondrial
_al lla-k e'o rcspim'ion
g1u lara IC deh
vel ro gcnast.
. ,p es 0 f the Un itcd States [) f !\ mcnea
reperfusion: Age-depend en I lIlacl"
Proceedings
of the National Academy 0 SfClcnc

96' 6689-6693.

>

Lvan8s~ 'i~839,

.
. ' S hu'z G. lImesono,k.
1C.p' Beato,M"
Mangeisdorf,D.J., Thumme,
Mark,M, Hcrrhch,l"
Chamboo,p., cand ; ' H M. 1995. The
Blumberg,B., Kastner,.,.
h ?Nd Decade. Cell 83. j .
Nuclear Receptor Superfarmly -t e"
..
"
fC'Il'lined
D 1994
P -4-'iO and ,Model
Systems _
Great DIverslt) 0 " . .
Mansuy,.
. . Cytochromes
1\ lied
Chenltstry 66'
J . 7"7-744,
.J

d

Reactions, Pure and

PP

~.

J

I'

ct[""ltor PL}tCII1'

')003, hYPOXld
Ro e 0 a \, C
Xlang, SHand
",
CVP7
,M.gene
- 10
.
'. If 0-hcllmai
Mar en,1NY
" Fiala-Beer,E"
humanMlU
1 raj P
in, the
down-regu1at'lOn. of the
.,

J

loumal373:

r

Y<

669-680.

_ ,.' P G. 2003.4-

' 'S Grasso,E.,
Long.
'o,V"
1 Idehyde and 9-ant
Biphenya

and

(Jen aSl, ,. ,
b't '''tes for. I-It.
hmlJchydc.. tWI) nuorcsccnl
•
XenoblOltcJ
PUCCIOJ,.,
SU SId ,: 31:
'f)

MannI. "

,

L

' 'p RiccardLn"

. 'r s in rat and human.
450 enzyme activi Ie

.
'>roduct of lip,d

.

determmll1g P
_ '-hydroxynoncnal, ai, N 'Ufoblology at
~ W
M "A.In 1998,
Fou~m Alzhel'mer's dIseasl;;, , c
Markesbcry,
. 'R,
. andisLovell,
increased
t he brain
. .'

I~stabr()ok,

peroxldatJon,
.[') . ')J"epara1Iull dl
'
19'33-36,
[)V,,11974, ,1C,
,
C'l\ccr
k 1'. .
R
hAgmg ,
1
\..
"
't. j"'(\cril'atlon.d
.
1 Dresrmatol)
anc " r tract anci theIr
C 1d u
'A " Bur
.'C,dent
T " Prough,
Matsu ar~,
al fractions
0 f 10
mlcrosom
J,

",

1 II If

,

Res. 34:2196-2203.
Matsunaga,T., Watanabe,K., Yamamoto,!', Ncgishi,M., Gonzalez,FJ., and Yoshimura.!l.
1994. cDNA cloning and sequence of CYP2C29 encoding PASO M UT-2. a
microsomal aldehyde oxygenase. Biochim. Biophys. Acta 1 U~4: 299-30 I.
Matsunaga.T., Watanabe,K., Yamamoto,I., Negishi,M., Gonzalez.FJ., and Yoshimura.J1.
1994. Cdna Cloning and Seqllence of Cyp2C29 Encoding P-4S0-Mllt-2. A
Microsomal Aldehyde Oxygenase. Biochimica et Hiophysica !\ctil-Biocnergelics
1184: 299-301.
Matsunaga,T., Iwawaki,Y., Watanabe,K., Yamamoto,1., Kagcyama,T., and Yoshimura.lI.
1995. Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 is(vymcs
purified from hepatic microsomes of monkeys. Life Sci. 56: 2089-2095.
Matsunaga,T., Iwawaki, Y., Watanabe,K., Yamamoto,I., Kagcyama.T .. and YoshimuraJ I.
1996. Microsomal aldehyde oxygenase (MALDO): puritication and
characterization of a cytochrome P450 isozyme responsible for oxidation 01" 9anthraldehyde to 9-anthracenecarboxylic acid in monkey liver. J. 13ioche111.
(Tokyo) 119: 617-625.
Matsunaga,T., Tanaka,H., Komura,A., Watanabe,K., YamamotoJ., and YoshimuraJI.
1997. Microsomal alcohol oxygenase: purification and characterization
a
cytochrome P450 responsible for oxidation of 7-hydroxy-dclta xtetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol in guinea pig liver.
Arch. Biochem. Biophys. 348: 56-64.

or

;Vlatsunaga,T., Shibayama,K., Higuchi,S., Tanaka,H., Watanabc,K .. and Yamamoto.I.
2000. Characterization of microsomal alcohol oxygenase catctly;ring the oxidation
of 7-hydroxy-delta 8-tetrahydrocannabinol to 7 -oxo-dclta 8-tetrahydrocannabil1oJ
in rat liver. BioI. Pharm. Bull. 23: 43-46.
Maurice.M., Pichard,L., Daujat,M., Fabre.I.. Joyeux.H., DomergueJ .. ami Maurcl,P.
1992. Effects of imidazole derivatives on cytochromes P450 from human
hepatocytes in primary culture. FASEB J. 6: 752-758.
McCracken,E., Graham,D.I., Nilsen,Moo Stewart,J., Nicoll,JA.R .. and 1Iorsburgh.K.
2001. 4-hydroxynonenal immunoreactivity is increased in human hippocampus
after global ischemia. Brain Pathology 11: 414-421.
McWalter,G.K., Higgins.L.G., McLellan,L.I., Henderson,C.L Song,L..!., Thornallcy,P.L
ltoh,K., Yamamoto,M., and Hayes,J.D. 2004. Transcription faetor nn2 is essential
for induction ofNAD(P)H : quinone oxidoreductase 1. glutathione S-transkrases.
and glutamate cysteine ligase by broccoli seeds and isothiocyanates. Journal or
Nutrition 134: 3499S-3506S.

195

Meyer,R.P., Hagemeyer,C.E., Knoth.R., Kurz.G., and Volk.B. 2001. Oxidative
hydrolysis of scoparone hy cytochrome P450CYP2C29 reveals a novel metabolitc
1. Biochemical and Biophysical Research Communications 285: 32-39.
Miller,K.P. and Ramos,K.S. 2005. DNA sequence determinants of nuclear protein
binding to the c-Ha-ras antioxidant/electrophile response element in vascubr
smooth muscle cells: identification ofNrf2 and heat shock protein 90 beta as
heteroeomplex components. Cell Stress & Chaperones 10: 114-125.
Montine,K.S., Kim,P.J., Olson,S.J., Markesbery,W.R .. and MOlltinc,T.J. 1997.4hydroxy-2-nonenal pyrrole adducts in human neurodcgenerativc disease
3. Journal of Neuropathology and Experimental Neurology 56: 866-871.
Munsch,N., Recondo,A.M.D., and FRA YSSIN.C 1973. Effects of Acrolein on DnaSynthesis In-Vitro. Febs Letters 30: 286-290.
Narimatsu,S .. Watanabe,K., Matsunaga,T., Yamamoto,I.. Tmaoka,S., Funae.Y" and
Yoshimura,H. 1990. Cytochrome P-450 isozymcs in metabolic activation oj" delta
9-tetrahydrocannabinol by rat liver microsomcs. Drug Mctab Dispos. 18: 9~;3948.
Narimatsu.S., WatanabeX .. Yamamoto,!., and Yoshimura,II. 1991. Sex differcnce in the
oxidative metabolism of delta 9-tetrahydrocannabinol in the rat. Biochem.
Pharmacol. 41: 1187-1194.
Narimatsu,S., Watanabe.K., Matsunaga.T .. YamamotoJ .. Imaoka.S., Funal'.Y .. and
Yoshimura,H. 1992. Cytochrome P-450 isozymes involvcd in the o."iJative
metabolism of delta 9-tetrahydrocannabinol by liver microsome:.; of adult female
rats. Drug Metab Dispos. 20: 79-83.
Nebert,D.W., Adesnik,M., Coon,M.J., Estabrook,R.W., GonzaJcz.FJ., GuellgerichYY"
Gunsalus,I.C., Johnson,E.F., Kemper,B., Levin,W., PhillipsJ.lL S'lto,R .. and
Waterman,M.R. 1987. The P450 Gene Superfamily - Recommended
Nomenclature. Dna-A Journal of Molecular & Cellular Biology 6: 1-11.
Ncri,F., Mari,M., Menniti.A.M., and Brigati,S. 2006. Activity oftrans-2-hexcnal against
Penicillium expansum in 'Conference' pears. Journal of Applied Microbiology
100: 1186-1193.
Olef<;ky,lM. 2001. Nuclear receptor minireview series. Journal of Biological Chemistry
276: 36863-36864.
Omura,T. and Sato,R. 1964. The carhon monoxide-binding pigment uf liver microsomcs.
I. Evidence for its hemoprotein nature. J BioI. Chem. 239: 2370-2378.
PHppa,A.E., Kupfner,J.G .. and Vasiliou,V.K. 2000. Polymorphism and species
differences of the corneal ALDH3Al.Investigative Ophthalmology & Visual
Science 41: S873.

196

Parent,R.A.. Paust.D.E .. SchrimpLM.K .. Talaat.R,E .. Doane.R.A .. Caravello.! !.F,.
Lee.S.J., and Sharp.D.E. 1998. Metabolism and distribution or 12.3-C-I+ lacro!cill
in Sprague-Dawley rats - II. Identitication of urinary and fecal metabolites.
Toxicological Sciences 43: 110-120.
PateU.M., Wood,J.C., and Leibman,K.C. 1980. The Biotransformation of Allyl Alcohol
and Acrolein in Rat-Liver and Lung Preparations. Drug Metabolism ,md
Disposition 8: 305-308.
Pearson,W.R., Reinhart,1., Sisk,S.C., Anderson.K.S .. and Adler'p.N. 1988. TissucSpecific Induction of Murine Glutathione Transferase Messenger-Rnas b)
Butylated Hydroxyanisole. Journal of Biological Chemistry 263: 13324-13)3:~.
Peterson.F.J., HoltzmanJ.L.. Crankshaw.D .. and Mason,R.P. 1998, 2 Sites or Am
Reduction in the Monooxygenase System. Molecular Pharmacology 34: 597-()()J,
Picklo.M.J .. Montine,T..J., Amarnath.V .. and Neely.M.D. 2002. Carbon!'1 toxicology and
Alzheimer's disease. Toxicology and Applied Pharmacology 18-L 187-197.
Pinkus.R., Weiner.L.M., and Daniel, V. 1996. Role of oxidants and antioxidants in the
induction of AP-1, NF -kappa B. and glutathione S-transrcrase gcne expressioll
6. Journal of Biological Chemistry 271: 13422-13429.
Poli,G. and Schaur,R.J. 2000. 4-Hydroxynonenal in the pathomechanisl11s of oxidative
stress. JUBMB. Life 50: 315-321.
Prestera,T.. Talalay,P .. Alam,J., Ahn,Y.I.. Lee.P.L and Ch()i.AM,j~. 1995, Parallcl
Induction of Heme Oxygcnase-I and Chemoproteetivc Phasc-2 Ell/ymc:; b:
Electrophiles and Antioxidants - Regulation by Upstream Anlioxid,ll1l-I-:'espollsi\l:
Elements (Are). Molecular Medicine l: 827-837.
Ramana,K.V .. Bhatnagar,A., Srivastava.S .. Yadav.U.C.. Awasthi,S .. i\wasthi.Y.C .. and
Srivastava.S. K. 2006. Mitogenic responses of vascular smooth mllscle cells to
lipid peroxidation-derived aldehyde 4-hydroxy-tralls-2-11onenal (I iNI'): role or'
aldose reductase-catalyzed reduction of the lINE-glutathione conjugates in
regulating cell growth. J. BioI. Chem. 281: 17652-17660.
Ranganna,K., Hayes,B.E., Milton.S.G., and Yatsu,F.M. 2000. Acrolein activates
mitogen-activated protein kinase (MAPK) signal transduction pathways in rat
vascular smooth muscle cells (SMCs). Faseb Journal 14: A 1455.
R(·mmer.H., Greim,H., Schenkman).B., and Estabrook.R. W. 1967, Mcthm\s for the
elevation of hepatic microsomal mixed function oxidase levels Lind cytochrome F~
450. Methods in Enzymology 10: 703-708.
!(obinson-Rcchavi,M., CrUfcia,H.E .. and Laudet.V. 2003. The nuclear receptor
superfamily. Journal oC Cell Science 116: 585-586.

197

Robinson,MJ. and Cobb,M.H. 1997. Mitogen-activated protein kinase path\\ays. Current
Opinion in Cell Biology 9: 180-186.
Schell,MJ., Maurice,M., Stieger,B., and Hubbard,A.L. 1992. 5'nucleotidase is sorted to
the apical domain ofhepatocytes via an indircct route. J. Cell BioI. 119: 11731182.
Schneider,C., Tallman,K.A.. Porter,N.A., and Brash,A.R. 2001. Two distinct pathways ni'
formation of 4-hydroxynonenal. Mechanisms of non-en;:ymatic transformation 0"
the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. (vol 276. pg
2083 L 2001). Journal of Biological Chemistry 276: 32392.
Shinmura,K., Bolli,R., Liu,S.Q., Tang,X.L., Kodani.E., Xu an, Y.T .. Srivastava,S., and
Bhatnagar,A. 2002. Aldose reductase is an obligatory mediiltor o/'the late philSC
of ischemic preconditioning. Circ. Res. 91: 240-246.
Siems, W.G., Grune,T., BeierLB., Zollner,H .. and Esterbaucr,l I. 1992. The metabolism ,)t'
4-hydroxynonenal, a lipid peroxidation product, is dependent on tumor age in
Ehrlich mouse ascites cells. EXS 62: 124-13 5.
Siems,W.G., Zollner,H., Grune,T., and Esterbauer.H. 1997. Metabolic Llte ot' 4hydroxynonenal in hepatocytes: 1A-dihydroxynonene is not the main product.
Journal of Lipid Research 38: 612-622.
Si,,;s,ll. 1991. Oxidative Stress - from Basic Research to
Journal of Medicine 91: S31-S38.

Clinical-ApJ11ica~ion.

American

Silva,J.M. and Obrien,PJ. 1989. Allyl Alcohol-Induced and Acrolein-Induced Toxicity in
Isolated Rat Hepatocytes. Archives of Biochcmistry and Biophysics 275: 5~' 1558.
SLctLP. and Bayliss.M. 1996. Time for a consistent approach to preparing and culturing,

hepatoeytes? Xenobiotiea 26: 1-7.
Sladek,N.E. Metabolism and pharmacokinetic behavior of cyclophosphamide and
related oxazaphosphorines. 79-156. 1994. Anticancer nntgs' Reuctil'e
Metabolism and Drug Interactions.

Srivastava,S., Conklin,DJ., Liu.S.Q., Prakash,N., BoorY ..!.. Srivastava,S.K .. and
Bhatnagar.A. 2001. Identification of biochemical pathways for the mctabol ism o!'
oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in
vascular smooth muscle cells. Atherosclerosis 158: 339-350.
Srivastava,S., Conklin,DJ., Liu,S.Q .. Prakash,N., Boor,PJ., Srivasta\'a.S.K .. and
Bhatnagar,A. 2002. Identitication of biochemical pathways for the metabolisllI 0['
oxidized low-density lipoprotein derived aldchyde-4-hydroxy trans-2-l1ol1enaJ in
vascular smooth muscle cells. Atherosclerosis 158: 339-360.

198

Standford Research Institutc, International. Acrolein. Acrylic acid. 197'1). Directory
Chemical Procedures, United States of America, SRI International. 426

or

Steinhrecher,U.P., Zhang,H.F., and Lougheed,M. 1990. Role orOxidativdy Moditied
Ldl in Atherosclerosis. Free Radical Biology and Medicine 9: 155-16~.
Sueyoshi,T. and Negishi,M. 2001. Phenobarbital response elcments of cytochromc P45(J
genes and nuclear receptors. Annual Review of Pharmacology and Toxicology
41: 123-143.
Thimmulappa,R.K., Mai,K.H., Srisuma,S., Kensler,T.W., Yama111ato,1\1 .. and Bis\vaLS.
2002. Identification ofNrf2-regulated genes induced by the ehemoprcvcntiyc
agent sulforaphane by oligonucleotide microarray. Cancer Research ()2: 51 %5203.
Thomas,R.S., Rank,O.R., Penn,S.G., Craven,M.W., Drinkwater,N.Te and Bradtield.C.J\.
2002. Developing toxicologically predictive gene sets using cDN.1\ microarray~
and Bayesian classification. Cytochrome P45(), Pt C 357: 198-20.".
Thweatt,W.O., Harward,C.N., and Parrish,M.E 2007. Measurement or acrokin and 1.:1·
butadiene in a single puff of cigarette smoke using lead-salt tunabic diode laser
infrared spectroscopy. Spectrochimica Acta Part A-Molecular and Biol1lolccular
Spectroscopy 67: 16-24.
Llchida,K., Szweda,L.L Chac,H.Z., and Stadtman,E.R. 1993. Immunochcmical Delcction
of 4-Hydroxynonenal Protein Adducts in Oxidizcd lTepatocytes. Procecdings \li'
the National Academy of Sciences of the United States oLl\merica 90: x74:8746.
Uehida,K., Kanematsu,M., Morimitsu,Y., Osawa,T., Noguchi,N .. and Niki.E. 1l)9S.
Acrolein is a product oflipid peroxidation reaction - Formation or tl-ee acrolein
and its conjugate with lysine residues in oxidized low density lipoproteins
99 . .Tournai or Biological Chemistry 273: 16058-J 60M.
lLhidaX., Shiraishi,M., Naito,Y., Torii,y', Nakamura,Y.. and OsawaJ. J 9l)9.
Activation of stress signaling pathways by the end product of lipid pCl"O'\idatioll .
4-hydroxy-2-nonenal is a potential inducer of intraccllular peroxide production
14 . .TournaI of Biological Chemistry 274: 2234-2242.
Uchida,K. 2003. 4-Hydroxy-2-nonenal: a product and mediator or (lxidative stress
Progress in Lipid Research 42: 318-343.
Visser,A.J.W.G. and Muller,r. 1979. Absorption and Fluorescence Studies on NeUtral
and Cationic Isoalloxazines. Helvetica Chimica Acta 62: 593-608.
\Vasserman,W.W. and FahLW.E. 1997. Functional antioxidant responsive clements
3. Proceedings Of the National Academy of Sciences of the United States or
America 94: 5361-Y166.

199

Watanabe.K., Narimatsu,S., Yamamoto,!., and Yoshimura,H. 1991. Oxygenation
mechanism in conversion of aldehyde to carboxylic acid catalyzcd by a
cytochrome P-450 isozyme. 1. BioI. Chem. 266: 2709-2711.
Watanabe,K., Hirahashi,N., Narimatsu,S., Yamamoto,I., and Yoshimura,H. 1991. MOllse
hepatic microsomal enzyme that catalyzes oxidation of 11-oxo-delta xtetrahydrocannabinol to delta 8-tetrahydrocannabinol-ll-oic acid. Drug Metab
Dispos. 19: 218-221.
Watanabe,K., Kimura,J., Iwawaki,Y., Matsunaga,T .. Yamamoto. I.. and YO:ihimund I.
1994. Metabolic Reaction ofTolualdehydes by Microsomal Aldchyde Oxygcnase
(Maldo) in Lung. Japanese Journal of Toxicology and Envirollmcntal IIealth ,:)0:
11.
WatanabeX., Matsunaga,T., Yamamoto,!., and YashimuraJ-I. 1995. Oxidation of
tolualdehydes to toluic acids catalyzed by cytochrome P450-depclldent aldehyde
oxygenase in the mouse liver. Drug Metab Dispos. 23: 261-265.
WesU.D. and Marnett,L.J. 2005. Alterations in gcne expression induced by the lipid
peroxidation product, 4-hydroxy-2-noncnal. Chemical Research in Toxicology
18: 1642-1653.
Wiu.,G. 1989. Biological Interactions of Alpha,Beta-Unsaturatcd Aldehydes. J.'ree
Radical Biology and Medicine 7: 333-349.
Yang,Y., Sharma,R., Sharma,A., Awasthi,S., and Awasthi,Y.C. 2003. I,ipid peroxidalioll
and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated
signaling. Acta Biochim. Pol. 50: 319-336.
Yuan,X.L., XU,C.J., Pan,Z., Keum,Y.S .. Kim,LB., Shcn.G.X., Yu.S.W., Oo,K.T ..
Ma,J.J., and Kong,A.N.T. 2006. Butylated hydroxyanisole regulates AREmediated gene expression via Nrf2 coupled with ERK and .INK signaling pathway
in HepG2 cells. Molecular Carcinogenesis 45: 841-850.
Zhang,Q.Y., Dunbar,D., and Kaminsky,L.S. 2003. Characterization ofmousc small
intestinal cytochrome P450 expression. Drug Metabolism and Disrosition 31:
1346-1351.

200

APPENDIX

LIST OF ABBREVIATIONS

4-HNE: 4-hydroxy-2-nonenal
5' -FS: 5' -flanking sequence
9-AA: 9-anthracene aldehyde
9-ACA: 9-anthracenc carboxylic acid
l)-AMeOH: 9-anthracene methanol
A1"-1: activation function-1
AF-2: activation function-2
AIN76A: American institute of nutrition diet 76A
AP-1: activator portien 1
ALDH: aldehyde dehydrogenase
AR: aldose reductase
ARE: antioxidant response element
HI IA: butylated hydroxy anisole

CAR: constitutive androstane receptor

CPM: counts per minute
CYP: cytochrome P450
DHN: 1,4-dihydroxy nonene
D PLe: dilauroylphosphatidylcholine
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(iC/MS: gas chromatography-mass spectrometry

CiST: glutathione S-transferasc
CiS-fINE: glutathione conjugate of 4-HNE

HNA: 4-hydroxynonenoic acid
I IPte: high performance liquid chromatography
Kcap I: Kelch-like ECH-associated protein I
NA])PH: nicotinamide adenine dinucleotide phosphate, reduced Corm
NADPH:CYPOR: NADPH/cytochromc P450 oxidoreductase
NFkH: nuclear factor kB

P450: cytochrome P450
RNA: ribunucleic acid

SD: standard deviation
tf?: retention time

PXR: pregnane X receptor
peR: polymerase chain reaction

PPAR: peroxisome proliferator activated receptor
QRT-PCR: quantitative real-timc peR

RXR: retinoic acid receptor
TBHQ: tcrtiary butylated hydroquinone

TeA: trichloroacetic acid
TRE: TPA (l2-0-tetradecanoyl-phorbol-13 acetate) response e1cnll'lll
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